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Chapter 1 
GENERAL INTRODUCTION 
THE HUMAN GENOME 
The diploid human genome is contained in 23 chromosome pairs, together 
comprising about 6 χ 10' base pairs of DNA. Estimates about the number of 
expressed genes in humans vary from 50,000 to 100,000 (McKusick 1989). As 
the average size of structural gene sequences is in the order of 2 to 4 kb, this 
means that only a few percent of human DNA is coding for proteins or 
structural RNAs. The remainder of the DNA consists of single copy and 
repetitive sequences (Jelinek and Schmid 1982). Based on reassociation kinetics, 
visualized by C0t curves, it was calculated that approximately 50% of the 
human DNA is represented in single copy sequences. A small fraction of this 
DNA may have a regulatory or structural function, for the majority the 
function is unknown. The repetitive DNA fraction is found in low, middle and 
highly repetitive sequences, which occur as clustered and interspersed repeats 
(Jelinek and Schmid 1982; Moyzis et al. 1989). 
Clustered repeats of relatively short sequences mainly reside in centromeric 
and telomeric chromosome regions. These highly repetitive elements (>106 
copies per haploid human genome) may have structural functions. For example, 
the TTAGGG repeat found at human telomers is thought to play a role in the 
attachment of the chromosome to the nucleoskeleton (Allshire et al. 1989). 
Likewise, long tandem arrays of 170 base pair monomers, constituting as much 
as 5% of total genomic DNA, are found in the pericentromeric regions of 
chromosomes of primates and man. These so-called alpha satellite or alphoid 
DNA elements, which consist of middle repetitive DNA, are organized in 
chromosome specific higher order repeats (Waye and Willard 1987) that may 
define distinct nucleosome-phasing frames in the centromeric chromatin 
(reviewed by Vogt 1990 and Willard 1990). The identification of centromere 
specific proteins (CENP), one of which (CENP-B) is directly attached to 
alphoid DNA sequences, additionally points to specific protein-DNA 
interactions involved in the organization of the centromere (Willard 1990). 
The interspersed repeats found on all chromosomes can be divided into 3 
main classes: the short interspersed repeats (SINES), the long interspersed 
repeats (LINES) and the simple sequence motifs (SSMs). Among primates these 
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classes of middle repetitive sequences are conserved and homologous sequences 
can be found in other mammals as well. However, DNA analyses have 
indicated that, probably due to mechanisms like gene conversion and unequal 
crossover, these elements are evolving in concert, such that they are more 
similar to each other within one species than between species (Scott et al. 
1987). The most typical and predominant representatives of the SINES and the 
LINES are the Alu repeats (0.3 kb sized monomer) and the Kpnl or LI repeats 
(6.4 kb sized monomer), respectively. The Alu family accounts for about 3-
6% of the human genome, which corresponds to a copy size of approximately 
9x10s per diploid genome (reviewed by Jelinek and Schmid 1982; Kariya et al. 
1987). Most Alu sequences are flanked by direct repeats, unique to each Alu 
sequence. Similar to direct repeats flanking bacterial transposons and other 
eukaryotic mobile elements, these direct repeats may have resulted from the 
duplication of a unique sequence at the target site of the insertion of the Alu 
element. The dispersion mechanism of Alu repeats is probably related to that of 
transposons (Jelinek and Schmid 1982). An alternative mechanism is 
comparable to that used by retroviruses. An RNA polymerase III promoter is 
present in Alu family members and those sequences may originate from 
defective 7SL RNA molecules, which have been reversely transcribed and 
inserted in the genome (Ullu and Tschudi 1984). For the Kpnl family, the copy 
number has been calculated to be at least 104 per diploid genome (Hwu et al. 
1986; Scott et al. 1987) of which the majority exist as 5' truncated copies of 
the basic repeat. Most repeats have a poly (A) tail at the 3' end (Scott et al. 
1987). The parental copies of the Kpnl repeats contain two long conserved 
open reading frames, of which the 3' open reading frame has (weak) homology 
to the polymerase domain of various reverse transcriptases (Rogers 1986; Scott 
et al. 1987). The members of the SSM family consist of repeats of short 
stretches of mono-, di- and trinucleotides. The (CA)n/(TG)n-motif is the most 
common among eukaryotes with an estimated copy number of about 100,000 
per diploid genome for humans (Sun et al. 1984; Tautz and Renz 1984). Most 
likely, these motifs have been generated by slippage of the DNA polymerase 
during replication (Tautz et al. 1986), although unequal crossover has been 
postulated as well (Litt and Luty 1989). More data on the nature and variability 
of these SSMs are presented on pages 25 to 28. 
In reviewing these data one might get the impression that the human genome 
is a random mixture of repeats and unique sequences with no apparent 
organization at all. Recent analysis with highly sophisticated molecular 
cytogenetic techniques has revealed that this conclusion is entirely false 
(Korenberg and Rykowski 1988) and that there is a characteristic ordering of 
distinct sequence elements, which is reflected in the Giemsa-banding pattern 
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observed on metaphase chromosomes. The Giemsa-positive bands contain pre-
dominantly (A+T)-rich DNA, DNA contained in the pachytene chromomeres, 
early condensating and late replicating DNA, the LINES and only a small 
portion of the genes (Korenberg and Rykowski 1988; Bickmore and Sumner 
1989). The opposite is found for the G-negative bands (the Reverse bands or R 
bands), which contain (C+G)-rich DNA, the interchromomeric regions and late 
condensating and early replicating DNA. The SINES and most of the genes are 
present in these bands (Korenberg and Rykowski 1988; Bickmore and Sumner 
1989). The relation between R bands and SINE repeats is particularly evident 
in chromosomes 17, 19 and 22, which are the most intensely R banded 
chromosomes and also the most densely seeded with Alu repeats (Korenberg 
and Rykowski 1988). If all interspersed repetitive sequences were randomly 
distributed, then the average spacing would be about 3 kb. However, local 
regions of "preference" or "exclusion" of integration, reflected in the banding 
pattern, lead to regions with higher density of either Alu or Kpnl repeats 
(Moyzis et al. 1989). The clustering of genes into areas with higher (C+G)-
content can be partly explained by the discovery of stretches of DNA, which 
are rich in (unmethylated) CpG dinucleotides. These so called CpG islands are 
associated with the S' region of housekeeping genes and many tissue specific 
genes. Clusters of CpG dimers, therefore, are an indication for the presence of 
expressed sequences (Bird 1980, 1986; Gardiner-Garden and Frommer 1987). 
Much of the currently available evidence supporting this biphasic organization 
of the genome has been obtained by randomly characterizing the properties of 
the DNA present in G-positive or G-negative bands. This model is much too 
simple, however, to explain the overall architecture of the human genome. 
Until now, only a minor fraction of the genome has been studied in some detail 
and moreover, the model does not provide a molecular explanation for 
chromosome banding. It is therefore clear that the actual picture will become 
increasingly complex as more genomic regions are studied with respect to the 
distribution, nature and organization of genes, single copy and repeat elements. 
GENOMIC INSTABILITY 
The eukaryotic genome is not in a stable state, but is subject to all kinds of 
changes. In fact, genetic variability is one of the basic phenomena of life. The 
cause of a mutation may be either spontaneous or induced. The latter changes 
in the DNA are associated with exogenous factors like genotoxic agents or 
ionizing radiation. Mutations can lead to microscopically visible chromosome 
alterations (e.g., numerical aberrations, translocations, deletions and 
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duplications) and to small sized changes, which are only detectable at the DNA 
level. The effect of the mutations on the phenotype can be neutral or, if 
expressed sequences are involved, detrimental to normal functioning at the 
biochemical, cellular or physiological level. Germ cell mutations then lead to 
genetic or inherited disorders, somatic mutations often to cancers (Vogel 1990). 
The molecular basis of mutation is, however, only poorly understood. Many 
of the mutations are thought to result from copy errors or slippage during DNA 
replication and/or failure of the repair machinery, resulting in small sized DNA 
variation (Vogel 1990). Among those genes studied for mutations, the globin 
gene is the most extensively examined and can serve to illustrate the molecular 
mechanisms involved. Analysis of the more than 100 variants of the jff-globin 
genes now identified from patients with (S-thalassemia has shown an almost 
random distribution of point mutations across the gene, although there seems to 
be a preference for certain single base alterations. The most common mutations 
involve CpG to TpG (or CpA), which are thought to result from deamination of 
5-methylcytosine (Cooper and Youssoufian 1988). 
Abnormal recombination is another source of mutation, which causes mainly 
deletions and duplications. Again, the globin cluster provides a number of 
examples. The jS-globin gene contains a nearly perfect duplication of 10 
nucleotides in codons 91-94 and in codons 96-98. Misalignment and subsequent 
crossover of these sequences may result in a deletion (-» hemoglobin Gun Hill) 
or duplication of codons 91-95 (reviewed by Gelehrter and Collins 1990). The 
same principle underlies larger deletions as well. The most common type of a-
thalassemia results from the loss of the a2 globin gene, due to unequal 
recombination between regions with more than 90% homology that include and 
surround the a2 and αϊ globin genes (reviewed by Fodde 1990). Yet, as not all 
deletion breakpoints are found at regions with high homology, illegitimate 
recombination or pairing at interspersed repeats may also play a role. AIu-Alu 
recombination, for example, was first described as an explanation for both a 
deletion (Lehrman et al. 1985) and a duplication in the low density lipoprotein 
receptor (LDLR) gene (Lehrman et al. 1987). Subsequently, the breakpoints of 
the (act)** deletion at the a-globin cluster were also found to have occurred 
between two copies of Alu repeats (Nicholls et al. 1987). Deletions involving 
the STS gene were reported to result from recombination between low 
repetitive elements, detected by probe pCRI-S232 (Yen et al. 1990). In 
contrast, 8 deletion junctions in the β globin gene, characterized by Henthorn et 
al. (1990), were not found within an Alu-repeat. Comparing all available data 
on deletion breakpoints in the β- and a-globin cluster revealed that the 
frequency of /3-globin deletion breakpoints in Alu- or KpnI-repeats was not 
significantly different from that expected by chance. Breakage in the /S-globin-
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cluster seems to occur most frequently within transcribed units. In contrast, 
breakage in the a-globin cluster does occur preferentially in Alu-repeats 
(Henthorn et al. 1990). Thus, multiple mechanisms exist for the generation of 
deletions in the human genome and the proneness to undergo genuine or 
illegitimate recombination may be clearly locus dependent. A role for nuclear 
DNA topology has been proposed to explain the clustering of deletion 
breakpoints (hot spots of recombination). Often, simple sequences with the 
potential to cause conformational discontinuities, such as Z-DNA, have been 
found at recombination breakpoints (Shen et al. 1981; Freund et al. 1989; 
Holliday 1989). Clustering has been observed in the a- and /3-globin clusters 
(Shen et al. 1981) and in the dystrophin gene (Koenig et al. 1987; Blonden et 
al. 1989). Non-homologous recombination does not only underlie deletions, but 
most likely also chromosomal translocations and the integration and excision of 
viral sequences and transposable elements (Henthorn et al. 1990; Boehm et al. 
1989; Holliday 1989). 
FORWARD AND REVERSE GENETICS 
Monogenic disorders 
Based on the various modes of inheritance, genetic disorders can be divided 
into three groups: 
- monogenic disorders 
- polygenic disorders 
- chromosomal aberrations 
In this thesis I will only deal with one example of the group of monogenic 
disorders, namely myotonic dystrophy (DM; see chapter 2). Despite the 
enormous variety of disease types, monogenic disorders have in common that 
they all are caused by single gene defects and are inherited in a Mendelian 
fashion. Depending on the location of the causative gene and the actual effect 
of the mutation involved, the disorders are classified as either autosomal 
dominant, autosomal recessive or X-linked. To date, the list of monogenic 
disorders comprises some 4,500 different entries (McKusick 1990). A small 
subgroup of 22 disorders (listed in table 1; updated from Ropers et al. 1988) 
accounts for approximately 75% of all disease causes. As the combined 
incidence of the entire group is only 1%, most monogenic disorders are rare 
(McKusick, 1990). 
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Disorder Incidence Chromosomal Mode of 
(per IO4 births) Location Inheritance 
Familial hypercholesterolemia 
(LDL-receptor deficiency) 
Adult polycystic kidney disease 
Huntington disease 
Neurofibromatosis 
Myotonic dystrophy 
Polyposis coli 
Osteogenesis imperfecta 
Tuberous sclerosis 
Marfan syndrome 
Hemochromatosis 
αϊ-antitrypsin deficiency 
Cystic fibrosis 
Phenylketonuria 
Adrenogenital syndrome 
(21-hydroxylase deficiency) 
Glycogen storage disease III 
Spinal muscular atrophy 
Fragile X mental retardation 
Duchenne muscular dystrophy 
X-linked ichthyosis 
Hemophilia A 
Hemophilia В 
Adrenoleukodystrophy 
20 
8 
5 
4 
2 
1 
0.5 
0.5 
0.2 
10 
7 
4 
1 
1 
1 
0.5 
5 
2 
1 
1 
0.2 
0.2 
19pl3.2-13.1 
16pl3 
4pter 
17qll.2 
19ql3.2-13.3 
5 
7q21.3-22.1 
9q34 
15ql5-q21.3 
7p21.3 
14q32.1 
7q31-32 
12q22-24.2 
6p21.3 
-
5qll.2-13.3 
Xq27 
Xp21.3-21.1 
Xp22.32 
Xq28 
Xq26.3-27.1 
Xq28 
Dominant 
Dominant 
Dominant 
Dominant 
Dominant 
Dominant 
Dominant 
Dominant 
Dominant 
Recessive 
Recessive 
Recessive 
Recessive 
Recessive 
Recessive 
Recessive 
X-linked 
X-linked 
X-linked 
X-linked 
X-linked 
X-linked 
Table 1: Frequent monogenic disorders 
To identify and isolate genes involved in monogenic disorders two general 
strategies can be applied. The classical forward approach aims at the 
identification of a specific metabolic abnormality from which the fundamental 
biochemical defect can be deduced. Isolation of the respective protein, usually 
an enzyme, then forms the basis for the isolation of the gene involved. This 
approach has been successfully applied to diseases like the Lesch-Nyhan 
syndrome (HPRT deficiency), phenylketonuria (phenylalanine hydroxylase 
(PAH) deficiency), hemophilia A (Factor VIII deficiency) and familial 
hypercholesterolemia (LDLR-deficiency; reviewed by White and Caskey 1988). 
If metabolic and biochemical clues are not available, other approaches, 
involving "reverse genetics" or, more appropriately called, "positional cloning" 
16 
strategies have to be applied. According to this concept, linkage studies in 
families are employed to precisely map the disease gene in a specific 
chromosomal region (Orkin 1986). Advanced molecular mapping and cloning 
techniques are then used to isolate candidate genes from the implicated region. 
In the absence of any structural chromosome aberration, the identification of 
the causative defect in a gene of unknown structure, situated in a region that 
may be many millions of bases in size, may be very tedious indeed. Ultimately, 
however, the complete characterization of the candidate genes and their 
products will inevitably lead to the elucidation of the biochemical disturbance 
involved. In these studies, the identification of structure-function relationships 
from protein or DNA databank searches is becoming increasingly important. 
Mapping of monogenic disorders 
Sometimes it is possible to infer the chromosomal location of a gene 
underlying a monogenic disorder from specific chromosomal aberrations that 
are found associated with the disease. If the same chromosomal region is 
involved in several patients with the disorder in question, then the site of the 
alteration is the site where the gene must reside. Once this site has been 
accurately defined, prospects of cloning the respective gene improve 
significantly. This approach was successfully applied for the localization and 
isolation of a large number of disease associated genes like those involved in 
Duchenne muscular dystrophy (DMD; Monaco et al. 1986; Koenig et al. 1987; 
Burghes et al. 1987), X-linked chronic granulomatous disease (Royer-Pokora et 
al. 1986), retinoblastoma (RB; Lee et al. 1987) and Wilms tumour (Call et al. 
1990; Gessler et al. 1990), colon carcinoma (Fearon et al. 1990), neuro-
fibromatosis I (Wallace et al. 1990; Viskochil et al. 1990; Cawthon et al. 1990; 
Xu et al. 1990), choroideremia (Cremers et al. 1990) and the fragile X 
syndrome (Verkerk et al. 1991). In case of Alport (Hostikka et al. 1990; 
Barker et al. 1990) and Hunter syndrome (Wilson et al. 1990) candidate genes 
were isolated by the strategy of forward genetics, but the assignment of the 
respective genes (type IV collagen a5 and iduronate-2-sulfatase) to the 
"correct" chromosomal regions (Xq22 and Xq28) provided strong additional 
evidence for the fundamental involvement of these genes. 
Whenever there are no detectable cytogenetic anomalies, linkage analysis has 
to be performed. In linkage analysis the fact is used that neighboring genes and 
genetic markers are transmitted together as part of chromosomal segments. 
Once linkage is established, then the map position of the disease gene can be 
inferred from the chromosomal location of markers, which cosegregate with the 
disease phenotype. These markers need to be polymorphic to discern the 
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chromosome segment carrying the gene defect from the corresponding segment 
on homologous chromosomes carrying the normal gene. The use of functionally 
neutral genetic markers to trace the segregation of disease loci in families was 
first proposed by Haldane in 1927. Throughout the last decades a number of 
marker systems have been developed for this purpose. The first were 
phenotypic traits or protein markers, like hair color, blood groups, isoen-
zymes, HLA determinants as well as chromosome banding polymorphisms 
(reviewed by Vogel and Motulsky 1986). The number of these polymorphic 
systems is, however, by far not large enough and moreover their distribution is 
not homogeneous enough to cover each chromosomal segment (Gusella 1986). 
A major breakthrough was the application of recombinant DNA technology to 
identify polymorphisms in the nucleotide sequence of the DNA (Grodzicker et 
al. 1974; Kan and Dozy 1978, see also pages 23 to 35). The frequency of 
nucleotide variants in the human genome is sufficiently high to generate 
markers for each genetic locus. Initially, it was postulated that a number of 
150-200 equally spaced markers would be adequate to establish a map with 10 
cM intervals (Gusella 1986). However, randomly isolated markers are not 
equally spaced nor optimally informative, which means that in practice many 
more markers will be needed to construct a linkage map of the desired density. 
Apart from their genetic distance to the gene of interest, the value of markers 
is dependent on their informativity, indicated by their "polymorphism 
information content (PIC)" (Botstein et al. 1980), which depends on die number 
of alleles and their respective frequencies. If a marker and a disease locus are 
closely linked then the chance of a crossover between the two loci is small and 
the number of misclassifications (and diagnostic errors) resulting from 
dissociation of the marker and the disease gene will be limited. For closely 
linked markers, genetic distances, which are expressed in centimorgans (cM), 
are equal to the percentage of recombination events. The determination of 
genetic distances is a statistical evaluation of family data, which means that for 
each genetic distance a likelihood, the so-called lod score, is given. Two of the 
most commonly used programs to test for linkage and calculate lod scores are 
the LIPED (Ott 1976) and LINKAGE programs (Lathrop and Lalouel 1984). 
An update of all disease loci mapped and refinements of their map position are 
given each year in the reports of the International Workshops on Human Gene 
Mapping (HGM). Many dozens of diseases have been mapped by the genetic 
linkage approach, among which are well known examples, like Huntington 
disease (HD), adult polycystic kidney disease (PKD1), myotonic dystrophy 
(DM), cystic fibrosis (CF) (Report of HGM10) and, recently, facioscapulo-
humeral muscular dystrophy (FMD; Wijminga et al. 1990). 
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Physical fine mapping 
Thus, by performing two- or multipoint linkage and haplotype analysis, one 
can position the causative mutation of a disease between two closely flanking 
crossovers that define the smallest relevant chromosomal segment. To 
characterize this region further, physical fine mapping is required. Apart from 
analyzing specific cytogenetic anomalies, as mentioned above, physical maps 
ranging from 1 to 100 megabases can be generated by using somatic cell 
hybrids, and maps spanning from 10 bases to 2 megabases can be obtained by 
(long range) restriction enzyme mapping. Somatic cell hybrids result from 
fusion of human and rodent cells. Upon continuous passage in culture, these 
hybrids tend to lose many human chromosomes. A specific gene or a marker 
can then be mapped on a panel of such hybrids by correlating the presence of 
individual chromosomes with that of the gene or the marker. More detailed 
subchromosomal localization can be achieved by constructing somatic cell 
hybrids containing cytogenetically defined translocation chromosomes (Wieacker 
et al. 1984; Schonk et al. 1989) or chromosome fragments. For the generation 
and transfer of chromosome fragments different methods have been developed, 
e.g., the irradiation and fusion gene transfer (IFGT; Goss and Harris 1975) and 
chromosome mediated gene transfer (CMGT; McBride and Ozer 1973). In the 
original IFGT experiments, human lymphocytes were lethally irradiated and 
transferred to a recipient hamster cell line (Goss and Harris 1975). However, 
the hybrids generated, contained fragments of multiple chromosomes. The use 
of somatic cell hybrids containing only a single human chromosome avoids this 
problem, although multiple fragments may still be present in the hybrids 
(Benham et al. 1989; Schonk et al. 1989). The problem of chromosome 
rearrangements is even more serious in CMGT. In this method (McBride and 
Ozer 1973), purified metaphase chromosomes are transferred to recipient cells 
in the presence of calcium phosphate and chromosome fragments are 
incorporated in the genome of the recipient cell. After selection for appropriate 
genetic markers, cells with specific chromosome segments can be isolated 
(reviewed by van Duin 1988). Presence or absence of specific chromosome 
segments in somatic cell hybrids can be monitored by determining the 
expression of enzymes or cell surface markers, by Southern blot analysis or by 
in situ hybridization, as exemplified on chapter 2 for chromosome 19 markers. 
For an extensive review on this matter see the thesis of Schonk (1991). 
Resolution of the physical map can be further improved by electrophoresis of 
restriction enzyme fragmented DNA on agarose gels. Until a few years ago the 
restriction enzymes available and the electrophoretic conditions used limited the 
size of these maps to the 0.01-30 kb range. The introduction of pulsed field gel 
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electrophoresis (PFGE) by Schwartz and Cantor (1984) together with the 
availability of restriction enzymes, which cut infrequently in the human 
genome, now allows the construction of maps up to 2 Mb in size. In PFGE the 
separation of molecules in a switching electric field is based on the rate at 
which these molecules alter their shape inside the gel matrix, which is highly 
size-dependent. Further improvement of the PFGE technology to obtain 
satisfactory results in the 50 to 2,000 kb size range was achieved through Field 
Inversion Gel Electrophoresis (FIGE; Carle et al. 1986), Contour-clamped 
Homogeneous Electric Field electrophoresis (CHEF; Chu et al. 1986) and 
Trans-Alternating Field Electrophoresis (TAPE; Gardiner et al. 1986). Details 
on the entire procedure concerning the preparation and digestion of the DNA 
and the subsequent electrophoresis and blotting have been described by van 
Ommen and Verkerk (1986) and Sambrook et al. (1990). The average size of 
fragments generated by restriction enzymes is dependent on the length and the 
sequence of the recognition site. For long range restriction mapping, enzymes 
with 6 or 8 basepair recognition sequences are used, most of which contain one 
or two of the relatively rare and frequently methylated CpG dimers. Since 
many of these enzymes do not cleave CpG-methylated DNA, the lengths of the 
resulting fragments will depend on the frequency of these CpG dimers and their 
methylation status in the respective chromosome region. In CpG rich regions, 
fragments can be rather small, even using these enzymes (Smeets et al. 1990, 
see appendix 5) and methylation-induced partial digests can be a complicating 
factor in long range restriction mapping (Smeets et al., unpublished 
observations). 
Cloning of genes 
The construction of a detailed physical map provides a framework in which 
new polymorphic and non-polymorphic markers can be positioned. Ultimately, 
the entire chromosomal region of interest has to be screened extensively for all 
expressed sequences that may be considered as candidate genes. Expressed 
sequences are only a minority of the unique sequence DNA and are not easily 
identified in genomic DNA. A number of strategies have been developed to 
solve this problem, either based on sequence features that are common to many 
genes at the DNA level (Bird 1986; Gardiner-Garden and Frommer 1987) or 
on the processing of these sequences during transcription and translation. 
Common to most gene clusters is the presence of a CpG island at the 5' end 
(Bird 1986; Gardiner-Garden and Frommer 1987), many of which can be 
recognized by restriction enzymes with a CpG motif in their recognition site. 
Lindsay and Bird (1987) tested the potential of restriction enzymes in detecting 
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gene associated CpG islands. Sites for the enzymes EagI, SacII and BssHII 
were present in each HTF island and 74% of these sites were located in an 
HTF island. So, by screening genomic DNA for clustering of cleavage sites of 
these enzymes one has a good chance of identifying gene associated regions. A 
second hallmark for expressed sequences is their evolutionary conservation. On 
"Zoo-blots", which contain DNA of several unrelated species, conserved 
sequences can be easily identified by the presence of hybridization signals in 
multiple lanes (Page et al. 1987). Because repetitive elements are usually not 
shared between distantly related species, it is often possible to use entire phage 
or cosmid clones in these cross-species hybridization experiments (Rommens et 
al. 1989). Conserved DNA sequences are tested for being expressed either by 
screening Northern blots or cDNA libraries, or by sequence analysis to identify 
open reading frames (Rommens et al. 1989). Homology between genes or 
functional domains of genes can be used to detect new members of gene 
families, as can be illustrated the rapidly expanding families of collagen, 
homeobox, Zn-fmgers, metalloprotease, and serine-tyrosine kinase genes. 
Methods for the cloning of transcribed sequences are based on the 
characteristics of the splicing mechanism. Oligonucleotides, hybridizing to 
consensus splice site sequences, have been used to identify human hnmRNA in 
somatic cell hybrids (Liu et al. 1989). Another method, called the exon trap 
method (Auch and Reth 1990) tests the actual splicing of DNA, cloned in a 
retroviral expression vector. 
The approach of cloning disease causing genes from the chromosomal region 
between two closely flanking crossovers has been successfully applied to the 
identification and isolation of the genes involved in CF (Kerem et al. 1989; 
Riordan et al. 1989; Rommens et al. 1989) and in familial hypertrophic 
cardiomyopathy (Tanigawa et al. 1990; Geisterfer-Lowrance et al. 1990). 
Especially, the methodology reported for the cloning of the CF gene and the 
identification of the gene defects are a paradigm for the reverse genetics 
strategy. 
DNA POLYMORPfflSMS AS GENETIC MARKERS 
Isolation of DNA probes 
A large variety of vector systems is available for the cloning of DNA 
fragments. Plasmids, phages, cosmids (Sambrook et al. 1989), Yeast Artificial 
Chromosomes (YACs; Schlessinger 1990) or PI (Sternberg 1990) vectors differ 
from each other with respect to the size limits of clonable DNA fragments, 
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ranging from several kb for plasmids up to several 100 kb for YACs and PI 
Plasmids. To facilitate the isolation of probes from distinct chromosomal 
regions, the DNA can be enriched prior to cloning by using flow sorted 
chromosomes (Fuscoe et al. 1986) or somatic cell hybrids (Schonk et al. 1991), 
by subtractive cloning using a phenol-enhanced reassociation technique (PERT; 
Kunkel et al. 1985), by coincidence hybridization (de Jong et al. 1990) or 
microdissection of chromosome regions (Lüdecke et al. 1989). Size 
fragmentation for library construction can be obtained by using rare cutting 
enzymes, as an alternative to partial cleavage with frequently cutting enzymes, 
like Haelll and Sau3A. To isolate randomly anonymous or expressed sequences 
that may serve as genetic markers or physical demarcation points, special 
emphasis must be directed to the removal of repetitive DNA elements that can 
obscure signals in routine Southern blot analysis. Alternatively, probes 
containing repetitive elements can be used directly following pre-hybridization 
with an excess of unlabeled genomic competitor DNA to improve signal to 
background ratios. The isolation of new clones at some distance from a starting 
probe has become feasible by the construction of linking and jumping libraries 
(Collins et al. 1987). 
The implementation of PCR-mediated DNA amplification has further 
improved our ability to isolate DNA segments from various sources such as 
blood (Saiki et al 1988), somatic cell hybrids or isolated chromosome 
preparations (Cotter et al. 1990) and has obviated the need of constructing 
libraries. As the majority (>80%) of the inter-Alu sequences is single copy 
(Cotter et al. 1990), primers directed to the human Alu repeat element (Nelson 
et al. 1989; De Jong et al. 1989) can be employed to generate random human 
specific DNA fragments from complex DNA sources. In the original paper by 
Nelson et al. (1989) Alu-PCR was applied for the isolation of human X-
chromosome probes from human/rodent hybrid DNA and YAC DNA, for the 
fingerprinting of somatic cell hybrids and YACs and for the isolation of the 
end-fragments of cloned DNA by using Alu and vector primers. These initial 
experiments were repeated by several other groups for the isolation of probes 
from chromosome 5 (Cotter et al. 1990), from chromosome 10 (Brooks-
Wilson et al. 1990) and from band Xq28 from the X chromosome (Ledbetter et 
al. 1990). For segments to be amplified, the Alu primers need to be 
complementary to the highly conserved Alu consensus sequence and need to be 
located close to the ends of this sequence (Nelson et al. 1989). For example, 
the Alu primers, used by Cotter et al. (1990) and Brooks-Wilson et al. (1990), 
are designed such that they strongly reduce the amount of Alu sequences in the 
PCR fragments. Co-amplification of rodent sequences can be avoided (Nelson 
et al. 1989; Brooks-Wilson et al. 1990), because Alu repeat elements are less 
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well conserved between species, than within the human species (Jelinek and 
Schmid 1982). The chromosomal mapping of Alu PCR probes can be done 
extremely fast by hybridization the clones to Alu-PCR-amplified somatic cell 
hybrids (Brooks-Wilson et al. 1990). Ledbetter et al. (1990) showed that 
primers hybridizing to other interspersed repetitive sequences, although less 
frequent than the Alu repeat, are also quite useful for the generation of DNA 
probes, either independently or in conjunction with Alu primers. Finally, vector 
Alu PCR (Nelson et al. 1989; Breukel et al. 1990; Shutler et al. 1990) has 
allowed new and fast ways for cosmid walking. 
Scanning for DNA polymorphisms 
A variety of methods are available for the identification of local DNA 
variation between individuals. In this section, several of the procedures to 
detect single base changes are discussed. Two reviews on this matter have been 
published recently (Landegren et al. 1988; Rossiter and Caskey 1990). 
Restriction Fragment Length Polymorphisms (RFLPs) 
DNA variations that change the length of restriction fragments are commonly 
referred to as RFLPs. The most common cause of RFLPs are mutations, 
destroying or creating specific restriction enzyme sites. However, insertion or 
deletion polymorphisms can be found as well. The enzymes that most 
frequently detect RFLPs in the human DNA have been selected purely 
empirically. Altogether, only 6 enzymes, namely Mspl, TaqI, EcoRI, Hindlll, 
PstI and Bglll account for 69% of the 3370 RFLPs reported at HGM10 (Kidd 
et al. 1989). Mspl (CCGG) and TaqI (TCGA) together already detect 40% of 
the total number of RFLPs. This can be explained by the preferential 
methylation of cytosine residues in CpG dinucleotides, which renders them 
prone to mutation due to deamination (Vogel 1990). However, RFLPs only 
represent part of the sequence variation in the genome, the majority of the 
mutations will not affect a restriction site. 
For a period of several years, initiated by the original work of Grodzicker et 
al. (1974) and Kan and Dozy (1978) genetic marker analysis was exclusively 
based on the use of RFLP detecting probes (see also Botstein et al. 1980). 
Genetic maps covering the genome at roughly 10-20 cM intervals have been 
published by several individual groups and consortiums of collaborating 
laboratories (Donis-Keller et al. 1987). The major limitation for the localization 
of (rare) genetic diseases is the restricted informativity of RFLP systems, which 
are usually only biallelic. The maximum PIC value that can be obtained with 
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two allele systems is 0.375 (Botstein et al. 1980). The informativity may 
increase substantially, if more than two alleles are involved or if haplotype 
construction is applied (Kidd et al. 1989). 
Variable Number of Tandem Repeats (VNTRs) 
The limitations described above can in part be overcome by the use of a new 
class of RFLP like markers, designated minisatellites (Jeffreys et al. 1985c; 
reviewed by Jarman and Wells 1989) or VNTR-markers (Nakamura et al. 
1987). These markers consist of stretches of tandem repeats (9-64 bp) of which 
the repeat number varies. The mean mutation rate has been estimated at 0.004 
per locus per gamete, but considerable variation in stability of minisatellite loci 
exists, rising up to 5% per gamete for the most instable locus (Jeffreys et al. 
1988). A usually GC-rich core sequence of 10-15 bp (Jeffreys et al. 1985c) is 
conserved among the various minisatellites. Hybridization of a minisatellite 
probe under non-stringent conditions or hybridization of the core sequence 
only, yields a complex, but individual-specific and heritable pattern of about 60 
bands. This so-called DNA fingerprinting (Jeffreys et al. 1985a) is a relatively 
new method that plays an increasing role in paternity testing, forensics 
medicine, transplant screening and ecological genetics (Jeffreys et al. 1985a; 
Gill et al. 1985; Jeffreys et al. 1985b; Jarman and Wells 1989). For 
hypervariable loci germ]ine instability must be taken into account in parenthood 
testing (Jeffreys et al. 1988). Stringent hybridization of a minisatellite probe 
reveals only a single locus (Nakamura et al. 1987). It has been estimated that 
more than 1,000 VNTR loci should be dispersed throughout the human 
genome. However, recent evidence indicates that their distribution is not 
random. Minisatellites show preferential localization to subtelomeric regions 
and it is currently unclear whether sufficient interstitial loci exist for the 
construction of high resolution linkage maps (Royle et al. 1988; Inglehearn and 
Cooke 1990). 
As VNTR alleles are characterized by differences in length, they can be 
identified by any enzyme that does not cut in the repeat region or between the 
probe and the repeat region (Nakamura et al. 1987). The first VNTR marker 
was isolated by chance (Wyman and White 1980). Since then other VNTR 
(sometimes called hypervariable region or HVR; Reeders et al. 1985) markers 
have been isolated near the light chain immunoglobulin locus, the insulin gene, 
the a globin gene cluster, the Harvey-ras oncogene, type II collagen gene, the 
apolipoprotein В gene and many other loci (Kidd et al. 1989 and refs therein). 
Jeffreys et al. (1988) showed that high fidelity amplification of minisatellite loci 
is possible, even with minute amounts of human DNA, extending the scope of 
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DNA fingerprint analysis to trace amounts of hair, blood and semen. PCR 
amplification of minisatellites permits detailed analysis of variation in the 
internal minisatellite structure and is capable of detecting over 10™ allelic states 
at a single locus (D1S8; Jeffreys et al. 1990). 
A number of processes have been postulated to play a role in the evolution of 
minisatellite loci. Considering the homology between the core sequence and the 
recombination signal χ of E.coli and phage λ, it is tempting to speculate that 
minisatellite sequences also initiate human chromosome recombination and 
promote the formation and variation of minisatellites through unequal crossing 
over (Jeffreys et al. 1985b). Recently, detailed analysis of 12 mutations in the 
VNTR markers YNZ22 and D1S7 revealed no exchange of flanking markers, 
making unequal crossover events an unlikely cause of variation in these cases 
(Wolff et al. 1988; 1989). Analysis of 19 different germline and 30 different 
somatic mutants in the internal minisatellite structure of the extremely variable 
locus D1S8 also revealed no case of interallelic recombination. Thus, the alleles 
seem to evolve along haploid chromosome lineages (Jeffreys et al. 1990). Other 
possible processes are gene conversion, which can play a role in the observed 
maintenance of homogeneity of the repeat sequences as well (Belmaaza et al. 
1990), replication slippage, which is thought to be a general mechanism for the 
generation of simple sequences, or unequal sister chromatid exchange (Jarman 
and Wells 1989; Jeffreys et al. 1990). 
Variable Simple Sequence Motifs (VSSMs) 
Length variability is characteristic for clustered repeat sequences of all sizes, 
including the huge centromere repeats (Willard et al. 1986). For several years 
this had been known already for the simple sequences with repeat units of 1, 2 
or 3 nucleotides (Slightom et al. 1980; Tautz et al. 1986; Schäfer et al. 1988; 
Kovacs et al. 1988), but the potential value of the VSSMs, or microsatellites, 
as polymorphic markers was recognized only recently. Four groups, including 
ours, reported almost simultaneously on the use of (CA)n repeats as genetic 
markers (Weber and May, 1989; Litt and Luty 1989; Tautz 1989; Smeets et al. 
1989g, see appendix 4). VSSMs or microsatellites can be visualized by 
combining in vitro DNA amplification using primers flanking the repeat and 
high-resolution gel electrophoresis. Since the original reports were published, 
new VSSM markers have become rapidly available (Dracopoli and Meisner 
1990; Fujita et al. 1990; Luty et al. 1990; Petersen et al. 1990; Richards et al. 
in press). The mapping of FMD on chromosome 4 by showing linkage to Mfd 
22 (D4S171), was obtained after testing 60 VSSMs to screen the remaining 
10% of the genome left on the exclusion map (Wijmenga et al. 1990). 
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Weber (1990) examined the informativeness of over 100 human (CA)n 
repeats. PIC values generally ranged from 0 for 10 or fewer repeats to above 
0.8 for 24 or more repeats and informativeness increases with increasing 
average length of the repeat. Interruptions in the run of repeats by non-repeat 
bases reduces the informativeness of the repeat and the length of the 
uninterrupted repeat turned out to be the best parameter for predicting the PIC 
value of such sequences. Compound repeats of adjacent but distinct SSMs 
showed high PIC values, but only three of such repeats have been studied at 
the moment (Weber 1990). The value of these markers is not only given by the 
generally high informativeness, but also by the high abundance and the 
supposed random distribution in the human genome (Litt et al. 1990). A 
frequency of 50,000 (TG)n-repeats per haploid genome was estimated by 
quantitative hybridization assays (Hamada et al. 1982; Jelinek and Schmid 
1982). Weber (1990) calculated that at least 12,000 (CA)n motifs should be 
present in the human genome with PIC values above 0.50. For about 7,000 of 
these motifs the PIC values should be greater than 0.7. A drawback of the 
system, observed by all authors, is that allelic signals often are represented by 
multiple bands and are not always easy to interpret when two alleles differ only 
by one or few repeat units. Whether the multiplicity of bands is an artefact of 
PCR amplification, which seems most likely, or represents somatic variation is 
as yet unclear (Weber and May 1989; Smeets et al. 1989g, see appendix 4). 
Several mechanisms have been postulated to play a role in generation and 
mutability of simple sequence repeats. Most likely involved is the process of 
strand slippage during replication, repair or recombination, although unequal 
crossing over might be involved as well (Tautz et al. 1986; Litt and Luty 1989; 
Weber 1990). In a number of VSSMs (Weber and May 1989; Litt and Luty 
1989; Smeets et al. 1991), the dinucleotide repeats show a non-gaussian length 
distribution and major and minor alleles can be discerned. This may reflect the 
existence of different mechanisms generating variability. In addition, these 
mechanisms might work differentially on VSSM loci depending on their 
chromosomal location. 
Accumulating evidence points to a role of (TG)n.(AC)n sequences in Z-DNA 
formation (Haniford and Pulleyblank 1983; Nordheim and Rich 1983) or tri-
ple-helical DNA formation (Lee et al. 1989). These DNA structures may 
facilitate binding of eukaryotic topoisomerase II (Spitzner et al. 1990), stimulate 
homologous recombination and gene conversion events (Shen et al. 1981; 
Kmiec and Holloman 1986; Hellman et al. 1988) or cause formation of 
chromosome translocations (Boehm et al. 1989). Z-DNA forming sequences 
have been identified as spontaneous deletion hot spots in E. coli by Freund and 
co-workers (1989). These authors conclude that slippage causes variation in the 
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1-2 repeat size range and that the Z-DNA conformation proper can induce 
deletions of more than 2 repeats. One may assume that similar behavior will be 
displayed in eukaryotes. 
(CA)n repeats by far outnumber all other simple sequence repeats and have 
therefore been the main subject of interest. Data on the variability of other 
microsatellites are scarce, but the finding that synthetic oligonucleotides 
representing (CAC)5, (GACA)4, (TCC)S, or (GATA), (Zischler et al. 1989) can 
be used for DNA fingerprinting suggests that variability is common to all 
simple sequence repeats. This is supported by reports on a polymorphic 
(TGGA)n repeat in the human myelin basic protein gene (Boylan et al. 1990) 
and polymorphic polyadenylate tracts of Alu repeats. The latter variability was 
discovered by Economou et al. (1990), who found VSSM like polymorphisms 
in the 3' ends of 2 out of 3 Alu repeats studied. For amplification a repetitive 
3' Alu primer was used together with a unique primer. Similar results were 
reported by Zuliani and Hobbs (1990) for a (TTA)n repeat in the vicinity of an 
Alu sequence. Testing of other (TTA)n repeats revealed that predominantly 
those repeats were polymorphic that were located adjacent to Alu repeats. As 
Alu repeats are the most abundant repeats and as similar poly(A) tracts are 
present near Kpnl and other repeats, Economou et al. (1990) conclude that Alu 
associated polymorphisms, or Alumorphs, may represent one of the most useful 
groups of DNA markers. However, additional data are lacking at the moment 
and in our own experience we encountered some serious problems in 
converting non-(CA)n repeats, including Alu poly (A) tracts into polymorphic 
single copy markers (Hermens and S meets, unpublished observations). 
Recent findings have indicated that VSSMs are not always neutral 
polymorphisms. In the candidate gene for the fragile X syndrome (FMR-I) a 
polymorphic stretch of arginine codons (CGG) was detected. Variation in repeat 
number, probably in combination with hypermethylation of this region, seems 
to be the direct cause of disease. In normal transmitters and their daughters the 
increase in length of the restriction fragment containing the repeat, ranges from 
150-400 base pairs, but individuals in the next generation who carry the 
mutation, display a generally heterogeneous increase of 1.5-3.5 kb (Oberle et 
al. 1991; Yu et al. 1991; Verkerk et al. 1991). The length of the insertion, 
probably due to amplification of the repeat, appears to be associated with the 
phenotypic expression of the disease. A similar finding has been reported in 
spinal bulbar muscular dystrophy, where doubling of a stretch of 20 glutamina 
codons (CAG) in the androgen receptor gene might be the causative mutation 
(La Spada et al. 1991). Therefore, instability of codon repeats may prove to be 
a general source of phenotypic relevant mutations. 
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Analysis of the melting temperature of double-stranded DNA 
The melting behavior of a DNA double helix is sequence dependent. Dis­
sociation due to increasing temperature, decreasing ionic strength or action of 
chaotropic agents occurs in a series of melting domains, each having its own 
distinct melting characteristics. This melting process can, for example, be 
visualized by Polyacrylamide gel electrophoresis, as the electrophoretic mobility 
of DNA is dependent on its secondary structure. The migration of a double 
stranded DNA fragment, when resolved on a gel with a temperature gradient or 
a gradient of denaturing agents, like formamide and urea, will almost stop once 
the melting point of the domain with the lowest melting temperature has been 
reached and transition takes place to unpaired chains. Lerman et al. (1983) 
have used this behavior to visualize mutations in specific domains. They 
showed that changes in the base composition alter the melting temperature and 
cause otherwise identical fragments to stop at different locations in the gel. 
With this procedure of denaturing gradient gel electrophoresis (DGGE) it is 
possible in principle to detect any DNA variation, like deletions, insertions and 
even single base substitutions and base modifications (Lerman et al. 1983; 
Lerman et al. 1984; Collins and Myers 1987). 
In order to make the procedure applicable for routine analysis of a given 
DNA segment it is essential to determine the melting point of that DNA 
fragment prior to the actual experiment. This can be done most easily by 
running a perpendicular denaturing gradient gel at the temperature of incipient 
DNA melting or by theoretical calculation of the melting profile of a DNA 
fragment of known sequence (Lerman et al. 1984). Then, multiple samples can 
be analyzed for sequence variation on a parallel denaturing gradient gel with a 
gradient around the transition point. The value of DGGE analysis has been 
demonstrated by the detection of mutations in several genes. Myers et al. 
(198Sd) have shown that four known β thalassemia mutations, each resulting 
from a single base substitution in the β globin gene, could be easily identified. 
A wild type β globin probe was hybridized to cloned and genomic DNA from 
β thalassanemia patients and the wild type/mutant heteroduplex could be 
separated from the wild type homoduplex for each mutation. The same 
approach was used for the identification of previously unidentified genomic 
DNA polymorphisms on chromosome 20 (Noll and Collins 1987). Though 
intrinsically a very powerful method, there are a few shortcomings to the 
resolving power of the technique. First, the maximum size of the DNA 
fragments is about 500-1000 bp, which is a consequence of the decreased 
resolution of DNA molecules with large melted regions. Secondly, mutations in 
the highest melting domain can not be identified, because at this melting point 
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the complete DNA fragment becomes single stranded and no further shifting of 
the electrophoretic mobility can be observed. The same is true for fragments 
which melt as a single domain. Therefore, on average, only 50% of all single 
base substitutions are detectable. This limitation can be partly overcome, as 
demonstrated first for cloned DNA, by joining a stretch of 40-50 bp consisting 
almost entirely of С and G nucleotides, to the DNA fragment of interest. In 
nearly all cases this "CG-clamp" will form the highest melting domain, 
meaning that approximately all mutations (95%) are detectable. The importance 
of a CG-clamp was shown by Myers et al. (1985a+b) in their study of 38 
different single base substitutions in the β globin promoter region. The 
introduction of the PCR technology allowed the screening of amplified genomic 
DNA fragments for mutations on ethidium bromide stained gels and also 
allowed the application of the CG-clamp methodology to the analysis of 
genomic DNA. For example, to the 5' end of one of the PCR primers a 40 
nucleotide long CG stretch was added (Sheffield et al. 1989) and again almost 
all β globin mutants studied could be detected. In the same way a mutation in a 
patient with ornithine carbamoyltransferase (OTC) deficiency was identified and 
direct mutational analysis by DGGE was applied for presymptomatic diagnosis 
in this family (Finkelstein et al. 1990). Heterozygotes for a mutation could be 
easily discovered, because they display four separate bands (two wild 
type/mutant heteroduplexes and both a wild type and mutant homoduplex). 
Recently, a modification of the procedure was reported using the CG-clamp and 
heteroduplex formation on restriction enzyme digested, but unamplified DNA 
(Abrams et al. 1990). 
A few variations of the original DGGE method have been described. First, 
apart from the analysis of DNA/DNA heteroduplexes, the method can be 
applied to the analysis of DNA/RNA and RNA/RNA heteroduplexes as well, as 
has been demonstrated for the analysis of single base mutations in the Influenza 
virus RNA molecules (Smith et al. 1986). Furthermore, others have adapted the 
procedure by the use temperature gradient gel electrophoresis (TGGE: Heneo 
and Heibey 1990; Wartell et al. 1990) and spectrophotometry to identify the 
melting peaks of a DNA segment (Razlutskii et al. 1987). 
Single strand DNA analysis 
Nucleotide differences can be detected in single strand DNA either by using 
nucleotide analogs that alter electrophoretic mobility of the single strand DNA 
(Kornher and Livak 1989) or by exploiting single strand DNA conformation 
polymorphisms (SSCPs; Orita et al. 1989a). The first method has been used to 
detect mutations in a PCR amplified segment of the insulin receptor gene. 
29 
Primer extension was performed with an internally hybridizing end labeled 
primer and a biotinylated nucleotide analog, which causes the DNA to migrate 
two bases slower than expected in a sequencing gel. In this way DNAs can be 
discriminated that are of the same length, but differ in the number of nucleotide 
analog molecules per strand (Kornher and Livak 1989). Only a single mutation 
has been studied at the moment, but one would expect that all types of 
nucleotide changes should be detectable by this method. 
The method of sequence dependent single strand DNA conformation detection 
is based on the fact that nucleotide substitutions in a single-stranded DNA 
segment cause conformational alterations, which lead to a mobility shift on non-
denaturing Polyacrylamide gels. As in DGGE analysis, only relatively small 
sized DNA segments can be analyzed. Initial procedures involved the use of 
restriction enzymes and DNA denaturation prior to electrophoresis, the position 
of the separate strands was revealed by electroblotting the gel onto a nylon 
membrane and hybridization with probes (Orita et al. 1989a). The use of the 
PCR technique in combination with labeled primers abolishes the need for 
digestion and blotting and permits the use of a thin gel to improve resolution. 
The percentage of the single base mutations that can be detected using this 
method is presently unclear. Orila et al. (1989a), in their analysis of 12 tumour 
cell lines that contain mutated HRAS, KRAS and NRAS, showed that SSCPs 
could be detected in every cell line. In addition, polymorphisms in Alu repeats 
could be identified at several chromosomal loci (Orita et al. 1989b). Successful 
applications of this method have been reported for the identification of 
mutations in the CF gene (Dean et al. 1990) and in the candidate gene for 
neurofibromatosis I (Cawthon et al. 1990). Hata et al. (1990) adapted the 
method to separate and sequence directly individual alleles of the human 
lipoprotein lipase gene. The single stranded DNA bands were cut from the gel, 
followed by elution, enzymatic amplification and direct sequencing. In this way 
a more reliable identification of nucleotide substitutions could be achieved in 
heterozygotes than by direct sequence analysis of the PCR mixture, containing 
both alleles. 
Enzymatic cleavage of mismatches 
Early experiments using SI nuclease to detect mutations in DNA hetero-
duplexes have not been very successful, since the ability of the enzyme to 
cleave one-nucleotide mismatches is limited. Better results were obtained by 
using RNaseA to cleave RNA:RNA (Winter et al. 1985) or DNA:RNA hetero-
duplexes (Myers et al. 1985c) with mispaired nucleotides. A 32P labeled RNA 
probe (100 to 1000 nt), synthesized in either the sense or antisense orientation, 
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is hybridized to denatured DNA or RNA, digested with RNase A and analyzed 
on a denaturing Polyacrylamide gel. If the hybrid contains a mismatch that can 
be cleaved by RNase A, two fragments will be seen on the autoradiogram. If 
there is a perfect match, RNase A will not cleave and only a single, probe 
sized band will result. The main drawback of the procedure is that RNaseA 
does not cleave every mismatch in every sequence context and is not always 
100% efficient. This complicates reliable identification of heterozygotes for a 
specific mutation. Another disadvantage of the use of nucleases is the presence 
of non-specific cleavage products, even in perfectly matching strands. 
The RNaseA method has been successfully applied to detect mutations in the 
c-K-ras (Winter et al. 1985) and c-myc oncogenes (Cesarman et al. 1987) and 
in the RB gene (Dunn et al. 1988) in DNA from human tumors of various 
origin. Single base mutations could be detected in the HPRT gene from Lesch-
Nyhan patients (Gibbs and Caskey 1987), in the omithine-6-aminotransferase 
gene of patients suffering from gyrate atrophy of the choroid and retina 
(Mitchell et al. 1988) and in the OTC gene in sparse fur mice (Veres et al. 
1987). In all these studies RNA:RNA duplexes were analyzed. This has the 
additional advantage that apart from the site of the mutation, the relative 
expression of the normal and mutant allele can be analyzed. Mutations that can 
be detected in RNA:DNA heteroduplexes have been extensively studied for a 
collection of cloned mouse β major globin mutants and for genomic DNAs of 2 
/3-thalassemia patients (Myers et al. 1985c). In vitro amplification of the 
template DNA facilitates the identification of mutants in these RNA:DNA 
duplexes and extends the scope of the method, as has been shown for mutant c-
K-ras genes, amplified from frozen human tumor specimens (Almoguera et al. 
1988), and factor VIII mutants (Levinson et al. 1987). The RNaseA mismatch 
cleavage method also provides a simple approach for the analysis of genetic 
variability of RNA viruses. For different influenza virus strains unique and 
characteristic patterns of resistant RNA fragments could be generated (Lopez-
Gal i ndez et al. 1988). 
Chemical modification ofrmsmatches 
Mismatches in DNA:DNA heteroduplexes can be chemically modified and 
subsequently identified by their effect on the electrophoretic mobility of the 
duplex (Novack et al. 1986) or on base pairing (Ganguly and Prockop. 1990), 
by immunomicroscopy (Ganguly et al. 1989) or by cleavage at the modified 
site (Cotton et al. 1988; Grompe et al. 1989). In the first method, hybrids 
between labeled probe and unlabeled target DNA are incubated with 1-
cyclohexyl-3-{2-[4-(4-methyl) morphodinyl] ethyl}-carbodiimide (CMC), which 
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reacts with unpaired G- and T-residues in single-stranded regions. Thus, 
mismatches between probe and target will reduce the electrophoretic mobility of 
the resulting double-stranded DNA hybrids. This can be visualized by 
electrophoresis on high percentage Polyacrylamide gels. The potential value of 
this method for detecting mismatches is unclear. For only two mismatches (T:G 
and G:T) results are described; results for G:G and T:T mismatches are 
mentioned but not shown. A modification of the method was reported by 
Ganguly and Prockop (1990). The CMC-modified, unpaired G- and T-residues 
in heteroduplexes were identified by a simple primer extension assay under 
conditions in which extension terminated at the site of the modified base. The 
procedure detected all mismatches in several sequence contexts of PCR 
amplified DNA. The sites of the mutations were located to within 15 bp. 
However, occasionally fortuitous bands were encountered as well and controls 
had to be employed in each assay. At the moment, insufficient data are 
available for a clear comparison between this and other methods with respect to 
sensitivity and specificity of the analyses. As an alternative, the binding of 
CMC with mismatches can also be visualized by electron microscopy, as shown 
by Ganguly et al. (1990). Heteroduplexes of phage M13 mutant and wild type 
DNA and of plasmids containing the hemoglobin types A and S were treated 
with CMC and then with polyclonal antibodies specific for CMC and with a 
second antibody linked to an electrodense marker. By examination of 100 to 
200 randomly photographed molecules the mutations were detected and the site 
of the mutation was determined within about 0.2 kb. Unlike many of the other 
procedures discussed above, this procedure allows the identification of single 
base mutations in relatively long stretches of DNA (several kb). However, 
shortcomings are that the procedure is time consuming (5-10 days) and can 
only be applied to cloned DNA. 
The chemical mismatch cleavage method is basically similar to the RNaseA 
mapping method, except that the heteroduplexes consist of two DNA strands 
and that the strand cleavage is chemically induced. Incubation of the 
heteroduplex with osmiumtetroxide (for Τ and С mismatches) or hydroxylamine 
(for С mismatches) modifies the mismatched base, which can then be cleaved 
by piperidine. Cleavage products are monitored by denaturing Polyacrylamide 
gel electrophoresis. The method was introduced by Cotton et al. (1988), who 
applied it to the analysis of the 21-hydroxylase gene. These authors showed that 
all C-mismatches (C:T, C:A, C:C) could be identified by hydroxylamine treat­
ment and all T-mismatches (T:C, T:G, T:T) by osmiumtetroxide treatment in 
the cloned 21-hydroxylase gene. Osmiumtetroxide also reveals C-mismatches, 
albeit at a slower rate than hydroxylamine. According to preliminary results of 
these authors unpaired С and Τ are also reactive, indicating that by using sense 
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and antisense probes, all types of mutations should be detectable. Grompe et al. 
(1989) adapted the method by incorporating the PCR methodology to scan for 
mutations in the human OTC gene. The amplified, 1062 bp long cDNAs of S 
patients with OTC deficiency were tested and presence of single mutations was 
shown for four patients, the other patient had acquired 2 mutations. Generally, 
the method allows the identification of mutations in relatively long stretches of 
DNA (up to 1200 bp tested) and concomitantly, the precise location of the site 
of mutation to within a stretch of 30 bp. Applications of the method have been 
reported for the study of single base mutations in the p53 cDNA (Rodrigues et 
al. 1990) and the Eia gene, causing pyruvate dehydrogenase deficiency (Dahl 
et al. 1990). Theophilus et al. (1989), however, were unsuccessful in 
determining all mutations in the human acid /3-glucosidase gene leading to 
Gaucher disease. They encountered a high background of aspecific cleavage 
after treatment with hydroxylamine and osmiumtetroxide even with perfectly 
matched duplexes. Whether or not those different findings are related to the 
different base pair composition of the various target genes is currently 
unknown. 
Direct sequence analysis 
Direct sequence analysis is the ultimate proof for the presence of mutations in 
the DNA. In fact, it is the only method to establish the exact nature of a 
mutation and will have to follow or replace the scanning methods described 
above. Several modifications of the original dideoxy sequencing method (Sanger 
et al. 1977) as well as its combination with the PCR technique has enabled a 
routine application of DNA sequencing in the detection of mutations. The first 
results on this new technology were published for the direct sequencing of 
mitochondrial (Wrischnik et al. 1987) and genomic DNA (c-Ki-ras mutations: 
McMahon et al. 1987; /3-globin mutations: Engelke et al. 1988), in vitro 
amplified with Klenow polymerase. The introduction of Taq polymerase 
increases the specificity of the PCR tremendously and facilitates the direct 
sequence analysis of genomic DNA, as demonstrated by Wong et al. (1987) 
who identified new mutations in the 0-globm genes of /3-thalassemia patients. 
Isolation of the PCR product from agarose gels, using the "freeze squeeze" 
method, yields double-stranded template DNA, which is very well suited for 
routine sequence analysis (Casanova et al. 1990). 
A further modification is the generation of single-stranded PCR products for 
sequence analysis (Stoflet et al. 1988), most easily performed by asymmetric 
PCR (Gyllenstein and Erlich 1988). Whatever the protocol employed to 
generate single-stranded DNA templates, their purification is essential for 
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proper sequence analysis. Usually centricon microconcentrators are used 
(Newton et al. 1988; Nichols et al. 1989; Higuchi et al. 1990; Graham et al. 
1990) to remove nucleotides and PCR primers prior to sequencing. A more 
sophisticated method involves the use of biotinylated PCR primers, which can 
be bound to avidin coated beads to capture biotinylated single-stranded DNA 
(Gibbs et al. 1990). As an alternative to strand purification, a protocol that 
couples PCR with direct sequencing was described by Ruano (1990 Cold Spring 
Harbor Meeting on Genome Mapping and Sequencing). He developed a 
biphasic protocol with a first phase of 15 cycles of amplification of a target 
sequence and a second phase of another 15 cycles including ddNTPs and one 
PCR primer radiolabeled and one unlabeled. Products of this reaction can be 
immediately analyzed on a sequencing gel. Sequence analysis of individual 
alleles can be achieved by combining the SSCP method with direct sequencing, 
as has been described above (Hata et al. 1990). 
For the identification of mutations in genes with small and limited number of 
exons and the characterization of relevant mutations in genes with a large 
number of insignificant mutations, like mitochondrial genes, direct sequence 
analysis is the method of choice. It may therefore not come as a surprise that 
this relatively new methodology has already been applied to a variety of genetic 
diseases (f.e. the identification of mutations in the factor VIII (Higuchi et al. 
1990) and IX gene (Green et al. 1989) of hemophilia A and В patients, 
respectively, the prealbumin (transthyretin) gene of patients suffering from 
amyloidotic polyneuropathy type II (Nichols et al. 1989), the α-1-antitrypsin 
gene (Newton et al. 1988; Graham et al. 1990), the p53 gene in colorectal 
cancer (Rodrigues et al. 1990), etc., etc.). Soon many other applications will 
follow, especially when automated sequence analysis has become common 
practice. 
Routine detection of DNA polymorphisms 
Once a mutation has been precisely determined by sequencing, routine 
screening of individuals for the presence of this mutation can be done much 
easier than by using the methods described above. A mutation destroying or 
creating a restriction site can be visualized by PCR amplification of the 
respective DNA fragment, followed by restriction enzyme digestion and direct 
visualization on ethidium bromide stained agarose or Polyacrylamide gels 
(Factor ІП mutations: Kogan et al 1987; apolipoprotein Cl (APOCl): 
Nillesen et al. 1990, see appendix 3). Also VNTR alleles can be visualized 
immediately upon PCR amplification, as has been illustrated for the 
apolipoprotein В 3' hypervariable region (Boerwinkle et al. 1989). The 
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remainder of the mutations can be detected easily by hybridizing allele specific 
oligonucleotides (ASOs) to PCR amplified DNA, either on dot blots or on 
Southern blots of PCR products, as shown for typing of HLA class II loci 
(Eriich et al. 1986) mutations in the β globin gene (Saiki et al. 1986), the ras 
oncogene ( егіаапчіе Vries et al. 1986) and the apolipoprotein E (APOE) gene 
(Smeets et al. 1988a+b, see appendix 1 and 2). The ASO hybridization 
method, which was originally developed by Conner et al. (1983), is based on 
differences in the melting temperature between an oligonucleotide with 
complete homology to the template DNA and one containing a mismatch. By 
choosing critical hybridization and washing conditions the formation of 
imperfect hybrids can be prevented. Both radioactive and non-radioactive 
oligonucleotide probes are suited (Saiki et al. 1986; 1988). The same principle 
underlies allele specific PCR. ASOs are used as PCR primers under critical 
conditions to make sure that only a perfect match will function as a starting 
primer and yield a PCR product. The presence or absence of a PCR product 
indicates which alleles are present. Conditions have to be very precisely 
determined, as the PCR method can tolerate certain mismatches. Therefore, the 
site of the mutation should always be at the 3' end of the discriminating PCR 
primer and sometimes an additional mismatch has to be introduced to enhance 
the destabilizing effect of mutated site (Gieselmann 1991). In the last two 
methods, the oligonucleotides hybridize adjacent to the polymorphic site. The 
oligonucleotide ligation assay (OLA) depends on the ligation of oligonucleotides 
that hybridize next to each other (Landegren et al. 1988). When there is a 
mismatch in the junction region then ligation is prevented. A mutation is 
monitored by the presence or absence of a ligation product. In the single 
nucleotide primer extension method (Kuppuswamy et al. 1991) a oligo­
nucleotide, which hybridizes immediately 5' to the polymorphic site, is 
elongated in four separate assays. In each assay only one of the four 32P 
labeled nucleotides is added. Only one (homozygote) or two (heterozygote) 
assays will show an elongation product, dependent on the nucleotide present 3' 
of the oligonucleotide. 
CONCLUSIONS 
The main issue of this thesis is the application of sophisticated methods for 
the detection of DNA polymorphisms in one particular chromosome segment, 
namely the q arm of chromosome 19. The DNA markers thus identified serve 
as molecular tools for the genetic and physical dissection of this chromosomal 
area in which the DM gene is located. As has been described above DNA 
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polymorphisms outnumber by far all other polymorphic systems and thus form 
the basic tools for this kind of approach. Generally, for a rough initial 
localization of a disease gene RFLP markers are the best choice. These markers 
are widespread and abundant throughout the genome. In case the isolation of 
additional markers should be imperative, the identification of new RFLP probes 
is technically straightforward and their application in linkage analysis is 
relatively simple. However, the lack of informativity of the RFLP systems (the 
highly informative VNTR markers are much less abundant and not randomly 
distributed) becomes increasingly disadvantageous as soon as the genetic locus 
of interest is more closely approached by linkage analysis. Eventually, there 
will be only a few families left showing crossovers between the disease locus 
and nearby markers. At this stage, new, highly polymorphic markers have to 
be generated and tested in these families to identify those markers that map 
even closer to the gene, i.e. that do not longer show crossovers with the 
disease. VSSMs, especially (CA)n repeats, are particularly well suited for this 
purpose, because VSSMs are more informative than RFLPs and more abundant 
than VNTRs. Moreover, results are usually obtained within two days. A 
drawback of the system is that in certain instances results can be difficult to 
interpret. 
When all crossover borders have been passed, then even more specific 
methods are needed to identify mutations that may be involved directly in the 
etiology of a disease. Of the methods listed above, the SSCP method is the 
simplest to perform, but as yet it is unknown whether all mutations can be 
identified by this technique. The 3 other broadly used methods (chemical 
mismatch cleavage, DGGE and enzymatic mismatch cleavage) have been 
evaluated in parallel for the detection of mutations in exon 9 of the human acid 
j8-glucosidase gene by Theophilus et al. (1989). These authors found that 
DGGE identified mutations that both other methods did not and that DGGE was 
the only method able to reliably determine homozygosity and heterozygosity for 
a given mutation. It is unclear whether their problems with the chemical 
mismatch cleavage method are indeed a drawback of the method or depend on 
the technical protocol used. Currently, the chemical mismatch cleavage method 
seems still preferable, because not only 100% of base changes were detected in 
a test system, but also the site of the base alteration is revealed. Moreover, the 
method is based on a technically well established protocol, which is not subject 
to variation due to impurities in the DNA preparations used. In general, the 
other methods are less preferable for mutation detection, because either specific 
equipment is needed and electrophoretic conditions have to be established for 
each single locus (in case of the DGGE method) or the outcome of analyses are 
less reliable (in case of the enzymatic mismatch cleavage methods). However, 
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tor routine analysis ot mutations in a specitic segment ot DNA in wfticti a large 
number of different mutations have been reported, like the jS-globin gene, 
DGGE is still very well suited (Fodde 1990). Finally, checking by sequence 
analysis of the mutations is necessary in any circumstance. Both for economical 
reasons and because the procedure is much less laborious than alternative 
procedures, direct sequence analysis of enzymatically amplified DNA seems 
most promising. 
OUTLINE OF THE STUDY 
Thus, the now existing sophisticated methods for detection of DNA variation 
enable us to identify almost any DNA alteration. Many of the procedures have 
been established only recently, during the period when studies for this thesis 
were performed. Moreover, much of our current theoretical knowledge about 
DNA variation has evolved in parallel. In the next section I shall describe the 
development of a subset of these methods and their application in a molecular 
genetic approach to the gene involved in the neuromuscular disorder myotonic 
dystrophy or DM. Our objectives were twofold. First, we wanted to generate 
new DNA markers for reliable diagnosis of DM. When we started with our 
studies in 1985, there were no really closely linked markers and the marker 
systems in general use were conventional two allele RFLP systems. By random 
isolation of DNA clones from the long arm of chromosome 19, to which the 
DM gene was assigned, we generated a large number of new RFLP markers, 
which were mapped physically to segments of 19q and genetically with respect 
to DM. These markers are described on pages 48 and S4/SS and appendix 3. 
Because only one third of the single copy clones identified RFLPs, we 
developed methods to identify other mutations in a clone as well. On page 46 
and appendices 1 and 2 we will describe the identification of single base 
mutations in the APOE gene. The three allele APOE system could be converted 
into a useful marker for DM. Next, we were among the first to recognize the 
value of simple sequence repeats as polymorphic markers. On pages 46/47 and 
54/55 and appendices 4 and 6 we report on the development of (TG)n-repeat 
markers in the apolipoprotein C2 (APOC2) gene and the excision repair gene 
ERCC1. Because these repeats are multi-allelic, highly informative, and closely 
linked to DM, they have replaced conventional RFLP systems for DNA 
diagnosis. Presymptomatic or prenatal diagnosis of DM can be reliably 
performed in almost any family using these closely linked (TG)n-repeats. 
Our second objective was the isolation of the gene involved in myotonic 
dystrophy, following the reverse genetics strategy. Testing of newly developed 
37 
markers in families with crossovers between DM and proximal or distal 
markers allowed us to approach the DM gene genetically. On page 54 and 
appendix 6 the exclusion of the DM gene from the region between APOC2 and 
ERCCl is reported, based on the (TG)n markers mentioned above. As a result 
of these studies and similar studies from other groups, the DM locus is 
confined to only a relatively small area in 19ql3.3 and physical cloning 
strategies become feasible. On page 53 and appendix 5 we report on a physical 
map of the region just proximal to the DM gene. A translocation breakpoint in 
this area forms a fixed starting point for cloning strategies in the DM region. 
The DNA studies described in chapter 2 together with analyses of somatic cell 
hybrids of 19q (Schonk, 1991) and linkage studies in DM families (Brunner, 
thesis in prep.) reduced the possible location from the DM gene from the 
complete long arm of chromosome 19 in 1985 to a small segment of a few 100 
kb at 19ql3.3 in 1991. From this region the DM gene has to be cloned. In the 
next chapter our results are discussed in connection with the results of other 
groups working on DM. 
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Chapter 2 
IN SEARCH OF 
THE MYOTONIC DYSTROPHY GENE 
MYOTONIC DYSTROPHY 
Clinical data 
Myotonic dystrophy or Dystrophia Myotonica Curschmann-Steinert (DM) 
(reviewed by Harper 1983, 1989; Appel and Roses 1983) is the most frequent 
inherited muscular dystrophy among adults, with an estimated frequency 
ranging from 1 in 50,000 to 1 in 7,500 individuals. The penetrance of the 
disease is high, but the expression is rather variable. DM is a multisystem 
disorder, named after the combined presence of progressive atrophy of the 
skeletal muscles and myotonia. It was first recognized as a separate disorder by 
Steinert and by Batten and Gibb in 1909. The major neuromuscular features 
and the inherited nature of the disease were described a few years later by 
Curschmann (1912) and Fleischer (1918). Some of the other complications, 
such as cataract, gonadal atrophy and cardiac involvement were already 
mentioned by these authors. 
The clinical picture of DM is extremely heterogeneous. The age of onset may 
vary from 0-60 years, but the mean age is 20-25 years. Some patients show the 
complete pattern of muscle weakness and wasting, others only develop specific 
cataracts. Highly specific for DM is the combination of type I fibre atrophy and 
type 2 fibre hypertrophy, which can be conveniently visualized by acid 
phosphatase staining on transversal studies of muscle biopsies. The facial 
muscles, the sternomastoid and the distal limb muscles are predominantly 
affected, giving the patient a characteristic elongated, lean face. Often ptosis 
and frontal balding is visible. Myotonia, the sustained contraction of the 
muscle, is the other characteristic feature. Myotonia can be elicited in almost 
every symptomatic patient and diagnosed either clinically or by 
electromyography. It is the most valuable sign of the disorder in 
presymptomatic gene carriers. Apart from striped muscle also smooth muscle, 
particularly of the gastrointestinal tract, is involved in DM. Cardiac 
involvement has been reported to occur in about two thirds of the patients and 
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syncope and sudden death are not uncommon. Electrocardiography reveals 
conduction defects in the majority of affected adults even in the absence of 
cardiac symptoms. Upon histological examination, the myocardium as a whole 
is usually relatively normal. 
As mentioned above, the first ocular abnormalities recognized in DM were 
cataracts. They are found in more than 90% of the adult patients and may 
sometimes be the only clinical expression of the disease. Cataracts are seldom 
seen in young children, but are increasingly found at higher age. The 
subcapsular opacities have a characteristic multicolored appearance and 
distribution, when viewed with the slit lamp. Also retinal changes are quite 
frequent. There are a number of abnormalities in the endocrine organs, the 
most significant being testicular atrophy. No comparable problem exists in 
women, but there is a high degree of spontaneous abortions. Diabetes mellitus 
is not very common (about 6% of the patients). However, there is widespread 
insulin resistance, although the mechanism underlying this resistance and the 
relation to DM remains to be determined. Other endocrine abnormalities are 
less evident. Finally, abnormalities in the central nervous system occur at high 
incidence. Common is a reduced intelligence in affected individuals, but the 
most frequent findings are personality changes. Patients appear apathetic and 
initiativeless and are relatively unconcerned about the degree and progression of 
the disorder. 
The expression of the disease is somehow related to the age of onset. The 
first symptom above the age of 50 is usually cataract, which may be followed 
by minor muscle weakness. If the age of onset is between 10 and 30 years, 
then the patients usually develop the characteristic pattern of progressive muscle 
weakness and myotonia. Cataracts are often present subclinically and mental 
changes usually appear in a later stage. In contrast, mental changes and 
retardation are the common features in the childhood form of DM, starting 
before the age of 10. In those cases muscle weakness and cataracts develop 
later. The severest form of DM is found in neonates and occurs only if 
transmitted via the mother (Harper and Dyken 1972). Usually symptoms can 
already be noticed during pregnancy, because the foetus shows reduced 
movements and hydramnios appears late in pregnancy. Many affected infants 
die soon after birth from respiratory problems. The most prominent features in 
these children are hypotonia and facial diplegia with a so-called tented mouth, 
giving the child's face a characteristic appearance. The neonates suffer from 
feeding difficulties and mental retardation is common in those who survive. 
Talipes occur frequent among a wide variety of other features. Myotonia and 
cataract are less prominent in these children. In most cases the children 
improve during the first decade. Later in life the progressive worsening features 
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of adult DM become apparent. 
The risk for a woman with DM to give birth to a living child with congenital 
DM is about 7-9%, 12% die perinatally and 30% develop DM at a later age. 
The other 50% are healthy. When a couple already has one congenitally 
affected child, then the chance that the next child carrying the DM gene will be 
severely affected is almost 100%. These gene carriers comprise more or less 
comparable groups of perinatal deaths, living children with congenital DM and 
children which are affected at a later age, but still usually severe (Harper 
1989). The influence of the sex of the transmitting parent is not completely 
understood. Harper and Dyken (1972) propose an maternal, intrauterine toxic 
factor, others think of epigenetic factors, like genetic imprinting (Clark 1990; 
Hall 1990). 
Anticipation is a controversial phenomenon in DM. In a first report Fleischer 
(1918) described that the severity of the disease increases with a concomitant 
decrease in age of onset after transmission from generation to generation. 
Penrose's interpretation (1948) that this phenomenon most likely is caused by a 
bias on index case selection was generally accepted. Some recent observations 
by Pryse-Phillips et al. (1982) and Höweler et al. (1989), however, do not fit a 
simple model of autosomal dominant inheritance. The latter authors claim that 
anticipation is a real biological phenomenon rather than a statistical artefact, 
because in 98% of the 61 parent-child pairs they had studied, an earlier onset 
was found in the younger generation. This difference was greater when the 
father was the transmitting parent. Comparison of the severity of the disorder 
was difficult in this study, however, because the affected family members had 
different symptoms. The pattern of symptoms was related to the age of onset, 
although this is not easy to determine exactly in DM. Höweler et al. (1989) 
excluded reduced fertility as an explanation for the anticipation phenomenon. 
For genetic counselling, linkage analysis and documentation of 
recombinations, diagnostic guidelines have been defined by Griggs et al. 
(1989). The criteria for considering a patient to have definite DM are set strict 
to be certain about phase determination of the markers used and about recom-
binations between DM and those markers in affected individuals. In non-
affected individuals recombination can never be firmly established, because a 
certain proportion of gene carriers never develop clinical symptoms. After 
thorough clinical assessment, electromyography and slit lamp examination the 
residual risk for apparently normal children of DM patients at 20-30 years of 
age of less than 10% that they carry the abnormal gene (Harper 1989; Brunner 
et al. in press). DNA diagnosis with very closely linked markers can further 
reduce this risk to < 1% in most cases. At present, DM can not be cured. 
Pharmacological approaches are based on empirical data and as yet no drugs 
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are known that cure or treat the progressive muscle weakness, which is the 
most disabling symptom for the majority of adult patients. The onset of the 
disorder can not be modified either. Therefore, a decrease of the incidence of 
DM has been tried to achieve by reducing the number of new cases by genetic 
counselling of individuals at risk. 
Biochemical data 
Unfortunately, biochemical studies have not provided a clue to the primary 
defect causing DM. In the second edition of his book on DM, Peter Harper 
(1989) states: " In rewriting this chapter (on biochemical studies in myotonic 
dystrophy) the author's first inclination was to omit entirely the large amount of 
work that now appears dated, trivial and of uncertain significance. (...) 
However, to omit this material would run the risk of investigators being 
unaware of it having been done and, even worse, trying to repeat it." Clearly, 
the biochemical cause of DM has not been identified at the moment. 
Electrophysiological studies on myotonia (reviewed by Riidel and Lehmann-
Hom 1985; Bretag 1987) were suggestive for membrane abnormalities. Most 
studies on animal models revealed a reduced chloride conductance of the 
muscle membrane as the main factor for the production of myotonia. Human 
myotonia congenita seems similar to the animal myotonia, but DM is quite 
different with only minimal reduction of chloride conductance. Recently, a 
progressive form of myotonia was described in foals, which more closely 
resembles human DM (Reed et al. 1988). Specific features of human DM are a 
reduced resting potential and an increased intracellular sodium concentration 
(Riidel and Lehmann-Hora 1985). The authors conclude that these findings are 
best explained by an altered sodium conductance at rest. However, results are 
sometimes conflicting and based on only few patients. Also, the effect of 
secondary damage, arising from the dystrophic process is as yet unclear 
(Harper 1989). 
In a number of studies biochemical and biophysical membrane changes were 
reported in DM patients. The fact that these changes were present in muscle 
membranes as well as in membranes of red blood cells and fibroblasts is 
consistent with the multisystemic nature of the disorder (Roses and Appel 
1973; 1974). The authors reported reductions in phosphorylation of membrane 
proteins, probably due to reduced activity of protein kinases. A relation 
between myotonia and protein kinase activity has been reported recently 
(Brinkmeier and Jockusch, 1987). Activators of protein kinase С induce 
myotonia via a reduction of the sarcolemmal chloride conductance. Yet, the 
latter finding seems at best an explanation for animal myotonia and human 
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myotonia congenita, which show reduced chloride conductance. In DM, 
chloride conductance is practically normal and protein kinase activity is reduced 
instead of increased. 
Changes have been observed in mono- and divalent cation pumps, in 
membrane ATP-ases and in the permeability for calcium, which is increased in 
myotonic red cell membranes (review: Rüdel and Lehmann-Horn 1985; Harper 
1989). Butterfield et al. (1976), using the electron spin resonance technology, 
reported an alteration in the fluidity of the red cell membranes of DM patients. 
This could not be confirmed by further studies (Gaffney et al. 1980). The lipid 
composition of red cell membranes is essentially normal in DM (Harper 1989). 
Alterations in membrane receptors have been reported as well. Insulin 
resistance is widespread in DM, but whether this is caused by abnormalities in 
the insulin receptors or a secondary effect of a membrane defect, is as yet 
unclear (reviewed by Harper 1989). Renaud et al. (1986) showed that the 
muscle membranes of patients with DM contain the receptor for the bee venom 
toxin apamin, a blocking agent of calcium activated potassium channels, 
whereas normal controls do not. So far, these data have not been confirmed 
and it is not clear whether this finding is specific for DM. In spinal horn 
atrophy, the only other disorder that has been tested, the apamin receptor is not 
expressed. 
In conclusion, there are distinct changes in membrane systems, when 
membranes of controls and DM patients are compared. The data, however, are 
not straightforward and often unconfirmed and therefore do not provide a real 
clue to the elucidation of the primary defect underlying DM and the 
identification of the DM gene. 
MAPPING OF THE DM GENE ON CHROMOSOME 19 
DM was one of the earliest autosomally inherited disorders, which was 
studied for its linkage relationships. The first evidence suggesting linkage 
between DM and the Lewis and Lutheran blood groups was presented by Mohr 
in 1954. This situation was complicated by the discovery that the Lewis red cell 
antigens were not determined by one locus alone, but were dependent on a 
locus controlling secretion of the ABH blood group antigens. The Lewis-
Lutheran linkage was shown to be in fact secretor-Lutheran by Greenwalt in 
1961. Later, linkage to DM was confirmed by Renwick and co-workers (1971) 
on data provided by Mohr, by means of a three locus analysis including DM, 
secretor and Lutheran (Renwick et al. 1971). The most likely order was DM-
secretor-Lutheran (Renwick and Rolling 1971). The genetic distances were 
43 
15cM (Zmax=18.4) for secretor-Lutheran, 5cM (Zmax=2.37) for DM-
secretor and lOcM for DM-Lutheran (Zmax=1.8). These data were confirmed 
by Harper et al. (1972), who proposed the same order and found somewhat 
larger recombination distances. 
The Se-DM linkage was important since it could be used for an indirect form 
of prenatal diagnosis. The secretor phenotype of the foetus can be determined 
from the amniotic fluid (Harper et al. 1971) and in suitable pedigrees DM 
could be predicted with 92% accuracy (Harper et al. 1972; Schrott et al. 1973). 
In 1982, Simóla et al. obtained evidence for Lewis-DM linkage independent 
from secretor-DM linkage, thus confirming the older findings of Mohr that 
were partly based on incomplete data. The linkage group was further extended 
with the third complement component (C3; Weitkamp et al. 1974). Whitehead 
(1982) assigned C3 to chromosome 19 using a monoclonal antibody with 
specificity for human C3 in a study on the expression of this complement 
component in somatic cell hybrids. Not much later, these findings were 
confirmed by using a human genomic C3 DNA probe, which hybridized to 
DNA samples from the same somatic cell hybrids. Thus, it was established that 
C3, Lewis, secretor, Lutheran and DM form a single linkage group on 
chromosome 19. Eiberg et al. (1983) linked one further marker, namely the 
peptidase D (PEPD) gene, to secretor and to this linkage group and proposed 
the sequence Lewis-C3-DM-(secretor-PEPD)-Lutheran. Weak evidence for 
linkage between PEPD and the Lutheran (0=0.25) and secretor loci (0=0.18) 
had been suggested from a general linkage study on peptidases (Cook et al. 
1972). PEPD had already been assigned to chromosome 19 by McAlpine et al. 
in 1976, providing additional evidence for synteny on chromosome 19. 
Once the location on chromosome 19 of this group was firmly established 
some other markers were added that had been mapped before to this chromoso-
me, but which were neither polymorphic nor linked to the linkage group. These 
include GPI, one of the first markers mapped to chromosome 19 (Hamerton et 
al. 1973) and the acidic lysosomal form of α-mannosidase (MANB; Ingram et 
al. 1978). Champion et al. (1978) confirmed the mapping of MANB, PEPD 
and GPI to the same chromosome by screening a somatic cell hybrid panel. 
Three other assignments were made on chromosome 19 during the mid-
seventies, namely, the poliovirus sensitivity (PVS ), echo-11 virus sensitivity 
and the Baboon virus M7 receptor (M7V1; HGM 3 and 4). The first 
apolipoprotein mapped to chromosome 19 was APOE. The APOE protein is 
polymorphic as a result of amino acid substitutions that lead to variation in 
electric charge, which in turn can be detected by isoelectric focusing (Utermann 
et al. 1977). APOE was linked to C3 (Olaisen et al. 1982) and Lutheran 
(Gedde-Dahl et al. 1984) and could therefore be located on chromosome 19. 
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APOE APOC1 APOC1* APOC2 
Polymorphisms: APOE-isoproteins 
APOC1 Hpal RFLP 
APOC2 RFLPs and VSSM 
Fig. 1. The apolipoprotein gene cluster on chromosome 19ql3.2. 
APOC1* is a pseudogene; the arrows indicate the 5'-*3' orientation. 
DNA MARKERS FROM THE DM REGION 
With the development of techniques for the isolation of DNA probes the 
number of markers, which could be assigned to human chromosomes raised 
tremendously (HGM 8, 9, 10, 10.5). As already discussed, the first 
polymorphic system in general use was the RFLP-system (reviewed by Botstein 
et al. 1980; Gusella 1986). Davies et al. (1983) showed linkage between C3 
and DM using a cloned C3 gene probe, which detects a number of RFLPs. The 
next highly useful RFLP was detected by a APOC2 probe (Humphries et al. 
1983), the second apolipoprotein to be assigned to chromosome 19, but now, in 
contrast to APOE, based on DNA hybridization. The two apolipoproteins were 
found very closely linked (Myklebost et al. 1984; Humphries et al. 1984). 
Slightly thereafter, a cDNA clone for human APOC1 was used to assign this 
gene also to chromosome 19 (Tata et al. 1985). More recent physical mapping 
studies have revealed that the distance between APOC1 and APOE is only 4.3 
kb (Myklebost and Rogne 1986; Davison et al. 1986) and that all 3 
apolipoprotein genes are part of a gene cluster covering about 55 kb of 
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chromosome 19 (Myklebost and Rogne 1988; Smit et al. 1988a). Not long after 
the assignment of APOC2 to chromosome 19 its potential value as a diagnostic 
marker for DM was recognized by various groups (Shaw et al. 1985; Hulsebos 
et al. 1985a; Pericak-Vance et al. 1986). The localization of the APOC2 gene 
on the long arm of chromosome 19 by in situ hybridization (Hulsebos et al. 
1985a) and by physical methods using a panel of somatic cell hybrids (Hulsebos 
et al. 1985b; Lusis et al. 1985; Schonk et al. 1989) was suggestive for a 
location of the DM gene on 19q. Independent evidence was obtained from a 
three point linkage analysis using C3, DM and a 19 С banding heteromorphism 
as genetic markers (Friedrich et al. 1987). In this study, a position of the DM 
gene between 19cen and C3, which is located on 19p (Ball et al. 1985; Lusis et 
al. 1986) could be excluded. 
In the years that followed, a large number of RFLPs were identified with 
APOC2 gene probes (Humphries et al. 1983; Myklebost et al. 1984; Wallis et 
al. 1984; Meredith et al. 1986; Frossard et al. 1986; Korneluk et al. 1987) and 
the genetic distance to DM turned out to be small (0=0.02-0.03, Zmax > 90; 
Shaw et al. 1985; Hulsebos et al. 1985a; LeBeau et al. 1989), rendering 
APOC2 one of the most suitable markers for DM diagnosis (Pericak-Vance et 
al. 1986). However, because of linkage disequilibrium between the different 
RFLP-systems, APOC2 is not informative in about half of the DM families. 
Therefore, our group initially chose to exploit other polymorphisms in the 
apolipoprotein cluster (Fig. 1). To this end we first developed a rapid method 
to identify the APOE type of an individual at the DNA level. In humans three 
major APOE isoproteins (e2, еЗ, e4) were known, defined by point mutations 
resulting in amino acid substitutions at positions 112 and 158 (Smeets et al. 
1988a+b, see appendix 1 and 2). Using a combination of the PCR and ASOs, 
APOE was applied as a polymorphic DNA marker in our DM families. For 
DM and APOE, a maximum lod score of 7.47 was obtained at a θ of 0.047. 
We did not find a recombination between APOE and APOC2 (Zmax = 5.61; 
Smeets et al. 1988a, see appendix 2), but APOC2 was not informative in one 
of the APOE recombinant families. Secondly, RFLPs had been described for 
APOC1 (Frossard et al. 1987a, 1987b) and for APOE (Klasen et al. 1987a). 
Only the APOE Hpal polymorphism, which is in fact located between the 
APOE and APOC1 genes, has allele frequencies suitable for linkage analysis 
and diagnostic purposes. The region, covering the polymorphic site, was 
sequenced (Smit et al. 1988b) and based on these data we were able to develop 
a PCR assay allowing routine screening for this RFLP on ethidium bromide 
stainable gels (Nillesen et al. 1990, see appendix 3). 
Finally, to transform the apolipoprotein locus into an even more useful 
marker, we specifically searched for new polymorphic systems in the 
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apolipoprotein cluster. We and others (Weber and May 1989; Litt and Luty 
1989; Smeets et al. 1989g, see appendix 4) independently had recognized 
SSMs, especially (TG)n repeats, as a potentially rich source of highly 
polymorphic markers. Using these repeats in an assay based on PCR 
amplification, high electrophoretic resolution and electroblotting, we developed 
a very useful marker for APOC2 and used it in our DM families. For the 
APOC2 VSSM, at least 8 alleles could be discerned. About 95% of our 
families were informative for this marker, thus demonstrating the value of 
VSSMs for linkage studies (Smeets et al. 1989g, see appendix 4). 
Reexamination of a family with an APOE-DM crossover revealed that this 
family was also informative for the APOC2-VSSM, thereby establishing the 
order APOE-APOC2-DM. 
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Fig.2. Panel of somatic cell hybrids, containing different parts of chromosome 19q (represented 
by vertical bars): 1040A6 (A), 908K1B17 (B), 908K1B23 (C), ORIM7-1 (D), 908K1B19 (E), 
908K1B26 (F), 908K1B15 (G), 908K1B2 (H), 1219G2 (I), 20XP3542-1-4 (J), 908K1B18 (K), 
GM89A99C-7 (L). 
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In an attempt to generate additional DNA markers from this region, our 
group initially focused on the construction of a somatic cell hybrid with a 
single human der(19) chromosome. The hybrid, designated 908K1, comprised 
the 19pl3.1-ql3.2 segment together with the distal part of the long arm of the 
X chromosome (Xq24-qter). A cosmid library, constructed from this somatic 
cell hybrid, was screened for chromosome 19 specific centromere repeat 
sequences and single copy probes (Hulsebos et al. 1985b). As APOC2 was, 
initially, mapped by in situ hybridization just subcentromeric on the long arm 
of chromosome 19 (Hulsebos et al. 1985a), centromere-specific repeats could 
be useful for the isolation of pericentromeric polymorphic markers and the 
selection of somatic cell hybrids, containing subcentromeric chromosomal 
segments. Ultimately two centromere specific clones were isolated from the 
chromosome 19 cosmid library (Hulsebos et al. 1988) and were used for in situ 
hybridization. Probe pG-A16 showed specificity for the centromeres of 
chromosomes 5 and, most prominently, chromosome 19 and probe pG-F2 for 
those of chromosomes 1, 5, 7 (only faint signals), 16, and 19 (Hulsebos et al. 
1988). However, as the location of APOC2 turned out to be more distally 
(Brook et al. 1987; Schonk et al. 1989), we concentrated on the distal part of 
the 19cen-ql3.2 region. 
The combination of genetic studies, using polymorphic markers, and physical 
mapping, using somatic cell hybrids, turned out to be a fruitful approach to 
characterize the 19cen-ql3.2 chromosomal area. In our laboratory (Hulsebos et 
al. 1985b; Schonk et al. 1989) and the laboratories of others (Lusis et al. 1986; 
Brook et al. 1987; Stallings et al. 1988) panels of somatic cell hybrids were 
established, by which the long arm of chromosome 19 could be divided into at 
least 12 distinct segments (Fig. 2). As an addition to the 19q cosmid library 
described above, we constructed a λ EMBL3 library from the somatic cell 
hybrid 908K1B18, containing only the long arm of the original hybrid 908K1 
(Schonk et al. 1989). By successive rounds of screening for human sequences 
and subcloning to generate single copy probes (see appendix 3), a large number 
of probes was isolated from the 19cen-ql3.2 region. Over the years, our group 
contributed approximately 30 new DNA probes from this region, 10 of which 
detected RFLPs, including pHW60 (D19S13; Hulsebos et al. 1986), pJSB6 
(D19S15) and pJSBll (D19S16; Schepens et al. 1987 a,b), pPM6.7 (D19S18), 
p5B18 (D19S28), pPM17.4 (D19S29), p20B18 (D19S30), p30B18 (D19S31)and 
p58B18 (D19S32; Smeets et al. 1987, 1989a,b,d,e,f) and pX75B (D19S112; 
Hermens et al. 1991). We also detected RFLPs with probes derived from the 
creatine kinase muscle type (CKM) gene (Coerwinkel-Driessen et al. 1988), 
which was assigned to 19ql3.2-13.3 (Nigro et al. 1987; Schonk et al. 1989), 
and kallikrein gene (KLK; Hermsen et al. 1990). Several other groups isolated 
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DNA markers as well, of which I only want to mention those that are most 
relevant with respect to the genetic mapping of DM. The group of Dr.A. Roses 
isolated probe pLDR152 (D19S19), which was initially reported to be close to 
DM and which detected part of a Na+K+ ATPase gene (ATP1A3; Bartlett et al. 
1987). However, additional physical and genetic mapping studies excluded the 
ATP 1 A3 locus from the DM region and excluded the Na+K+ ATPase gene as a 
candidate gene for DM (Harley et al. 1988; Schonk et al. 1989). Dr. В. 
Komeluk and co-workers isolated probe pal.4 (BCL3; McKeithan et al. 1987; 
Komeluk et al. 1989), which is close to DM but still proximal to the 
apolipoprotein cluster. From the 19ql3.2-qter region they mapped the pEWRB 
probes (D19S50; Komeluk et al. 1989). The Cardiff group, including Dr. D. 
Shaw and co-workers, initially added 4 anonymous RFLP markers, detecting 
the loci D19S7, D19S8, D19S9 and D19S11 (Shaw et al. 1986), but none of 
these markers mapped close to the DM gene. 
Meanwhile, a number of expressed sequences were assigned to distinct 
segments of chromosome 19 by physical and, for those detecting poly­
morphisms, genetic methods. The thesis of Schonk (1991) gives a detailed 
overview of many gene loci mapped on chromosome 19q. The majority of 
these genes can be excluded as candidates for DM because of their physical 
location. The localization to 19q of the ryanodine receptor gene (RYR; 
MacLennan et al. 1990), encoding a T-tubuli associated protein, initially caused 
some excitement. However, MacKenzie et al. (1990) could exclude this gene as 
a candidate for DM. At present, even the more likely possibility that the 
ryanodine receptor gene is involved in the predisposition to malignant 
hyperthermia in man (MacLennan et al. 1990) still awaits experimental 
conformation. For the mapping of the ryanodine receptor gene the same probes 
and panels of somatic cell hybrids were used as for DM (MacLennan et al. 
1990; MacKenzie et al. 1990), illustrating the general value of the panel of 
DNA markers for mapping studies on the long arm of chromosome 19. 
Polymorphic gene probes, which were chosen for linkage analysis in DM 
families, are those coding for APOC1, APOC2 and APOE, for CKM and 
for cytochrome P450 (CYP), subfamily 2A and 2B (LeBeau et al. 1989). 
Reviewing all data on genetic and physical mapping made clear that APOC2 
and CKM were the most closely linked proximal markers (Brunner et al. 
1989a-l-b; Komeluk et al. 1989; LeBeau et al. 1989). Locus BCL3 and the loci 
detected by the probes pJSB6 and pJSBll have a somewhat more proximal 
location, but are still tightly linked to DM. Closest on the distal side was 
pEWRB (D19S50), which is 9 cM from the DM gene (Komeluk et al. 1989). 
More distal is the location of the protein kinase С gamma (PRKCG) gene, 
which can therefore be excluded as a candidate gene for DM (Johnson et al. 
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Fig.3. Genetic (3a) and physical map (3b) of chromosome 19. 
For abbreviations see the report of HGM 10.5. 
1988). As has been illustrated in Fig. 3, the best currently available genetic 
order agrees very well with the physical order, making it highly likely that it is 
correct. The finding of linkage disequilibrium in a French-Canadian population 
(MacKenzie et al. 1989) and in a Finnish population (Nokelainen et al. 1990) 
between APOC2 and DM again points to a location of the DM gene in the 
immediate vicinity of APOC2. A detailed overview of all known two-point and 
multipoint linkage data in the DM region will be given in the thesis of Brunner 
(in preparation). Of all markers tested the CKM gene was found the most 
tightly linked. Initially no crossovers were identified in a large sample of 
families analyzed by several groups in Europe, the USA and Canada, which 
rendered the CKM gene a serious candidate gene for DM. Testing the CKM 
gene of DM patients by PCR amplification and direct sequencing of all 
individual exons, however, did not reveal any abnormalities, thus arguing 
against a direct causative role of CKM in DM (collaboration of our group with 
the group of B. Korneluk, Baily et al. 1991). These results have been 
confirmed recently by the identification of crossovers between CKM and DM 
that position CKM at 1 cM proximal to DM (LeBeau et al. 1989). 
A fixed demarcation point for the DM region forms the breakpoint of the 
908K1 hybrid, which carries a X;19 translocation. We detected that the 
translocation breakpoint in hybrid 908K1 is within the CKM gene (Smeets et 
al. 1990, see appendix 5). The breakpoint could be precisely mapped in a 2 kb 
Hindlll/PstI fragment in intron IV of the CKM gene by screening the hybrid 
908K1 and its counterpart the GM89A99C-7 hybrid (Hellkuhl and Grzeschik 
1978) with exon derived probes from the CKM gene (v.d. Kerkhof et al., 
unpublished). Because hybrid 908K1 contained only markers that are proximal 
to DM, including APOC2 and the 3' end of CKM, this finding indicated that 
the DM gene had to be located just distal to the 908K1 translocation breakpoint 
(Fig. 4). 
Long range restriction mapping studies were initiated with probe BCL3 
(McKeithan et al. 1987; Korneluk et al. 1989), the apolipoprotein cluster and 
the CKM gene, which are genetically closest to DM. These markers, together 
with the repair genes ERCC1 and ERCC2 are present on somatic cell hybrid 
20XP3542-1-4, which contains only 5-10 Mb of DNA from 19q (Stallings et al. 
1988). A restriction map around these loci covering 1300 kb has been 
constructed by Shaw et al. (1989). This map locates locus BCL3 proximal to 
APOC2 on the same Noti fragment. Probes for the loci D19S7, D19S8, 
D19S9, D19S19, D19S22, PM6.7, ATP1A3, CKM, ERCC1 and CYP2A 
(Shaw et al. 1989) and pJSB6 (Smeets et al. unpublished results) detect Noti 
and Mlul fragments, different from those revealed by APOC2. 
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Fig.4. Map of the 908K1 translocation breakpoint in intron Г of the CKM gene. 
In conclusion, at the end of the year 1989 we defined the CKM gene as the 
closest proximal marker at 1 cM from the DM gene. Not long thereafter 
Johnson et al. (1990) published the identification of a new marker D19S51 
which was at 2.5 cM distal to DM. For historical reasons described above, no 
further close distal markers were available at that time. 
CLOSING IN ON THE DM GENE 
In narrowing down the region from which the DM gene must be cloned we 
followed the route described in the previous section with some modifications. 
First, we physically dissected the pertinent 19ql3.3 by using somatic cell 
hybrid techniques and macrorestriction mapping. Secondly, we evaluated 
several genes from the midportion of 19q for being candidate genes for DM. 
Furthermore, new markers were generated from physically well characterized 
loci in order to determine additional crossover borders inside the DM region. 
And, finally, we started with chromosome jumping and walking strategies to 
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clone the DM relevant segment. These latter studies were done in collaboration 
with the groups of Drs. В. Korneluk in Ottawa, Canada and P. De Jong at the 
Lawrence Livermore National Laboratories, Livermore CA, USA. 
A detailed physical map from 19ql3.2-13.3 
The area between the proximal marker CKM and the distal marker D19S51 is 
contained as a whole or in segments in several somatic cell hybrids now 
available. The 19q segment in the somatic cell hybrid GM89A99C-7 (Hellkuhl 
and Grzeschik 1978) spans the entire segment between the (X;19) translocation 
breakpoint in the CKM gene and the telomere. The somatic cell hybrids 
20XP3542-1-4 and -1-6 were derived from a repair deficient chinese hamster 
ovary cell line, fused with human lymphocytes (Stallings et al. 1988). Both cell 
hybrids contain segments of 19q that include the proximal loci BCL3, APOC2 
and CKM and the distal locus D19S51, but the segment in the -1-6 hybrid 
extends to further distal loci including D19S50, KLK, RRAS and PRKCG. By 
irradiating hybrid 20XP3542-1-4, Drs. D.Shaw and D.Brook generated a series 
of new hybrids containing even smaller segments of 19ql3.2-13.3 (International 
Workshop on Chromosome 19; Charleston August 3-5, 1990). These somatic 
cell hybrids have proven particularly useful for determining the order of loci in 
the DM area. 
To yield independent and more detailed information about the true physical 
distances between loci, macrorestriction mapping was used. Starting at the 
proximal border, our group and several others mapped the ERCCl and ERCC2 
genes on a single Noti fragment of 250-290 kb and distal to the CKM 
breakpoint in GM89A99C-7 (Thompson et al. 1989; Mohrenweiser et al. 1989; 
Smeets et al. 1989c; 1990, see appendix 5). In addition, we were the first to 
show that the CKM gene was present on the same Noti fragment and we 
determined the order and chromosomal orientation of these three genes (Smeets 
et al. 1990, see appendix 5). Unfortunately, long range mapping of the segment 
distal to the ERCCl gene has not been very successful. Unpublished 
observations show that there is considerable variation in Sfil, Mlul and Noti 
fragments with sizes depending on the DNA source and the experimental 
conditions used. This can be most easily explained by cell specific variations in 
CpG methylation. As we saw variation in the extend of cleavage and also a 
significant discrepancy between the number of Mlul and Sfil sites on the 
preliminary long range map and in cloned material of the ERCC1-D19S51 
interval, we conclude that the entire region may be highly methylated 
(H.Smeets, G.Jansen, M.Coerwinkel, N.Wormskamp, unpublished data). 
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Exclusion of candidate genes for DM 
A number of genes, which were assigned to 19q, could be excluded from 
being the DM gene. Using a panel of somatic cell hybrids, the 
carcinoembryonic antigen gene cluster (CEA), the hormone sensitive lipase 
gene (LIFE, Holm et al. 1988), the small nuclear ribonucleoprotein (SNRP) A 
gene and PVS (Siddique et al. 1988) all mapped proximal to the t(X;19) break-
point in the CKM gene (Schonk et al. 1990). At the distal side, the genes for 
SNRP 70 kD protein, KLK and RRAS could be excluded from being relevant. 
All three gene probes do not hybridize to DNA from the somatic cell lines 
20XP3542-M and 908K1B18 and are, therefore, assigned to the region 
19ql3.3-qter (Schonk et al. 1990). Furthermore, more direct evidence was 
obtained from haplotype analysis of DM chromosomes with the rather 
infrequent Mspl polymorphism at the KLK locus (Hermens et al. 1991; Smeets 
et al. 1991) and the two allele (TG)n repeat in the RRAS gene (Smeets et al. 
1991). Crossovers were identified that position both genes between D19S50 and 
D19S22 (Smeets et al. 1991). At that moment no further genes were available, 
which could be considered as candidate genes for DM. 
New markers for DM 
For the isolation of new markers from the DM region two strategies were 
applied. First, a directed search for VSSMs in and around genes, which were 
located distal to CKM, was performed. In this study we detected a highly 
polymorphic (TG)n repeat in the 9th intron of the ERCCl gene (PIC=0.66). 
As this motif was informative in the APOC2/DM crossover family identified 
earlier and mapped proximal to DM, our results excluded the DM gene from 
the region proximal to ERCCl (Smeets et al. 1991, see appendix 6) and made 
ERCCl the closest proximal marker published thus far. Data in this family 
were confirmed with probe pE0.8, which detects a common RFLP situated just 
3' of ERCCl gene (Shutler et al. 1991a+b). 
A directed approach to enter the DM region, involving the screening of a 
jumping library (Collins et al. 1987) with single copy probes derived from the 
CKM and ERCCl genes failed, because no positively reacting clones could be 
identified. We think that the generally large EcoRI fragments in this 
chromosomal region may have caused an underrepresentation of clones from 
this area in the library. Meanwhile, Korneluk and co-workers (Ottawa, Canada) 
started cosmid walking telomeric from ERCCl in collaboration with P. de Jong 
(Lawrence Livermore National Laboratories). At the International Workshop on 
Chromosome 19 (Charleston, August 3-5, 1990) they presented a walk of about 
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300 kb applying the Alu-vector PCR strategy. At 80 kb, 100 kb, 180 kb and 
240 kb distal to ERCC1 polymorphic markers were identified [loci D19S116-
119; Tsilfidis et al. (1991a+b); Shutler et al. (1991a+c); Korneluk et al. 
(1991)]. The recombination event in our ERCC1/DM crossover family could be 
precisely mapped between 180 kb (D19S118) and 240 kb (D19S119) distal to 
ERCC1 (B.Korneluk personal communication), making the breakpoint in this 
family the nearest proximal demarcation point for the DM region. A crossover 
family, recently identified in Nijmegen, maps D19S117 proximal to D19S118, 
D19S119 and DM, and confirms the physical data (M. Nelen, personal 
observation). 
Secondly, the somatic cell hybrid 20XP3542-M (Stallings et al. 1988), was 
used for constructing genomic libraries and performing the Alu PCR technology 
for the random isolation of new markers. Two polymorphic markers (pDIO, 
locus D19S63 and pD8, locus D19S62; Brook et al. 1990a,b) were isolated 
from a λ EMBL3 library from the same hybrid. Probe pDIO detects a 3 allele 
polymorphism and is highly informative. In our ERCC1/DM crossover family 
D19S63 co-segregates with DM. At present, no recombination has been 
reported between DM and D19S63. Probe pD8 was not informative in our 
crossover family, but could be mapped close to D19S51 using the irradiation 
panel of Shaw and co-workers. Our group succeeded in isolating three probes, 
which map distal to CKM. Only 1 probe, pX75B (D19S112), detects an Mspl 
RFLP (Hermens et al. 1991, see appendix 3). Recent studies revealed the 
presence of a (TG)n motif near pX75B, which was converted into a 
polymorphic marker. Marker pX75B was mapped distal to DM in a French-
Canadian DM/D19S51 crossover family (Jansen et al. in prep.). Mapping of 
pX75B (D19S112), pl34C (D19S51) and pD8 (D19S62) on the irradiated 
20XP3542-1-4 hybrids from Drs. Brook and Shaw, localizes pl34C and pD8 
distal to pX75B (Jansen et al. submitted). In conclusion, the DM gene has to be 
isolated from a DNA segment of a few hundred kb between the closest flanking 
markers pKEXO.8 (D19S118) and pX75B (D19S112). 
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Chapter 3 
CONCLUDING REMARKS 
AND FUTURE PROSPECTS 
From the results described above we can conclude that the DM gene must be 
located on a small DNA segment in 19ql3.3. At the moment, there are only 
five families known, two with proximal and three with distal crossovers, which 
can be used to narrow down the DM region further. Unfortunately, the two 
proximal recombinants, one between CKM and DM (M. Speer, International 
Workshop on Chromosome 19; Charleston August 3-5, 1990) and the other 
between D19S116 and DM (H.Smeets, personal observation) are not 
informative with other markers from the DM region. Therefore, the 
recombination event in both situations might even have occurred proximal to 
the closest recombination known at the moment (Smeets et al. 1991; В. 
Komeluk et al. pers. communication). Of the 3 distal pl34C/DM recombinant­
families, one can not be resampled (Johnson et al. 1990) and does not fit, in 
this respect, to the criteria defined by Griggs et al. (1989) for the 
documentation of recombinants. About the other two families insufficient 
documentation is available at the moment (B. Korneluk, personal 
communication). Still, we can conclude that the genetic approach of the DM 
gene has almost arrived at a natural ending. As the proximal region is 
extremely well characterized it is unlikely that crossover events have been 
overlooked. However, distal markers have only been scarcely available and 
were for various reasons not typed in all family material. It might thus be 
worthwhile to run the highly informative closely linked distal marker near 
X75B, developed by Jansen et al. (submitted), through all DM families as yet 
uncharacterized for distal markers. 
A rather different approach was performed to gather linkage data for all 
markers, either polymorphic or non-polymorphic, from the DM region. 
Between proximal mouse chromosome 7 and human 19ql3.2-13.3 is a highly 
syntenic relationship (Saunders and Seldin, 1990; Cavanna et al. 1990). In mice 
any given locus can be accurately mapped by use of interspecific backcross 
analysis of recombinant inbred strains (Avner et al. 1988; Taylor 1989). 
Comparison of the mouse and human map (Saunders and Seldin, 1990) showed 
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that the linkage groups were highly syntenic and contained both proximal 
(APOE, CKM and ERCC2) and distal loci (PRKCG and D19S51) with respect 
to DM, indicating that the DM gene should also be located on proximal 
chromosome 7 of the mouse. However, the advantage of the informativity of 
the markers and the ease of crossing in mice has been undone by the low 
recombination frequencies compared to humans. The interval between PRKCG 
and CYP2A, which covers 32.1 cM in humans (LeBeau et al. 1989) is 
compressed to 3.3 cM in mice (Saunders and Seldin 1990). Therefore, the 
contribution of mouse genetics in narrowing the linkage map in the DM region 
will only be very limited. 
At the moment, we must consider all expressed sequences from the area 
between the crossover borders as candidate genes for DM. The density of genes 
is rather high in the CpG rich 19ql3.3 region. For example, four genes (CKM, 
ERCC2, ERCC1 and ASE1) cover a DNA segment of only 250 kb. Screening 
a large number of genes to identify a mutation specific for DM patients, which 
would prove that the gene indeed is the DM gene, is a laborious task for which 
at the moment no real alternative is available. As a first step the physical 
cloning of the region between the crossover borders in overlapping cosmids 
should be completed. Similar to the search for the CF gene, these cosmids 
could be applied for cross species hybridization. Subsequent screening of cDNA 
libraries with conserved DNA segments will yield a number of cDNAs from 
the DM region. The comparison of the same cDNA from normal individuals 
and DM patients, using any of the methods for the detection of mutations, must 
eventually lead to the identification of DM causing mutations. 
Although the DM gene has not been cloned at the moment, our group has 
started to develop the necessary technology for creating an animal model for 
the disease. Gene transfer (Smithies et al. 198S) in combination with the use of 
embryonic stem cells (Hooper et al. 1987) will enable the construction of 
animal models of human disease. By homologous recombination of a series of 
overlapping cosmids from the disease carrying chromosome, we want to 
introduce the gene area that carries the DM mutation into the mouse. As the 
DM mutation acts dominantly, we anticipate it to interact with the normal 
mouse background and to convey a DM phenotype. Whether the mouse model 
will reflect the human disease to any extent and may create an opening towards 
therapy is purely speculative as long as the gene remains uncharacterized. 
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Note on Methodology 
abbreviations: a po, apolipoprotein; e, apolipoprotein E allele; VLDL, very low density 
lipoproteins; HDL, high density lipoproteins; PCR, polymerase chain reaction. 
SUMMARY 
A procedure based on selective hybridization with allele-specific oligonucleotides was developed 
for typing apolipoprotein E variants from human genomic DNAs. Two sets of oligonucleotides 
were synthesized and used to discriminate either between «3 and «4 alleles or between t3 and «2 
alleles. Combination of the allele-specific oligonucleotide hybridization with the method for in 
vitro DNA amplification (Polymerase Chain Reaction) (Saiki R.K. et al. 1985. Science 230: 
1350-1354) (1) dramatically improved the sensitivity and the reliability of the procedure. Adap­
tation of a simple strategy involving direct cloning and DNA sequencing of in vitro amplified 
DNA enables rapid identification of any mutation within the apoE gene area encoding the 
receptor binding domain. 
Supplementary key words DNA typing with oligonucleotides * DNA in vitro amplification * 
rapid cloning of gene variants 
INTRODUCTION 
Apolipoprotein E (apoE) is a constituent of plasma lipoproteins such as chylomicrons, very low 
density lipoproteins (VLDL), and high density lipoproteins (HDL). The major physiological 
function of apoE is its mediation of uptake of lipoproteins through specific cell surface receptors 
and its regulation of cholesterol metabolism (2). In addition, apoE may play a role as regulator 
of cellular activity in the immune system (3) and in development and regeneration of the nervous 
system (4). In humans, three major apoE isoproteins, apoE-2, E-3, and E-4 are known (5). The 
synthesis of these isoproteins is genetically controlled by three co-dominant alleles (t2, «3, and 
c4) on one polymorphic locus assigned to chromosome 19q. From epidemiological studies, the 
alleles c2 and e4 are found associated with hypertriglyceridemic and hypercholesterolemic states, 
respectively (6). Type III hyperlipoproteinemia, characterized by an accumulation of remnants of 
triglyceride-rich proteins, is associated with the apoE phenotype E2/2 (7). ApoE-2 has a reduced 
ability to bind apoB.E receptors (8). In addition, there is a questionable relationship between type 
V hyperlipoproteinemia and apoE4/4 (9,10). 
Besides apoE-2 (cys,^, cys1M), E-3 (cys,,!, arg,,,) and E-4 (argm, arg,,,) (11), several other rare 
apoE isoproteins have recently been described. Those variants which bear a conformational 
distortion of the receptor binding domain (amino acid residues 140-160 (12)) predominantly are 
found associated with type III hyperlipoproteinemia (12-17). Others are associated with different 
types of hyperlipoproteinemia or with no disease at all (18-20). 
Most of our present knowledge of apoE protein variants has been gathered through amino acid 
analysis and protein sequencing (reviewed in ref. 21). ApoE phenotyping is routinely done by 
isoelectric focusing of VLDL арюlipoproteins. As this method is based on charge differences 
between the ApoE isoproteins, it is not possible to identify neutral amino acid substitutions or 
neutralizing double mutants, nor to locate the site of the mutation. Moreover, this apoE protein 
typing cannot be applied in those cases where only limited amounts of serum are available. Since 
many apoE variants have recently been characterized at the DNA level (20, 21), it is now 
possible to solve these problems by application of DNA typing methods. In this report we present 
a new method for routine detection of apoE alleles based on hybridization with allele-specific 
oligonucleotides and the polymerase chain reaction (PCR) technique of Saiki et al. (1). The 
method can be applied to detect any pretyped mutation within the gene area encoding the 
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receptor binding region of apoE or, after modification, for any other relevant portion of the 
gene. The potential value of the method is demonstrated by genotyping individuals homo- or 
heterozygous for the common E3 (cys,,^ arg1M), E2 (cysnj, cys,,,), and E4 (arg,,,, arg,„) 
proteins. In addition, we present a rapid technique for the identification of new mutations in the 
portion of the apoE gene encoding the receptor binding domain. For either application only 
minute quantities of human DNA are required. The potential of these techniques in the discovery 
and typing of apoE variants in patients at risk for hyperlipoproteinemia and atherosclerosis will 
be discussed. 
MATERIALS AND METHODS 
Sera and DNAs 
Blood samples were obtained from patients who visited the lipid clinic in our hospital. ApoE 
typing in sera of patients and normal individuals was as described earlier (22,23). Plasmid pEB4 
containing a 930-bp insert of human АроЕЗ cDNA (24) was a gift of Dr. S. Humphries, 
London. High molecular weight DNA from peripheral blood was isolated according to Aldridge 
et al. (25) with minor modifications. 
BamHI 
-0 
Sac 
EcoRI Bgll Pst\ PstlNarlPstl 
4 (kb) 
Pstl EcoRI 
AE-2 
228 η I 
AE-1 gcgggcacggctgtccaagg 
AE-2 ccggcctggtacactgccag 
AE-tll2 gaggacgtgtgcggccgcct — 63 
АЕ-СІ12 gaggacgtgcgcggccgcct —» 64 
AE-tl58 ctgcagaagtgcctggcag — e2 
АЕ-СІ5 ctgcagaagcgcctggcag — 63 
Fig. 1. Schematic representation of various demarcation pointa in the apoE gene, la) Gene organization and 
restriction enzyme map of the apoE gene, lb) Structure of the relevant portion of exon IV and positioning of 
the amplification primers AE-1 and AE-2 (given by open boxes). Closed boxes indicate the positions of the 
oligonucleotides used to discriminate between c3 and (4 alleles and between c3 and (2 alleles. 1c) Sequences 
of the amplification primers and allele specific oligonucleotides. 
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Oligonucleotides and in vitro amplification of genomic DNA 
Oligonucleotides used as starting primers for the polymerase chain reaction and for detection of 
c3, e4 and «2 alleles were synthesized by the phosphoramidite method using a Cyclone DNA 
synthesizer from Biosearch Inc., New Brunswick Scientific Co. Oligonucleotides were eluted 
from the column-support and deprotected by treatment in 25% (w/v) ammonia, purified by 
acrylamide gel electrophoresis where necessary, recovered by precipitation in four volumes of 
ethanol and finally dissolved in water at a concentration of 1 μg/μl and stored until use at -
20 e C. 
The PCR technique used to amplify local areas of the apoE gene in genomic DNA was a 
slightly modified version of the original method of Saiki et al. (1). The reaction was started with 
1 μg human DNA in a buffer contoining 7 mM Tris-HCl, pH=7.5, 7 mM MgC^, 20 mM NaCl, 
0.1 mM EDTA, 1.5 mM DTT, 10% v/v dimethylsulphoxide (DMSO), 1.5 mM dATP, 1.5 mM 
dGTP, 1.5 mM dCTP, 1.5 mM dTTP, and 1 μΜ each of the amplification primers (oligonu­
cleotides AE-1 and AE-2, see text) in a total volume of 100 μΐ. For the first cycle the reaction 
mixture was heated at 95 * С for 5 min to denature the DNA prior to annealing the primers at 
41 "C for 2 min. Next, 1 unit of Klenow DNA polymerase I (BRL) (in buffer as specified above) 
was added and primer elongation was allowed to proceed for 4 min at 41SC. For all subsequent 
cycles the denaturation step was shortened to 2.5 min. The total number of consecutive cycles 
used is further specified in the text. The amplified DNA was recovered by ethanol precipitation 
and one third was electrophoresed on a 4% (w/v) agarose minigel in 40 mM Tris-acetate, 
pH=7.8, 1 mM EDTA until the bromophenol blue marker dye reached 4 cm. 
Southern blotting and oligonucleotide analysis 
Restriction endonuclease-digested DNA or DNA resulting from PCR amplification was 
immobilized on either Biotrace-RPM (Gelman) or Gene Screen Plus (New England Nuclear) 
membranes by conventional Southern blotting, using conditions as given by the manufacturers. 
For dot-blotting, DNA mixtures were denatured in 0.25 N NaOH, diluted to 0.125 N NaOH, 
0.125xSSC (10 χ SSC = 0.15 M Na citrate, 1.5 M NaCl, pH=7) and immobilized on Gene 
Screen Plus membrane using a Schleicher and Schuell dot-blot manifold. 
Oligonucleotides were 5'-end labeled with T4-polynucleotide kinase (11.5 U, Pharmacia-P&L 
Biochemicals) in a 10-μ1 reaction mixture containing 2 pmol of oligonucleotide, 4 pmol of y-2P 
ATP (Amersham, > 5000 Ci/mmol) in 50 mM Tris-HCl, pH=9.5, 10 mM MgClj, 5 mM DTT 
for 30 min at 37 e C. Unincorporated y-,2P ATP was removed by passage through a Sephadex 
G50 column. Specific activity was between 10' and 10' cpm per ^g. 
Filter-immobilized DNA was prehybridized in 5 χ SSPE (20 χ SSPE= 3.0 M NaCl, 200 mM 
NaHjP04, 20 mM EDTA, pH 7.4), 0.3% (w/v) SDS, and 10 μg/ml single-stranded herring 
sperm DNA (Gene Screen Plus) or 0.5 mg/mi (Biotrace). Hybridization was performed overnight 
(16h) under similar conditions at probe concentrations of 0.3-1 χ 10' cpm/ml and temperatures as 
specified below or in the text. Stringency conditions of hybridization and washing were 
dependent on the set of oligonucleotides used. ApoE-3 and apoE-4 specific oligonucleotides AE-
t l l 2 and АЕ-СІ12 were hybridized at 65SC and washing was done in two cycles of 5 χ SSPE, 
0.3% (w/v) SDS for 5 min each, followed by one wash at 65<,C for 10 min in 1 χ SSPE, 0.3% 
(w/v) SDS. ApoE-2 and apoE-3-specific oligonucleotides AE-tl58 and АЕ-СІ58 were hybridized 
at 60oC and washed three times for 5 min at 63°С in 5 χ SSPE, 0.3% (w/v) SDS. Autoradio­
graphic exposure to Kodak X-Omat S film was at -70° С with 2 intensifying screens (Cronex 
Lightning Plus, Dupont) for the periods given. 
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Ooning and sequencing of in vitro amplified ApoE DNA 
One tenth of the amplified DNA (equivalent of IS μΐ reaction mixture, either diluted directly or 
following ethanol precipitation) was digested with S units endonuclease PstI (BRL) in a total 
volume of SO μΐ for 1 h at 37 0C. Next, the DNA was phenol-extracted, recovered by ethanol 
precipitation, and dissolved in 10 μΐ sterile water. An amount of DNA equivalent to 1% of the 
amplified DNA was ligated into 20 ng pGEMS plasmid vector (Promega Biotec). Vector DNA 
was Pstl-clcaved, treated with calf intestine alkaline phosphatase, and purified on 1% (w/v) low 
gel temperature agarose (Biorad). Ligation was for 16 h in 66 mM Tris-HCl, pH 7.2, 7 mM 
MgCl,, 10 mM DTT, 0.2 mM ATP and 400 U T4-ligase (New England Biolabs) in a volume of 
10 μΐ at іб"С in presence of the agarose (26). The ligation mixture was heated to 65°С for S 
min, diluted and transfected into E.Coli HB 101. Resulting Amp' recombinant colonies were 
replicated onto nitrocellulose filters and screened with a 5'-"P-labeled oligonucleotide (5'-
gcgcacccgcagctcctcg, codons 131-137) at 55 0C in 5 χ SSPE, 0.3% w/v SDS, 10 μg/ml herring 
sperm DNA. Washing was done in the same buffer without herring sperm DNA at 55'C. 
Positively hybridizing colonies identified by autoradiography were purified and grown for DNA 
preparation. Plasmid DNA was purified and sequenced by the dsDNA method essentially as 
described by Hattori and Sakaki (27), using T7 and/or SP6 sequencing primers (Promega Biotec). 
E3/3 E3/4 M ЕЛ/Л (kb) E 3/3 ЕЗ/4 M ЕЛ/Л (kb) 
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Fig. 2. Direct blot analysis of genomic DNAs with the {3-c4 allele-specific oligonucleotides. Chromosomal 
DNAs of individuals typed to be heterozygous (E3/4) or homozygous (E3/3; E4/4) for apoE isoproteins were 
EcoRI-digested and subjected to Southern blot analysis using the allele-specific AE-tll2 (¡panel a) and AE-
cll2 (panel b) oligonucleotide probes as described in Materials and Methods. ApoE genotypes are indicated 
above each lane. M, Е Р З'-end labeled DNA marker fragments (НіпаЩхМЖА). Autoradiography was for 
seven days with two intensifying screens. 
RESULTS 
Identification of ApoE DNA polymorphisms 
From gene sequencing data it is known that the apoE-2 and apoE-3 genes differ only by having 
either а С or Τ nucleotide at the first nucleotide of codon 1S8. In the apoE-3 and apoE-4 genes 
only the first nucleotide of codon 112 (C or T, respectively) is at variance. In analogy to 
methodology already published (28,29) we have used allele-specific oligonucleotides for the 
identification of these three apoE gene variants. The two sets of synthetic oligonucleotides used 
to distinguish the apoE-3 and E-4 specific codons (oligomers AE-tll2 and АЕ-СІ12) and the 
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ApoE-2 and E-3 specific codons (oligomers AE-tl58 and АЕ-СІ58) are given in Fig. 1. The 
most fruitful conditions for discriminating between mismatched and perfectly matched duplexes 
(see Materials and Methods) were empirically established for each set of oligonucleotides on dot 
blots of plasmid pEB4 DNA (results not shown). Subsequently, we tested hybridization and 
washing conditions on genomic DNAs from individuals with known apoE phenotypes. For this, 
restriction endonuclease EcoRI- cleaved DNA was resolved by agarose gel electrophoresis and 
subjected to the discriminative hybridization and washing cycles in a conventional Southern 
analysis procedure with the АЕ-СІ12 and АЕЧ112 oligonucleotides. As shown in Fig. 2, results 
were in agreement with the ApoE phenotype inferred from protein typing, though the hybridi­
zation signals at the 2- kb band were rather weak, especially with the ES-specific AE-tll2 
oligonucleotide. 
We therefore decided to employ the PCR method for DNA amplification in vitro (1,30,31). 
The amplification-priming oligonucleotides selected (oligonucleotides AE-1 and AE-2) are 
displayed in Fig. 1. They are 188 bp apart and bracket the complete receptor binding domain 
encoding region of ApoE. The reaction conditions for the PCR procedure were established by 
tests of the AE-1 and AE-2 primers on plasmid pEB4 DNA (24). The conditions finally chosen 
are only slightly different from the conditions originally established by Saiki et al. (1), the main 
differences being the extended reaction times for denaturation and DNA polymerase-mediated 
elongation and the somewhat higher annealing and elongation temperature. After 10 amplifica­
tion cycles the plasmid DNA (100 ng) showed a distinct band at 228 bp which could be 
visualized by ethidium bromide staining (Fig. 3a). Amplification of chromosomal DNA resulted 
in a broad smear of DNA in which the ApoE-specific band shows up only after blotting and 
hybridization with an oligonucleotide complementary to sequences comprised in the 228 bp 
segment (Figs. 3b and 3c). We observed that a series of 15-16 consecutive amplification cycles 
gave optimal signal intensity. For unknown reasons, prolonged incubation (20-25 cycles) did not 
result in further increase of hybridization intensity at the 228-bp band (results not shown). We 
estimate that the sensitivity of the analysis was improved at least 10,000-fold by the PCR 
technique. Fig. 4a shows the result of amplification of 300 ng of genomic DNA from E3/3 and 
E4/4 homozygotes and one E3/4 heterozygote and screening with the "P-5' end-labeled АЕ-СІ12 
and AE-tl 12 oligonucleotides. Both alleles can be clearly inferred from the autoradiogram after a 
3.5-hr exposure. Fig. 4b shows the oligonucleotide typing of two E2/2 homozygotes, one E3/3 
homozygote and one E2/3 heterozygote using the АЕ-СІ58 and AE-tl58 oligonucleotides for 
which a somewhat longer autoradiographic exposure was consistently required. 
Cloning and sequencing of amplified apoE DNA 
To show that the amplification of the exon IV DNA domain could be utilized for rapid 
identification of ApoE mutations, we performed a model cloning experiment. Therefore, the 
DNA of an E4/3 heterozygote individual was amplified through 16 cycles of PCR reaction and 
1% of the material was cloned into а рСЕМЗ vector plasmid in E.Coli HB101. Of the 
approximately 500 colonies obtained, 3 positively hybridizing colonies were identified with an 
oligonucleotide spanning codons 131-137. From direct cloning of Pstl-cleaved DNA 
approximately 1 in lOMO7 clones would be expected to originate from apoE DNA. The observed 
incidence of ApoE-specific clones (3 in 500) therefore indicates a specific enrichment in the 
order of 10,000- to 100,000-fold by the amplification step. This corroborates the estimate from 
direct hybridization and is in the same order of magnitude as reported from similar studies 
involving the human globin and HLA gene loci (30, 31). In order to prove that the insert of the 
three clones indeed originated from the pertinent ApoE gene-domain we sequenced the DNAs. 
The sequences read were completely concordant with the apoE-3 and apoE-4 sequences across 
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the 188-bp segment already published by others (32, 33) Two e4 alleles and one e3 allele were 
identified (results not shown, DNA clones available upon request). 
1 2 3 (bp) 
-228 
-190 
fig. 3. Gel analysis and hybridization detection of the in vitro amplified apoE gene segment. a,b) Ethidium 
bromide-stained reaction product(s) of PCR amplified plasmid pEB4 DNA (panel a) and amplified total 
genomic DNA of three unrelated individuals (panel b). Oligonucleotides AE-1 and AE-2 (see Fig. 1) were 
tested by amplification (10 cycles) of the pertinent 228 bp segment from denatured double-stranded pEB4 
plasmid DNA. Stained bands of the reaction product and of the oligomer primers (arrow) are visible. Sizes of 
various marker fragments are indicated. Upon PCR-amplification of chromosomal DNAs (16 cycles, panel b) 
no distinct reaction products can be visualized, c) Hybridization screening of the reaction products shown in 
panel b by use of oligonucleotide AE-tl 12 as probe. The intensely hybridizing band at 228 bp is the expected 
amplification product of the apoE gene segment; the additional weakly hybridizing band at about 190 bp is of 
unknown origin. Autoradiography was for 4 hours. 
DISCUSSION 
Our results clearly show that typing of the three major apoE variants from minute quantities of 
DNA can be reliably done using the PCR methodology in conjunction with allele-specific oligo­
nucleotide hybridization. The method presented in this paper is inherently more sensitive than 
currently existing methods based on protein characterization and can be applied on each tissue 
specimen from which DNA can be obtained. 
Moreover, by employing appropriate sets of oligonucleotides, the technique will allow 
discrimination between similar but distinct mutations in apoE variants now commonly referred to 
as being of either E-2, E-3 or E-4 type. For example, no less than four allelic subtypes each are 
known for the б2 (13, 14, 16, 21) and fiv the e3 (17, 21) variants. These alleles all have similar 
amino acid substitutions at distinct positions and the commonly used phenotyping based on charge 
alterations in the protein usually cannot discern between different sites of mutation in such 
subtypes. Moreover, the latter method may lead to misclassification in a small number of cases. 
In considering the evident advantages of our apoE DNA typing method, however, one has to 
keep in mind that for each new set of allele-specific oligonucleotides the method becomes more 
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laborious and conditions for discriminative hybridization have to be reassessed. In our 
experiments, discrimination of e3-i4 and e2-e3 alleles is based on the difference in thermal 
stability between fully matched 19- or 20-mers and duplexes with a mildly disruptive G-T 
mismatch or duplexes with a more destabilizing C-Α mismatch. To fully exploit the 
discriminative power of the allele-specific oligonucleotides, optimized conditions for stringency of 
hybridization and washing would be required for every individual oligonucleotide. Therefore, we 
decided to use the PCR method for generation of signals that were much stronger and less 
affected by non-homologous hybridization. We chose to combine this method with Southern 
analysis rather than dot-blot assays (33) to avoid further complication. Though it is inherently 
simpler than Southern blot analysis, dot-blotting does not discriminate between genuine and 
background signals and would probably lead to ambiguities in the interpretation. Presumably, 
namely due to their rather high G + С content (a feature found throughout the entire apoE gene) 
and the non-critical annealing temperature, the AE-1 and AE-2 amplification primers displayed a 
tendency to hybridize at multiple loci on the genomic DNA. Furthermore, a pseudo-apoE gene 
was recently reported on chromosome 16 (34) and we cannot exclude that several other loci with 
homology to apoE- specific oligonucleotides exist throughout the genome. This might explain 
why in some experiments, in addition to the ApoE specific 228-bp signal another band at about 
190 bp and a weak background smear of hybridization were observed (Fig. 3c). 
Fig. 4. Oligonucleotíde-mediated apoE-allele screening of PCR-amplified genomic DNAs. Genomic DNAs 
obtained from individuals with known apoE types were amplified (16 cycles), resolved on agarose gels, 
blotted and screened with apoE allele-specific oligonucleotides. Panel a: lane 1, E3/3 DNA; lane 2, E4/4 
DNA; lane 3, E3/4 DNA screened with oligonucleotide AEcll2 (upper part) or AE-tll2 (lower part). Panel 
b: lane 1, E2/3 DNA; lane 2, E3/3 DNA; lanes 3 and 4, E2/2 DNAs screened with oligonucleotide AE-
СІ58 (upper part) or AE-tl58 (lower part). Autoradiography was for 3.5 hr (panel a) and overnight (panel b), 
respectively. 
Appropriate sets of oligonucleotides can be designed for any mutation outside the crucial 188-
bp domain, too. From comparison, however, of overall amplification efficiencies, we observed 
that regions with high С + G content consistently seem more refractory to Klenow DNA-
polymerase-mediated amplification than regions with a more average base composition (not 
shown). Various apoE gene regions, therefore, may be particularly difficult to amplify. As 
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reported recently, most of these difficulties can be overcome, and a more locus-specific DNA-
amplification can be obtained by employing the heat-stable Thermus aquaticus DNA polymerase 
and higher temperatures for primer annealing and elongation (35). 
The PCR-amplification, combined with rapid cloning and sequencing methods will greatly 
facilitate the identification of new apoE mutations in individuals where alterations in apoE 
receptor binding affinity are evident or even in apparently healthy individuals. This abolishes the 
need to establish complete gene libraries from every individual with anomalous apoE sequences 
and will deepen the overall insight in the association between ApoE haplotypes and the incidence 
of hyperlipidemia and atherosclerosis in the human population. 
We thank Drs.S.Humphries and B.Williamson for providing us with apoEB4 plasmid DNA and 
Prof. G.Tesser and Dr. C.Claesen for initial help in oligonucleotide synthesis. This work was 
supported in part by the Deutsche Forschungsgemeinschaft, Grant Ro 389/15-1 to H.H. Ropers 
and by the Dutch Praeventiefonds, Grant 28-1165. 
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SUMMARY 
In 16 families with myotonic dystrophy (DM) a novel approach based on use of allele-specific 
oligonucleotides has been employed to study the linkage relationship between the apolipoprotein 
E (APOE) gene and DM. Synthetic oligonucleotides, designed to discriminate between APO E 
alleles «3 and c4, enabled us to distinguish heterozygous carriers in a hybridization assay. In a 
subset of families, the relevant segment of the APOE gene was enzymatically amplified to 
increase the sensitivity of the method. For DM and APOE, a maximum lod score (z_J of 7.47 
was obtained at a recombination frequency (Θ) of 0.047 (male θ = female Θ). No recom­
bination (maximum lod score of S.61 at θ = 0.0) was found between APOE and the 
apolipoprotein СП (APOC2) gene. These results suggest that, in addition to APOC2, APOE is a 
useful marker for presymptomatic DM diagnosis. 
INTRODUCTION 
In the absence of reliable clues to the functional defect underlying myotonic dystrophy (DM), 
direct approaches to unravel the molecular basis of this disorder are not available, and biochem­
ical diagnosis is not possible. Therefore, recent efforts have concentrated on the search for 
closely linked genetic markers, which can be employed as diagnostic tags and as possible starting 
points for the molecular isolation of the DM gene. 
The apolipoprotein СИ (APOC2) gene is one of the few markers which is both closely linked to 
DM and highly informative: restriction fragment length polymorphisms (RFLPs) have been 
described with 7 different endonucleases (Humphries et al. 1983; Myklebost et al. 1984; Wallis 
et al. 1984; Meredith et al. 1986; Frossard et al. 1986; Komeluk et al. 1987). APOC2 is located 
on chromosome 19q (Hulsebos et al. 1986) as are two other genes encoding apolipoproteins, 
apolipoprotein CI (APOC1) and apolipoprotein E (APOE) (Lusis et al. 1986). For both of these, 
RFLPs have been described recently (Frossard et al. 1987a, 1987b; Klasen et al. 1987a). Studies 
involving molecular cloning and physical mapping have indicated that APOC1 and APOE are 
only 4 kb apart (Myklebost and Rogne 1986; Davison et al. 1986). Tight genetic linkage has 
been reported for APOE and APOC2 (Humphries et al. 1984; Myklebost et al. 1984; Naylor et 
al. 198S) and all three genes are found to be part of a gene cluster (Smit et al. 1988). 
However, studies to determine the genetic distance between apoE and apoC2 or DM have not 
fully exploited the informational content of the numerous DNA polymorphisms reported for the 
apoE gene region. As yet only the use of allelic isoproteins, resulting from amino acid sub­
stitutions that lead to variation in the isoelectric charge, has been described. The three most 
common alleles are «3 (cys,,,, arg,,,), e4 (arg,,,, arg1Ä), and e2 (cys,,,, cys in), where «3 is 
considered the most common allele and e4 and ¿2 have resulted from mutations involving the 
first base of the codons 112 and 158, respectively (Breslow et al. 1982). 
Here we report on the use of allele-specific oligonucleotides (ASOs) for detection of DNA 
sequence variation at codon 112. This technique, which is analogous to methods originally 
developed for the identification of point mutations in the β-globin gene (Conner et al. 1983), has 
been used in combination with primer-directed enzymatic DNA amplification by the polymerase 
chain reaction (PCR) (Saiki et al. 1985) and employed to obtain accurate estimates of the linkage 
relationships between APOE, APOC2 and the DM gene. 
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MATERIALS AND METHODS 
Materials 
Peripheral blood samples of individuals with known APOE type (analysed by isoelectric 
focusing) were a kind gift of Drs. Stuyt and Stalenhoef (Department of Internal Medicine, 
Nijmegen). Myotonic dystrophy families were ascertained through various neurological centers in 
the Netherlands, as reported elsewhere (Friedrich et al. 1987). 
DNA isolation and Southern blot analysis 
Chromosomal DNA from peripheral blood was isolated according to Aldridge et al. (1984), 
with minor modifications. Chromosomal DNA (IS μg) was digested with restriction enzyme 
EcoRi and resolved by electrophoresis on a 0.7% (w/v) agarose gel. Gels were soaked in 0.2S M 
HCl for 10 min to partly depurinate the DNA and DNAs were denatured in 0.4 M NaOH and 
transferred onto BioTrace (Gelman Science) membrane in the same solution (6-12 h). DNA-blots 
were washed in 2 χ SSC (0.3 M NaCl, 30 mM sodium citrate) and dried at room temperature. 
In vitro DNA amplification 
For amplification of the relevant APOE gene segment two oligonucleotide primers 
complementary to codons 89-96 and 159-165 were used. Starting from 1 /ig of genomic DNA, 
the pertinent segment of the apoE exon IV gene sequence was amplified in 16 consecutive PCR-
cycles (Saiki et al. 1985). Detailed reaction conditions will be described elsewhere (Smeets et al. 
1988). Products from the reaction mixture were precipitated with ethanol, dissolved in water, 
separated on a 4% (w/v) agarose gel and transferred to Gene Screen Plus membranes by 
conventional Southern blotting techniques. 
Generation of oligonucleotide probes and hybridization procedure 
Oligonucleotides were designed and synthesized as described (Smeets et al. 1988). 
Oligonucleotides (2 pmoles of either AE-tll2 or АЕ-СІ12; fig. 1) were 5' end-labelled using γ-
['2P] ATP (4 pmoles, >5000 Ci/mmol, Amersham) and T4 polynucleotide kinase (11.5 units, 
Pharmacia-P&L) in a 10μ1 reaction mixture containing 50 mM Tris-HCl, pH 9.5, 10 mM MgCl,, 
2mM dithiothreitol. Unincorporated γ-["Ρ] ATP was removed by passage through a Sephadex 
G50 column. Specific activity was between 10' and 10' cpm/^g. 
Blots were pre-hybridized overnight at 650C in 5 χ SSPE (1 χ SSPE is 0.15 M NaCl, 0.01 M 
sodium phosphate, 0.001 M EDTA), 0.3% SDS and 0.5 mg/ml single-stranded herring sperm 
DNA. Hybridization was performed under similar conditions at probe concentrations of 0.3-1 χ 
10' cpm/ml. The blots were washed twice for 5 min in 5 χ SSPE, 0.3% SDS at 65 eC and once 
for 10 min in 1 χ SSPE, 0.3% SDS at 65°C. Gene Screen Plus membranes carrying amplified 
DNA were treated similarly, but pre-hybridization was restricted to 2-4 h and lower concentra­
tions of herring sperm (10^g/ml) were used. Blots containing total genomic DNA or amplified 
DNAs were exposed to Kodak X-Omat S-film with two intensifying screens for periods of up to 
7 days or for 4-16 h, respectively. 
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Linkage analysis 
Two-point linkage analyses were performed employing version 4.6 of the LINKAGE program 
package (Lathrop and Lalouel 1984). 
RESULTS 
The sequences of the oligonucleotide probes AE4112 and АЕ-СІ12 are shown in Fig. 1. 
Discriminative hybridization and washing conditions were determined empirically by dot blot 
hybridization of plasmid pEB4 (Wallis et al. 1983), which contains an АРОЕЭ cDNA insert 
spanning the entire gene area between codon 45 and the termination codon. Next, these hybridi­
zation conditions were employed for oligonucleotide screening on blots of EcoRI-cleaved 
genomic DNAs from various individuals with known APOE type. Figure 2a shows that the 
signals were of the expected size (2 kb) and concordant with the known APOE phenotype. 
A major problem encountered in the direct oligonucleotide screening assay is that generally 
bands are weak and show up only after prolonged periods of autoradiography. To increase the 
sensitivity and speed of the ASO hybridization procedure and to avoid any ambiguity in the 
interpretation of the results, DNA from several individuals was re-typed after amplification of the 
relevant APOE gene region by the PCR technique. We have recently adapted this technique to 
obtain 10,000-fold amplification of the apoE exon Г gene region spanning the polymorphic 
codons at positions 112 and 158 (H. Smeets et al. 1988). Because the method is yet too laborious 
to be applied routinely in a large number of pedigrees we only re-analysed a selected subfraction 
of the DNAs. Haplotypes of eight individuals that were re-examined in this way were in 
agreement with those of the direct assay (see Fig. 2b). 
9a 95 ie« 
glu Qlu thr arg al· arg lau ваг lya glu lau gin ala ala 
GAG GAG ACG CGG GCA CGG CTG ТСС AAG GAG CTG GAG GCG GCG^ 
AE-1 5 ' HG CGG~5"CÂ~ CEE-gTg ТСС ЛАВ В 
110 115 
aap mat glu aap val суш gly arg lau val gin 
GAC A TG GAG GAC GTG TGC GGC COC CTG GTG CAG 
AE-tll2 5 
АЕ-СІ12 S'-EASZEÜ 
Ιββ 16S 
gin lya arg lau ala val tyr gin ala gly ala arg 
CAG AAG CGC CTG GCA GTG TAC CAG GCC GGG GCC CGC 
ВАС ССПГАС ATO 7 
Hg. 1. Structure of DNA and protein across the polymorphic region in the APOE gene and Bequences of 
oligonucleotides used for allele-specific hybridization and in vitro amplification. Positions of homology for 
amplification oligonucleotides (AE-1 and AE-2) and for c3- and c4-specific oligonucleotides (AE-tl 12 and 
АЕ-СІ12) are indicated by boxes. 
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In a sample of 45 unrelated Caucasian individuals, allele frequencies of the cysl 12 (e3) and the 
argll2 («4) variant were 88.9% and 11.1%, respectively. To estimate the genetic distance 
between the myotonic dystrophy locus and the APOE gene, 16 myotonic dystrophy families were 
screened with the АЕ-СІ12 and AE-tll2 probes. Seven families were informative for the 
polymorphism. Only two crossovers - doubly checked both by direct hybridization and after 
combination with primer-directed enzymatic DNA amplification (see Fig. 2b) - were observed in 
a total of 42 fully or partly informative méioses, yielding a maximum lod score of 7.47 for a 
recombination fraction of 0.047 (male θ = female Θ). 
APOC2-TaqI haplotypcs were determined in the same families. No recombination was found 
between APOC2 and DM (z^, = 8.30) nor between APOC2 and APOE ( z ^ = 5.61). The two 
families showing crossovers between APOE and DM, were not informative for the APOC2-TaqI 
polymorphism. Results of two-point linkage analysis with lod scores calculated for males and 
females combined (male θ = female Θ) or calculated separately are given in Table 1, parts A 
and В respectively. A multi-point linkage map spanning the DM gene and a variety of other 
chromosome 19 markers will be presented elsewhere. 
(bp) 
2000-« i · 
FAMILY 10 
Or· (bp) 4 i 
™-m*fEß 
FAMILY 13 
• T D 
• à 
wwmm 
228-
• f · t 2000- Щ m a 33 3/4 4/4 b 3ß 3/4 3/3 3/4 3/4 3/3 3/4 3/3 
Fig. 2a. Direct haplotyping of individuals with known ApoE phenotype by hybridization with APOE allele-
specific oligonucleotides. DNA blots of genomic DNAs digested with restriction enzyme EcoRI were 
sequentially hybridized with oligonucleotide AE-tll2 (top) and АЕ-СІ12 (bottom) and exposed for autoradio­
graphy for 7 days. Only the relevant portions of the autoradiographs containing the 2000-bp signals are 
shown, b. APOE haplotyping of DM (crossover) families using hybridization of APOE allele-specific 
oligonucleotides combined with in vitro amplification of DNAs. Small samples of genomic DNAs of 
individuals from DM families 10 and 13 were amplified and reaction products were blotted as given in 
Materials and Methods. Oligonucleotide hybridization was as given for (a) and autoradiography was for 16h. 
Only the portions of the autoradiographs containing the 228-bp signals of the amplified DNAs are shown. 
Relevant parts of DM pedigrees containing the APOE-DM crossover are given on top of both panels. Known 
(a) or determined (b) APOE-phenotypes (3/3, 3/4 or 4/4) are given below each lane. 
DISCUSSION 
Oligonucleotide hybridization procedures have been used previously for detection of mutant 
alleles in various disorders like sickle cell anaemia and phenylketonuria. As demonstrated here, 
this procedure can also be employed for routine linkage analysis. In principle, oligonucleotide 
hybridization allows detection of virtually any kind of allelic DNA sequence variation, whether in 
expressed genes or in anonymous loci, and unlike the RFLP approach is not confined to sequence 
variation in restriction enzyme cleavage sites. Methodological and technical progress has 
rendered oligonucleotide synthesis both rapid and affordable. The only major drawback of the 
89 
use of oligonucleotides for routine linkage analysis lies in their limited sensitivity. This limitation 
can be overcome by use of the technique for in vitro DNA amplification which tremendously 
increases both speed and sensitivity of the method and enables reliable haplotyping, even when 
only very limited amounts of DNA are available (Saiki et al. 1985; Embury et al. 1987). The 
polymerase chain reaction, as described by Saiki et al. (1985), is a quick, but rather laborious, 
process requiring serial pipetting. Therefore, we have only applied it to DNA samples from a 
selected subset of individuals and to samples that could not be scored unambiguously in the direct 
hybridization assay. Recent improvements of this technique involving the application of heat-
stable DNA polymerase of Thermits aquatieus (Saiki et al. 1988) and the automation of various 
steps involved in consecutive reaction cycles soon should pave the way for facile parallel 
processing of greater numbers of samples and, consequently, should widen the scope for 
oligonucleotides as tools for diagnosis and linkage studies. 
A 
locus 
vs locus 
ОЙ-APOE 
AP0C2-AP0E 
DH-AP0C2 
В 
locus versus 
DH-APOE 
AP0C2-AP0E 
DM-APOC2 
Lod score et recombination frequency (Θ) 
(male θ = female Θ) 
0.00 0.02 0.04 0.06 0.08 0.10 
-β 
5.61 
8.30 
locus 
7.22 
5.39 
7.98 
7.46 
5.16 
7.65 
z
max 
8.35 
5.60 
8.29 
7.44 
4.93 
7.31 
7.32 7.12 
4.70 4.46 
6.95 6.59 
max 
0.001 
0.001 
0.001 
z
max
 (e
max> 
7.47 (0.047) 
5.61 (0.00) 
8.30 (0.00) 
θ^-females 
0.117 
0.001 
0.001 
Table 1. Two point linkage data for DM, APOE and APOC2: A shows the combined lod scores (z) 
calculated under the assumption that male and female recombination rates are equal; В gives the maximum 
lod scores at independent estimation of optimum male and female recombination frequencies. Tested were 16 
families with myotonic dystrophy comprising 156 individuals. In the population sample tested, allele 
frequencies were 88.9% for APOE-tll2 and 11.1% for АРОЕ-СІ12. This agrees well with the published 
Qoinl) frequencies of the alleles ύ. and «3 and the frequency of c4, respectively, as determined by protein 
typing (Breslow et al. 1985; Kissen et al. 1987b). 
Compared to other chromosome 19 markers, surprisingly little has been published about the 
linkage between the APOE gene and DM. In the only other study that we are aware of, Laberge 
et al. (1985) examined protein polymorphisms in a large French-Canadian kindred and obtained a 
lod score of 7.2 at a recombination fraction of 0.10 (males and females combined). APOE and 
APOC2 have been found to be very tightly linked by others (Myklebost et al. 1984; Naylor et al. 
1985) which is confirmed by our data (z^, = 5.61 at θ = 0.0). Only one recombination event 
between these two markers has ever been reported (Berg et al. 1985). This provides further 
circumstantial evidence for APOE and DM being closely linked, as suggested by our present 
study, because of the tight linkage between APOC2 and DM ( θ „ = 0.04, z^. > 30; Naylor et 
al. 1985; Pericak-Vance et al. 1986; Wieringa et al. 1988; Shaw and Eiberg 1987). Physical 
evidence in support of APOE, APOC2 and APOCl to be part of a gene cluster has been 
published recently (Smit et al. 1988). Already earlier it was known that all three genes map into 
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results; Hulsebos et al. 1986; Wieringa et al. 1988). 
Because of its close linkage, APOC2 is currently being used as one of the most useful diagnos­
tic markers of DM. Unfortunately, however, as a result of linkage disequilibrium between the 
various RFLPs that have been detected, this marker is not infonnative in a substantial proportion 
(approximately 50%) of DM families. Preliminary evidence from our laboratory indicates that 
indeed, useful diagnostic linkage information could be obtained by APOE typing in those families 
that were not informative for any of the APOC2 markers (B. v. Oost and H. Brunner, unpublish­
ed results). Therefore, it appears that APOE can be added to the list of polymorphic DNA 
markers that can be employed profitably for presymptomatic diagnosis of myotonic dystrophy. 
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Appendix 3 
RFLP REPORTS 
A LOCUS AT 19cen-ql3.2 (D19S15) CONTAINING THREE RFLPS 
LINKED TO MYOTONIC DYSTROPHY (DM) IS RECOGNIZED BY 
PROBE pJSB6 
Schepens J, Hulsebos T, Smeets H, Coerwinkel M, Brunner H, Ropers HH, 
Wieringa В 
Nucleic Acids Res (1987) 15:3193 
ISOLATION OF A POLYMORPHIC DNA SEQUENCE pJSBll (D19S16) 
FROM THE HUMAN CHROMOSOME 19cen-ql3.2 REGION LINKED 
TO THE MYOTONIC DYSTROPHY (DM) GENE 
Schepens J, Smeets H, Hulsebos T, Branner H, Wieringa В 
Nucleic Acids Res (1987) 15:3192 
EcoRI RFLP AT 19cen-ql3.2 IDENTIFIED BY THE ANONYMOUS DNA 
SEQUENCE pPM6.7 (D19S18) 
Smeets H, Markslag Ρ, Bril J, Hulsebos Τ, Brunner Η, Schonk D, Ropers HH, 
Wieringa В 
Nucleic Acids Res (1987) 15:8120 
Ncol RFLP AT THE CREATINE KINASE-MUSCLE TYPE GENE 
LOCUS (CKMM, CHROMOSOME 19) 
Coerwinkel-Driessen M, Schepens J, van Zandvoort P, van Oost В, Mariman 
E, Wieringa В 
Nucleic Acids Res (1988) 16:8743 
TaqI RFLP AT 19ql3.1 IDENTIFIED BY THE ANONYMOUS DNA 
SEQUENCE p5B18 (D19S28) 
Smeets H, Schepens J, Coerwinkel M, Brunner H, Schonk D, Ropers HH, 
Wieringa В 
Nucleic Acids Res (1989) 17:3325 
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Mspl RFLP AT 19cen-ql2 ΙϋΕΝΤΙΠΕΟ BY THE ANONYMOUS DNA 
SEQUENCE pPM17.4 (D19S29) 
Smeets Η, Markslag Ρ, Hulsebos Τ, Brunner Η, Schonk D, Ropers HH, 
Wieringa В 
Nucleic Acids Res (1989) 17:3324 
Mspl RFLP AT 19ql2-ql3.1 IDENTIFIED BY THE ANONYMOUS DNA 
SEQUENCE p20B18 (D19S30) 
Smeets H, Schepens J, Coerwinkel M, Brunner H, Schonk D, Ropers HH, 
Wieringa В 
Nucleic Acids Res (1989) 17:3323 
Mspl RFLP AT 19ql2-ql3.1 IDENTIFIED BY THE ANONYMOUS DNA 
SEQUENCE p30B18 (D19S31) 
Smeets H, Coerwinkel M, Schepens J, Brunner H, Schonk D, Ropers HH, 
Wieringa В 
Nucleic Acids Res (1989) 17:3627 
EcoRI RFLP AT 19ql3.1 IDENTIFIED BY THE ANONYMOUS DNA 
SEQUENCE p58B18 (D19S32) 
Smeets H, Coerwinkel M, Schepens J, Brunner H, Schonk D, Ropers HH, 
Wieringa В 
Nucleic Acids Res (1989) 17:3628 
Mspl RFLP DETECTED BY THE HUMAN GLANDULAR KALLIKREIN 
GENE (hGK) ON CHROMOSOME 19q 
Hermens R, Coerwinkel M, Trapman J, Riegman PHJ, Vlietstra RJ, Smeets Η 
and Wieringa В 
Nucleic Acids Res (1990) 18:208 
HUMAN APOCI Hpal RESTRICTION SITE POLYMORPHISM 
REVEALED BY THE POLYMERASE CHAIN REACTION 
Nillesen WM, Smeets HJM, Oost van В 
Nucleic Acids Res (1990) 18:3428 
Mspl RFLP AT 19ql3.3 IDENTIFIED BY THE ANONYMOUS DNA 
SEQUENCE pX75B (D19S112) 
Hermens R, Coerwinkel M, Brunner H, Smeets H, Wieringa В 
Nucleic Acids Res (1991) 19:1726 
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Isolation of probes detecting RFLPS 
During the project, several genomic DNA libraries were used as a source for 
the isolation of probes from the long arm of chromosome 19. These libraries 
include a pcos2 EMBL library from the somatic cell hybrid 908K1 (described 
in Hulsebos et al. 1985)1, a λ EMBL3 libraries from somatic cell hybrids 
908K1B18 (Schonk et al. 1989)' and 20XP3542-1-4 (Stallings et al. 1988)', and 
the λ charon 40 and cosmid Lawrist S libraries of sorted chromosome 19 
(obtained from Dr. DeJong, LLNL, Livermore). Initially, the libraries were 
screened for human specific clones with 32P labeled Alu-repeat DNA or sheared 
total human genomic DNA as a probe. All positive clones were grown as single 
cosmids or phage lysates in single wells of microliter plates (Kohara et al. 
1987)1 and used to establish enriched sublibraries of 19q specific clones. More 
recently, we used the Alu PCR method to generate human specific DNA probes 
from somatic cell hybrid 20XP3542-1-4. Subsequent hybridization of this probe 
mixture to the chromosome specific, λ library facilitated screening procedures 
and yielded several additional clones from the 19ql3.2-13.3 region, many of 
which were especially suited for resolving the DM area further. Using either 
single cosmid or phage DNA, or pools of clones as starting material, the actual 
DNA probes were generated by subcloning of EcoRI/PstI, BamHI/PstI, 
SacII/PstI or Sau3A fragments in pSP64/65 or pGEM3/4 plasmid vectors. 
Human specific, single copy probes were mapped to specific regions of 19q, 
using panels of somatic cell hybrids (Schonk et al. 1989; Schonk, 1991)1. 
Next, useful single copy probes, together with gene-derived probes from 19q, 
isolated by our own group (CKM; Mariman et al. 1987)' or received from 
collaborating groups, were employed to search for RFLPs. To this end, we 
compared the hybridization signal of a DNA pool of 10 unrelated individuals 
with the signal of DNA from a somatic cell hybrid, containing only 1 copy of 
chromosome 19. This comparison, which was performed with at least 11 
different restriction enzymes for each probe, allows easy and efficient detection 
of RFLPs (Murray et al. 1987)1. For each probe that detected an RFLP, allele 
frequencies and genetic distances to DM and other 19q markers were 
established, using linkage analysis in DM families (Brunner et al. 1989a+b)'. 
During the period 1985-1990, more than 30 19q specific single copy and 3 
low repetitive probes were isolated. About one third (12 probes) detect RFLPs. 
A collection of the RFLP reports is given in this appendix. Together, our 
probes constitute a fixed set of demarcation points that can be used as a 
framework for all further mapping on human 19q. 
1
 References are listed at pages 59 to 73. 
95 
A LOCUS AT 19cen-19ql3.2 (D19S15) 
CONTAINING THREE RFLPS LINKED TO MYOTONIC 
DYSTROPHY (DM) IS RECOGNIZED BY PROBE pJSB6 
J. Schepens, T. Hulsebos, H. Smeets, 
M. Coerwinkel, H. Brunner, H.H. Ropers and B. Wieringa 
Department of Human Genetics, University of Nijmegen, 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: Probe pJSB6-a 2.5 kb EcoRI-PstI partially digested DNA segment subcloned 
in pSP64 (Promega Biotec) and originating from a human der 19 specific pcos2 EMBL 
cosmid library (Hulsebos et al., 1986). Complete Pstl-EcoRI digestion yields single copy 
probe fragments of 500 and 450 bp detecting С and A or В alleles, respectively. 
Polymorphisms: TaqI (T'CGA) identifies three polymorphic systems with bands at either 6.0 kb 
(Al) or 6.5 kb (A2), 4.5 kb (Bl) or 2.7 kb (B2) and 3.3 kb (CI) or 1.6 kb (C2) and 
invariant bands at 3.3 kb (weak) and 1.3 kb. 
Frequency: Studied in a total of 52 unrelated European Caucasians: 6 kb Al allele 0.038, 6.5 kb 
A2 allele 0.962, 4.5 kb Bl allele 0.116, 2.7 kb B2 allele 0.884 and 3.3 kb CI allele 0.077, 
1.6 kb C2 allele 0.923. 
Not polymorphic for: EcoRI, Hindlll, PstI, PvuII and Sad. 
Chromosomal localization: Polymorphic bands assigned to chromosome region 19cen-ql3.2 by 
Southern blot analysis of human-Chinese hamster cell hybrids containing unique subregional 
fragments of chromosome 19 (Schonk et al., in prep). 
Mendelian inheritance: Co-dominant segregation demonstrated in 9 DM families. Linked to DM 
at recombination frequency 0.06, lod score 4.48 (H. Brunner, E. Lambermon et al. in prep.). 
Probe availability: Available for collaborators, contact B.W. or H.H.R.. RFLPs observed at 
usual stringency conditions (0.1 SSC, 65°C), low background. Subcloned fragment 
recognizing A and С or В alleles only available. 
Reference: T. Hulsebos, B. Wieringa, R. Hochstenbach, D. Smeets, J. Schepens, F. Oerlemans, 
J. Zimmer, and H.H. Ropers (1986) Cytogenet. Cell Genet. 43, 47-56 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, and 
by the Deutsche Forschungsgemeinschaft, grant Ro 389/15-1 to H.H. Ropers. 
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ISOLATION OF A POLYMORPHIC DNA SEQUENCE pJSBll (D19S16) 
FROM THE HUMAN CHROMOSOME 19cen-ql3.2 REGION LINKED 
TO THE MYOTONIC DYSTROPHY (DM) GENE 
J. Schepens, H. Smeets, T. Hulsebos, H. Brunner and B. Wieringa 
Department of Human Genetics, University of Nijmegen, 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: Probe pJSBll- a 0.75 kb EcoRI-PstI single copy DNA segment subcloned in 
pSP64 (Promega Biotec) and originating from a human der 19 specific pcos2 EMBL cosmid 
library (Hulsebos et al., 1986). 
Polymorphisms: TaqI (T'CGA) identifies a two allele polymorphism with bands at either 8.5 kb 
or 6.5 kb and invariant bands at 6.7, 3.4, 3.2, 1.6 and 0.9 kb. 
Mspl identifies alleles at 1.7 kb and 1.6 kb. 
Frequency: Studied in a total of 40 unrelated European Caucasians for TaqI alleles only: 8.5 kb 
allele 0.36, 6.5 kb allele 0.64. 
Not polymorphic for: BamHI, EcoRI, Hindlll, Rsal, PstI, PvuII and Sad. 
Chromosomal localization: Polymorphic bands localized on chromosome region 19cen-ql3.2 by 
Southern blot analysis using a panel of human-Chinese hamster cell hybrids containing unique 
subregional fragments of chromosome 19 of man (Schonk et al., in prep.). 
Mendelian inheritance: Co-dominant segregation demonstrated in 13 DM families. Locus linked 
to myotonic dystrophy at recombination frequency 0.05, lod score 4.98 (H. Brunner et al., in 
prep.). 
Probe availability: Available for collaborators, contact B.W. 
Other comments: Another plasmid pJSC3 derived from same cosmid recognizing same alleles in 
context of a variety of invariant band available. RFLP observed at usual stringency conditions 
(0.1SSC, 65°C). 
Reference: T. Hulsebos, B. Wieringa, R. Hochstenbach, D. Smeets, J. Schepens, F. Oerlemans, 
J. Zimmer and H.H. Ropers (1986) Cytogenet. Cell Genet. 43, 47-56. 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, and 
by the Deutsche Forschungsgemeinschaft, grant Ro 389/15-1 to H.H. Ropera. 
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EcoRI RFLP AT 19cen-ql3.2 mENTIFIED 
BY THE ANONYMOUS DNA SEQUENCE рРМб.7 (D19S8) 
H. Smeets, P. Markslag, J. Bril, T. Hulsebos, H. Brunner, 
D. Schonk, H.H. Ropers and В. Wieringa 
Department of Human Genetics, University of Nijmegen, 
ГО Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: A 0.75 kb BamHI/PstI DNA segment subcloned in pGEM4 (Promega 
Biotec) and derived from a human der 19 specific pCos2 EMBL library (Hulsebos et al., 
1986). 
Polymorphisms: EcoRI (GAATTC) identifies a two allele polymorphism with bands at either 40 
kb (Al) or 25 and 15 kb (A2) and an invariant band at 4.5 kb. The probe is also 
polymorphic for Mspl (CCGG) with bands at either 5 kb (Bl) or 3.5 kb (B2) and an 
invariant band at 4.0 kb. 
Not polymorphic for TaqI, PvuII, PstI, BamHI, Rsal, and H indili, when tested on 
chromosomal DNA of 5 unrelated individuals. 
Frequency: Studied for EcoRI alleles in 44 unrelated Caucasians: 40 kb allele (Al) 0.65; 25 
kb/15 kb allele (A2) 0.35. 
Frequency Mspl polymorphism not studied. 
Chromosomal localization: Localized at 19cen-ql3.2 by Southern blot analysis using a panel of 
human Chinese hamster cell hybrids containing unique subregional fragments of chromosome 
19 (Schonk et al., in prep). 
Mendelian inheritance: Co-dominant segregation demonstrated in 12 myotonic dystrophy (DM) 
families. Linked to the DM gene at male recombination frequency 0.10 (Lod-score=2.62). 
Probe availability: Available -for collaboration only- from B. Wieringa. 
Reference: T. Hulsebos, B. Wieringa, R. Hochstenbach, D. Smeets, J. Schepens, F. Oerlemans, 
J. Zimmer, and H.H. Ropers (1986) Cytogenet. Cell Genet. 43, 47-56 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, and 
by grant Ro 389/15-1 to H.H. Ropers from the Deutsche Forschungsgemeinschaft. 
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Ncol RFLP AT THE CREATINE KINASE-MUSCLE TYPE GENE 
LOCUS (CKMM, CHROMOSOME 19) 
Marga Coerwinkel-Driessen, Jan Schepens, Peter van Zandvoort, 
Bernard van Oost, Edwin Mariman and Bé Wieringa 
Department of Human Genetics, University Nijmegen, Radboud Hospital M318, 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: A 3.2 kb human genomic DNA fragment (BamHI-Sau3A) of the 3 ' 
untranslated and 3 ' flanking region of the CKMM gene was isolated and subcloned into the 
BamHI site of vector pSP64 (Promega Biotec). 
Polymorphism: The CKMM 3'-probe identifies a 2-allele polymorphism with bands at 2.3 and 
1.0 kb (allele A) and 3.3 kb (allele B). In addition a weak constant 4.2 kb band is observed. 
This probe also detects a 2-allele TaqI RFLP reported previously (1), as either a 4.3 kb (A) 
or 4.2 kb (B) band. 
Frequency: Estimated from 30 unrelated Caucasians. 
A allele: 0.68 
В allele: 0.32 
Not polymorphic for: BamHI, Hindlll, EcoRI, EcoRV, Mspl, PstI, PvuII, Rsal, Sad and 
Xbal. 
Chromosomal localization: The CKMM locus previously has been assigned to 19ql3.2-ql3.3 
(2). 
By Southern blot analysis of human-rodent somatic cell hybrids containing unique subregional 
fragments of chromosome 19 of man (3) we have assigned the gene to 19ql3.2 (J. Schepens 
et al., in preparation). 
Menddian inheritance: Co-dominant segregation in 8 families with 3 generations. 
Other comments: Low background/high signal with final wash at 6S0C in 0.1 χ SSC/0.1% (w/v) 
SDS. The CKMM locus is closely linked to the myotonic dystrophy locus (H. Brunner et al., 
in preparation). 
Probe availability: On collaborative basis, contact B.W. 
References: 1. Putney, S. et al., J. Biol. Chem. 250, 14317-14320 (1984). 
2. Nigro, J.M. et al., Am. J. Hum. Genet. 40, 115-125 (1987). 
3. Hulsebos, T. et al., Cytogenet. Cell Genet. 43, 47-56 (1986). 
Acknowledgements: Supported by grants (28-1165) from the Netherlands Prevention Fund, (Ro 
389/15-2) from the Deutsche Forschungsgemeinschaft and (900-501-057) of the " Stichting 
voor Medisch Onderzoek en Gezondheidsonderzoek", NWO. 
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TaqI RFLP AT 19ql3.1 ШЕІ ППЕО BY THE ANONYMOUS DNA 
SEQUENCE p5B18 (D19S28) 
H. Smeets, J. Schepens, M. Coerwinkel, H. Brunner, D. Schonk, 
H.H. Ropers and B. Wieringa 
Department of Human Genetics, University of Nijmegen, 
ГО Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: A 0.5 kb EcoRI/PstI DNA segment subcloned in pSP64 (Promega Biotec) 
and derived from a human der (19q) specific lambda EMBL3 library (Smeets et al., in prep). 
Polymorphisms: TaqI (TCGA) detects a two allele polymorphism with bands at either 2.7 kb 
(Al) or 1.7 kb (A2) and no constant bands. 
Not polymorphic for BgUI, Eco RI, EcoRV, Mspl, PvuII, Rsal and Sad, when tested on 
chromosomal DNA of 10 unrelated individuals. 
Frequency: Studied for TaqI alleles in 41 unrelated Caucasians: 2.7 kb allele (Al) 0.55 and 1.7 
kb allele (A2) 0.45. 
Chromosomal localization: Localized at 19ql3.1 by Southern blot analysis using a panel of 
human-rodent somatic cell hybrids containing unique segments of 19q (Schonk et al. 1989). 
Mendelian inheritance: Co-dominant segregation demonstrated in 16 myotonic dystrophy (DM) 
families. Linked to the DM gene at recombination frequency 11.8 cM with lod score 2.92 
(Brunner et al., submitted). 
Probe availability: Available, contact B. Wieringa. 
References: Schonk et al. (1989) Genomics 3, in press. 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, by 
grant Ro 389/15-2 to H.H. Ropers from the Deutsche Forschungsgemeinschaft, by the 
Prinses Beatrixfonds, grant 87-2694, and by the Muscular Dystrophy Association, under the 
Association's Task Force on Genetics Grant Program. 
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Mspl RFLP AT 19cen-ql2 roENTIFlED BY THE ANONYMOUS DNA 
SEQUENCE pPM17.4 (D19S29) 
H. Smeets, P. Markslag, T. Hulsebos, H. Brunner, D. Schonk, 
H.H. Ropers and B. Wieringa 
Department of Human Genetics, University of Nijmegen, 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: A 1.8 kb BamHI/PstI DNA segment subcloned in pGEM4 (Promega Biotec) 
and derived from a human der 19 specific pCos2 EMBL library (Hulsebos et al., 1986). 
Polymorphisms: Mspl (CCGG) detects a two allele polymorphism with bands at either S.S kb 
(Al) or 3.S kb (A2) and an invariant band at 3.6 kb. 
Not polymorphic for BamHI, EcoRI, Hindlll, PstI, PvuII, Rsal and TaqI, when tested on 
chromosomal DNA of 5 unrelated individuals. 
Frequency: Studied in 55 unrelated Caucasians: 5.5 kb allele (Al) 0.48 and 3.5 kb allele (A2) 
0.52. 
Chromosomal localization: Localized at 19cen-ql2 by Southern blot analysis using a panel of 
human-rodent somatic cell hybrids containing unique segments of 19q (Schonk et al. 1989). 
Physically linked to centromere specific alphoid sequences. 
Mendelian inheritance: Co-dominant segregation demonstrated in 16 myotonic dystrophy (DM) 
families. Linked to the DM gene at recombination frequency 12.S cM with lod score 1.24 
(Brunner et al., submitted). 
Probe availability: Available, contact B. Wieringa. 
References: Hulsebos et al. (1986) Cytogenet. Cell Genet. 43:47-56; Schonk et al. (1989) 
Genomics 3, in press. 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, by 
grant Ro 389/15-2 to H.H. Ropers from the Deutsche Forschungsgemeinschaft, by the 
Prinses Beatrixfonds, grant 87-2694, and by the Muscular Dystrophy Association, under the 
Association's Task Force on Genetics Grant Program. 
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Mspl RFLP AT 19ql2-ql3.1 ГОЕШЧПЕО BY THE ANONYMOUS DNA 
SEQUENCE pP20B18 (D19S30) 
H. Smeets, J. Schepens, M. Coerwinkel, H. Brunner, D. Schonk, 
H.H. Ropers and В. Wieringa 
Department of Human Genetics, University of Nijmegen, 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: A 0.4 kb EcoRI/PstI DNA segment subcloned in pSP64 (Promega Biotec) 
and derived from a human der (19q) specific lambda EMBL3 library (Smeets et al., in 
prep.). 
Polymorphisms: Mspl (CCGG) detects a two allele polymorphism with bands at either 3.0 kb 
(Al) or 2.5 kb (A2) and no constant bands. The probe is also polymorphic for Pstl. 
Not polymorphic for BgUI, EcoRI, EcoRV, Hindlll, PvuII, Rsal, Sad and TaqI, when tested 
on chromosomal DNA of 10 unrelated individuals. 
Frequency: Studied for Mspl alleles in 39 unrelated Caucasians: 3.0 kb allele (Al) 0.63 and 2.5 
kb (A2) 0.37. 
Chromosomal localization: Localized at 19ql2-ql3.1 by Southern blot analysis using a panel of 
human-rodent somatic cell hybrids containing unique segments of 19q (Schonk et al. 1989). 
Mendelian inheritance: Co-dominant segregation was demonstrated in 16 myotonic dystrophy 
families. Linked to the DM gene at recombination frequency 9.9 cM with lod score 2.1 
(Brunner et al., submitted). 
Probe availability: Available, contact B. Wieringa. 
References: Schonk et al. (1989) Genomics 3, in press. 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, by 
grant Ro 389/15-2 to H.H. Ropers from the Deutsche Forschungsgemeinschaft, by the 
Prinses Beatrixfonds, grant 87-2694, and by the Muscular Dystrophy Association, under the 
Association's Task Force on Genetics Grant Program. 
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Mspl RFLP AT 19ql2-ql3.1 mENTIFIED BY THE ANONYMOUS DNA 
SEQUENCE p30B18 (D19S31) 
H. Smeets, M. Coerwinkel, J. Schepens, H. Brunner, D. Schonk, 
H.H. Ropers and B. Wieringa 
Department of Human Genetics, University of Nijmegen, 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: A 0.65 kb EcoRI/PstI DNA segment subcloned in pSP64 (Promega Biotec) 
and derived from a human der (19q) specific lambda EMBL3 library (Smeets et al., in 
prep.). 
Polymorphisms: Mspl detects a two allele polymorphism with bands at either 13 kb (Al) or 4.3 
kb (A2) and no constant bands. Not polymorphic for BgUI, EcoRI, EcoRV, PvuII, Rsal and 
Sad, when tested on chromosomal DNA of 10 unrelated individuals. 
Frequency: Studied for Mspl alleles in 28 unrelated Caucasians: 18 kb allele (Al) 0.93 and 6.7 
kb allele (A2) 0.07. 
Chromosomal localization: Localized at 19ql2-ql3.1 by Southern blot analysis using a panel of 
human-rodent somatic cell hybrids containing unique segments of 19q (Schonk et al. 1989). 
Mendelian inheritance: Co-dominant segregation demonstrated in 7 myotonic dystrophy (DM) 
families. 
Probe availability: Available, contact B. Wieringa. 
References: Schonk et al. (1989) Genomics 3, in press. 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, by 
grant Ro 389/15-2 to H.H. Ropers from the Deutsche Forschungsgemeinschaft, by the 
Prinses Beatrixfonds, grant 87-2694, and by the Muscular Dystrophy Association, under the 
Association's Task Force on Genetics Grant Program. 
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EcoRI RFLP AT 19ql3.1 ГОЕ№ГІИЕО BY THE ANONYMOUS DNA 
SEQUENCE p58B18 (D19S32) 
H. Smeets, M. Coerwinkel, J. Schepens, H. Brunner, D. Schonk, 
H.H. Ropers and В. Wieringa 
Department of Human Genetics, University of Nijmegen, 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: A 1 kb EcoRI/PstI DNA segment subcloned in pSP64 (Promega Biotec) and 
derived from a human der (19q) specific lambda EMBL3 library (Smeets et al., in prep.). 
Polymorphisms: EcoRI (GAATTC) detects a two allele polymorphism with bands at either 6.5 
kb (Al) or 3 kb (A2) and no constant bands. 
Not polymorphic for BgUI, EcoRV, Hindlll, Mspl, PstI, PvuII, Rsal, Sad and TaqI, when 
tested on chromosomal DNA of 10 unrelated individuals. 
Frequency: Studied for EcoRI alleles in 46 unrelated Caucasians: 6.5 kb allele (Al) 0.67 and 3 
kb allele (A2) 0.33. 
Chromosomal localization: Localized at 19ql3.1 by Southern blot analysis using a panel of 
human-rodent somatic cell hybrids containing unique segments of 19q (Schonk et al. 1989). 
Menddian inheritance: Co-dominant segregation demonstrated in 16 myotonic dystrophy (DM) 
families. 
Probe availability: Available, contact B. Wieringa. 
References: Schonk et al. (1989) Genomics 3, in press. 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, by 
grant Ro 389/15-2 to H.H. Ropers from the Deutsche Forschungsgemeinschaft, by the 
Prinses Beatrixfonds, grant 87-2694, and by the Muscular Dystrophy Association, under the 
Association's Task Force on Genetics Grant Program. 
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Mspl RFLP DETECTED BY THE HUMAN GLANDULAR 
KALLIKREIN GENE (hGK) ON CHROMOSOME 19q 
R. Hermens1, M. Coerwinkel1, J. Trapman2, P.H.J. Rìegman2, 
R.J. Vlietstra2, H. Smeets1 and B. Wieringa1 
'Department of Human Genetics, University of Nijmegen, 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
department of Pathology, Erasmus University, 
PO Box 1738, 3000 DR Rotterdam, The Netherlands 
Source/description: A 1.5 kb hGK-cDNA segment cloned in the EcoRI site of pUC9. 
Polymorphism: Mspl (CCGG) detects a two allele polymorphism with bands at either 2.0 kb or 
1.8 kb. Faint constant bands light up at 2.4 kb, 1 kb and 0.8 kb. 
Not polymorphic for TaqI and PstI, when tested on chromosomal DNA of ten unrelated 
individuals. 
Frequency: Studied in 60 unrelated Caucasians: 2 kb allele (Al) 0.2 and 1.8 kb allele (A2) 0.8. 
Chromosoms! localization: Localized at 19ql3.2-qter by Southem blot analysis using a panel of 
human-rodent somatic cell hybrids containing unique segments of 19q (Schonk et al. 1989). 
Mendelian inheritance: Co-dominant segregation demonstrated in 8 myotonic dystrophy 
families. 
Probe availability: Contact P. Riegman 
Reference: Schonk et al. (1989) Genomics 4:384-396 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, by 
grant Ro 389/15-2 to H.H. Ropers from the Deutsche Forschungsgemeinschaft, by the 
Prinses Beatrixfonds, grant 87-2694, by the American Muscular Dystrophy Association and 
the Dutch Cancer Society (KWF). 
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HUMAN APOCI Hpal RESTRICTION SITE POLYMORPHISM 
REVEALED BY THE POLYMERASE CHAIN REACTION 
W.M. Nillesen, H.J.M. Smeets and B.A. van Oost 
DNA-Diagnosis Laboratory, Institute of Human Genetics, 
University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Source/description: Klasen et al. (1) described a Hpal site polymorphism that is located at the 5' 
end of the ApoCl gene. Using the published sequence data (2) we have selected primers to 
amplify a 222 bp fragment encompassing the polymorphic Hpal restriction site. 
5'-primer upstream: S'-TTT GAG CTC GGC TCT TGA G AC AGG AA-3'. 3'-primer 
downstream 5'-GGT CCC GGG С AC TTC CCT TAG CCC CA-3'. 
Protocol: The PCR was performed using 1 /ig of DNA and 10 pMoles of each primer. DNA 
was amplified for 30 cycles using a New Brunswick thermal cycler: denaturation: 50 sec 
95°C, annealing: 50 sec 58°C, elongation: 90 sec 72°C. Ten μί of the reaction mixture 
was incubated with 20 U Hpal (Beekman Instruments Nederland) in 15 μί 20 mM potassium 
chloride buffer (pH 7.4). The reaction mixture was analysed directly on a 3.75 % agarose, 
0.25% NuSieve agarose (FMC BioProducts, Rockland, ME) gel run in 40 mM Tris-Acetate 
buffer (pH 8.0). 
Polymorphism: Allele 1 (Hpal restriction site absent) is 222 bp and allele 2 (Hpal restriction site 
present) is 159 bp. The smaller fragment of 63 bp is usually not visible. 
Frequency: Allele 1: 0.65, allele 2: 0.35. 
Chromosomal localization: 19ql3.2 
Mendelian mheritance: Co-dominant segregation was observed in 12 myotonic dystrophy 
families (see also figure). No recombinants between the ApoCI locus and the DM gene were 
observed in this set of families (Maximal LOD score of 6.6 at zero percent recombination). 
References: 1) Klasen, E.C. et al. (1987) Hum. Genet. 75, 244-247. 2) Smit, M. et al. (1988) 
Biochem. Biophys. Res. Com. 152, 1282-1288. 
• 1 О 
Hh Hh 
¿ ό ό Α ώ ό ώ 
Hh hh Hh Hh hh hh Hh 
с 
- + - + — + -+—+—4-—+ — + - + 
Direct visualization of the amplification products before (-) and after (+) digestion with Hpal 
in an ethidium bromide-stained gel (see protocol). Both alleles are visible for the 
heterozygous parents (Hh), while their children are either heterozygous or homozygous for 
the smaller allele (hh). 
ЧыУЯЯ№Я 
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Mspl RFLP AT 19ql3.3 ГОЕІ ТІПЕО BY THE ANONYMOUS DNA 
SEQUENCE pX75B (D19S112) 
R. Hermens, M. Coerwinkel, H. Brunner, H. Smeets and B. Wieringa 
Department of Human Genetics, University of Nijmegen, 
P.O. Box 9101, 6S00 HB Nijmegen, The Netherlands 
Source/description: A 1.7 kb DNA segment, subcloned in a modified pGEM3 vector (Promega 
Biotec) and derived from a λ EMBL3 library, constructed from the somatic cell hybrid 
20XP3S42-1-4 (Stellings et al. 1988). SacII/PstI double digestion yields two inserts of 1.2 kb 
and 0.5 kb. The 1.2 kb insert is used for labeling. 
Polymorphism: Mspl (CCGG) detects a two allele polymorphism with bands at either 1.3 kb 
(Al) or 0.8 kb and 0.5 kb (A2). 
Not polymorphic for EcoRI, EcoRV, BgUI, Η indili, Sad, TaqI, PstI, BamHI, Ncol, and 
PvuII. 
Frequency: Studied in 43 unrelated Caucasians: Al 0.92 and A2 0.08. 
Chromosomal localization: Localized at 19ql3.3 distal to the breakpoint in the CKMM gene in 
the t(X;19) somatic cell hybrid 908K1B18 (Smeets et al. 1990). 
Mendelian inheritance: Co-dominant segregation demonstrated in 6 myotonic dystrophy 
families. Linkage data will be reported elsewhere (Brunner et al. in prep). 
Probe availability: Available for collaborative work on Myotonic Dystrophy, contact B. 
Wieringa. 
References: Stallings et al. (1988) Am. J. Hum. Genet. 43:144-151 
Smeets et al. (1990) Am. J. Hum. Genet. 46:492-501 
Acknowledgements: This work was supported by the Dutch Praeventiefonds, grant 28-1165, by 
the Prinses Beatrixfonds, grant 87-2694, by grant Ro 389/15-2 to H.H. Ropers from the 
Deutsche Forschungsgmeinschaft and by the American Muscular Dystrophy Association. 
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Appendix 4 
USE OF VARIABLE SIMPLE SEQUENCE MOTIFS (VSSMs) AS 
GENETIC MARKERS: APPLICATION TO STUDY OF 
MYOTONIC DYSTROPHY 
Hubertus J.M. Smeets, Han G. Brunner, 
Hans-HHger Ropers and Bé Wieringa 
Department of Human Geneticis, Radboud Hospital, University Nijmegen 
PO Box 9101, 6500 HB Nijmegen, The Netherlands 
Published in: 
Human Genetics (1989) 83:245-251 
SUMMARY 
Among the many classes of repetitive elements present in the human genome, the ubiquitous 
"simple sequence motifs" (SSMs) composed of [A]n, [TG]n, [AG]n or codon-tandem repeats 
form a major source of genetic variation. Here we report on a detailed molecular genetic study 
of a "variable simple sequence motif" (VSSM) in the apolipoprotein C2 (apoC2) gene, which 
maps to the 19ql3.2 region in the vicinity of the myotonic dystrophy (DM) locus. By combining 
in vitro DNA-amplification using the polymerase chain reaction and high-resolution gel 
electrophoresis, we could demonstrate a high degree of allelic variation with at least ten alleles, 
which differ in the number of repeated [TG] or [AG] dinucleotide units. Similar results were 
found for the somatostatin I gene locus. To evaluate the usefulness of SSM-length polymor-
phisms as genetic markers, the apoC2-VSSM was employed for linkage analysis in DM families. 
Our results establish that the orientation of the apolipoprotein gene cluster on 19q is cen-apoE-
apoC2-ter and indicate that the many thousands of structurally similar VSSMs in the human 
genome represent a rich source of highly informative genetic and diagnostic markers. 
INTRODUCTION 
Systematic searches for DNA polymorphisms have led to the isolation of an enormous diversity 
of genome elements that display frequent variation because of small sequence alterations such as 
single base mutations or deletions, or because of genome rearrangements involving translocation, 
transposition and DNA amplification. These changes frequently lead to RFLPs (restriction 
fragment length polymorphisms) that can be detected by hybridization with locus specific probes 
(Gusella 1986). Other types of DNA sequence polymorphisms can be detected using allele 
specific oligonucleotides (Conner et al. 1983), the polymerase chain reaction (PCR) (Saiki et al. 
1985, 1988) or comparable sophisticated methodology (Landegren et al. 1988). 
Most of the DNA polymorphisms known to date consist of simple two-allele systems with 
limited genetic mformativity. Loci containing VNTR (variable number of tandem repeat) markers 
are exceptional in this respect (Nakamura et al. 1987). They result from unequal crossover events 
between tandem arrays of short sequences, so-called minisatellite elements, which are thought to 
play a role in recombination or transposition (Jeffreys et al. 1985). The minisatellite or VNTR 
loci are usually multi-allelic and therefore have become valuable tools for the construction of 
linkage maps of the human genome (Nakamura et al. 1987). 
In the course of a study on myotonic dystrophy (DM; a common autosomal dominant disease, 
characterized by myotonia, muscle wasting, cataract, mental deterioration and various other 
clinical abnormalities), we have conducted a systematic search for loci displaying DNA 
polymorphism on human chromosome 19q, where the DM gene is known to reside. We have 
previously described and mapped several new tightly linked RFLP markers that were detected 
with anonymous DNA elements and gene specific probes (Schepens et al. 1987a,b; Smeets et al. 
1987; Coerwinkel-Driessen et al. 1988; Brunner et al. 1989a,b). Recent linkage analysis, 
performed in collaboration with the group of Dr.B.Komeluk at Ottawa, Canada, assigned the 
DM-locus to 19ql3.2, close to the creatine kinase M (CKMM) gene and just distal to the 
apolipoprotein E-C1-C2 gene cluster (Brunner et al. 1989a, b). No recombination between DM 
and CKMM was found in 25 Dutch families. In the previously identified apoC2-DM crossover 
families, however, CKMM was not informative, and linkage studies with other DM markers 
were similarly impaired by the scarcity of informative polymorphisms. In order to increase the 
information content of individual marker loci in the vicinity of the DM gene, we initiated an 
extensive search for DNA-sequence polymorphisms in all material cloned from the 19ql3.2 
region. 
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As a part of this effort we compared nucleotide sequences of the apoC2 gene, previously 
reported by several groups (Wei et al. 1985; Das et al. 1987; Fojo et al. 1987). No major 
discrepancies were found except for a striking heterogeneity in the dinucleotide number of a 
[TG]n[AG]m segment, located in the first intron of this gene. These findings reminded us of the 
previously described instability of "simple sequence motifs" (SSMs), which are ubiquitously 
dispersed throughout the genome of almost all higher eukaryotes and are thought to induce DNA 
variability as a result of recombination or DNA slippage and mispairing during replication (Tautz 
and Renz 1984; Tautz et al. 1986). We report here a detailed molecular genetic study of the 
length variation in the apoC2-bound [TG]n[AG]m block. A method was developed that combines 
PCR and high-resolution gel electrophoresis to convert the SSM into a locus specific, multi-
allelic and highly informative marker of DM. In addition we demonstrate that similar variability 
is associated with other SSM loci and we briefly discuss the potential value of the many V 
(variable) SSM markers for mapping studies and as diagnostic tags of genetic disorders. 
MATERIALS AND METHODS 
Materials 
Peripheral blood samples were collected from myotonic dystrophy families as published 
elsewhere (Friedrich et al. 1987; Brunner et al. 1989a,b). The diagnosis of patients was based on 
the clinical criteria established recently by the myotonic dystrophy working group (Griggs et al. 
1989). Oligonucleotides used for priming the PCR [AC-1 and AC-2 for the apoC2 locus (for 
details see below) and SOM-1 (S'-TTATCTTACCAGAACGGTCTTTA-S·) and SOM-2 5'-
ACCTTTCTGTCCCTGTAGACTTA-3') for the somatostatin I locus] or for detection of the 
amplified SSM ([TG],T) were synthesized by the phosphoramidite method on a Cyclone DNA 
synthesizer (Biosearch-Milligen, Bedford, Mass., USA ). 
PCR amplification and analysis of amplification products 
Blood DNAs used for in vitro DNA amplification with the PCR technique (Saiki et al. 198S, 
1988) were prepared according to standard procedures (Aldridge et al. 1984). 
Amplification with Thermus aquatic us (Taq) DNA polymerase (New England Biolabs, 
Severely, Mass., USA) was performed in a reaction volume of 100 μΐ containing 1 μg genomic 
DNA and 1 μg each of the PCR-amplification primers (AC-1 and AC-2 or SOM-1 and SOM-2) 
in 16.6 mM ammonium sulphate; 67 mM Tris-HCl (pH 8.8 at 25 e C); 6.7 mM magnesium 
chloride; 10 mM beta-mercaptoethanol; 6.7 mM EDTA; 10% v/v dimethylsulfoxide with 170 
μg/ml bovine serum albumin (Boehringer Mannheim) and dNTPs (dATP, dCTP, dGTP, dTTP, 
Pharmacia & PL, Uppsala, Sweden) at 1.0 mM each. Samples were heated to 90oC for 10 
minutes to denature the DNA, spun down for 5 sec and incubated briefly at 40oC to anneal the 
primers. Subsequently, Taq DNA polymerase (New England Biolabs, Beverely, Mass., USA, 1 
unit) was added to each reaction vessel, and mixtures were overlaid with paraffin oil and 
immediately incubated for 2 min at 65°С to elongate the primers. Subsequent rounds of amplific­
ation consisted of a 30 s denaturation step at 90 oC, cooling to 40oC for 30 s, and a 2 min 
elongation step at 65 0C. Fresh Taq DNA polymerase (1 unit) was added prior to cycles 11 and 
21. In total, 30 reaction cycles were used. DNA was freed from protein and paraffin oil by 
phenolxhloroform (1:1 v/v) extraction, recovered by ethanol precipitation, and finally 
resuspended in 20 μΐ sterile HjO. Reaction products contained in an aliquot of 2 μΐ were resolved 
on a 4% agarose gel in 40 mM TRIS-acetic acid (pH 7.8), 1 mM EDTA, and stained with 
elhidium bromide. 
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Fig. la-C. Structure of the ApoC2 gene region around the variable [TG]n[AG]m motif, a. Organization of the 
apoC2 gene. The 4 exons (black boxes) are indicated by Roman numerals. The location of isolated Alu 
sequence elements (A) and Alu-specific tandem repeats (AR) are shown, b. Detailed representation of the 
SSM containing area in the first intron and positioning of the primers AC-1 and AC-2 used for PCR 
amplification (open boxes), c. Sequences of the 23-mer amplification primers AC-1 and AC-2. 
Southern analysis of PCR amplification products 
Samples of 2 μί of the amplification products above were mixed with an equal volume of 
formamide dye (94% formamide; 0.05% xylene cyanol; 0.05% bromophenol blue; 10 mM 
EDTA, pH 7.2), incubated for 3 min at 90oC to denature the DNAs and quickly quenched on 
ice. Samples were loaded on a 0.4 mm thick 10% w/v acrylamide/bis-acrylamide (19:1 w/w) 
sequencing gel containing 8 M urea. Electrophoresis was performed in 100 mM TRIS Borate, 
5mM EDTA, pH 8.3 (1 χ TBE) until the xylene cyanol dye had migrated 20 cm. The gel part 
above the xylene cyanol dye was lifted with Whatmann 540 paper and placed on 2 pieces of 
Whatmann 3MM supported by a Scotch Brite pad prewetted in 0.5 χ TBE. The gel was washed 
three times with 0.5 χ TBE to remove excess urea, and a nylon membrane (Gene Screen Plus) 
was placed on the gel without trapping air or buffer at the interface. Two pieces of Whatmann 
3MM and a Scotch Brite support pad were placed on top and the entire sandwich was transferred 
into an electroblot device (BRL, Gaithersburg, Mo., USA). DNA was blotted using a field 
strength of 5 V/cm. The nylon membrane was lifted from the gel, washed in 2 χ SSC (1 χ SSC 
= 150 mM NaCl/15 mM sodium citrate pH 7.0) and air dried at room temperature. 
The DNA filters were prehybridized for 1 hour at 40 e C in 5 χ SSPE (20 χ SSPE = 3.0 M 
NaCl, 200mM NaHJO,, 20mM EDTA, pH 7.4), 0.3% SDS containing 10 μg/ml herring sperm 
DNA. The VSSM-specific [TG]7T oligonucleotide was labeled with 7-'2P ATP to a specific 
activity of approximately 10'-109 cpm per μg as described before (Smeets et al. 1988a) and added 
to the same solution at a concentration of 0.5 χ l(f cpm per ml. After 2-4 h of hybridization, the 
membranes were washed 3 times for 5 min and once for 30 min in 5 χ SSPE, 0.3 % SDS at 40 
SC. These conditions, at moderate stringency, were found to yield an optimal compromise 
between signal strength and specificity and were used throughout all experiments. Autoradio­
graphic exposure onto Kodak X-Omat S film was carried out for 1-2 hours with 1 intensifying 
screen. 
All other methods were according to standard procedures (Maniatis et al. 1982). 
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Linkage analysis 
Linkage analysis was performed using the MLINK program of the LINKAGE program 
package, version 4.7, of Lathrop and Lalouel (1984). For the apoC2 locus, the information from 
the VSSM-polymorphic system was used to define alleles at a single locus. Procedures used for 
processing of apoC2- and CKMM RFLP typings and DM genotyping and details regarding 
family material have been published previously (Brunner et al. 1989 a,b). 
RESULTS 
Identification of a variable simple sequence motif (VSSM) in the apoC2 gene 
The location of the SSM containing region in the first intron of the apoC2 gene and the 
hybridization site of the oligonucleotides chosen to serve as unique starting primers for PCR 
amplification are shown in Fig.l. To avoid any interference from homology to nearby Alu 
elements, the 5' and 3 ' primers were designed to bind immediately adjacent to the [TG]n[AG]m-
motif in the apoC2 gene. The length variation of the VSSM ranges from 8 GT repeats followed 
by 8 GA repeats (Wei et al. 1985) to 21 or 22 GT repeats followed by 7 GA repeate (Das et al. 
1987; Fojo et al. 1987). Samples of genomic DNAs from several unrelated individuals were 
subjected to 30 cycles of Taq DNA-polymerese catalyzed PCR-amplification to demonstrate this 
length variation. As shown in Fig.2a, individual variation could be visualized directly by 
ethidium bromide staining of reaction products resolved on 4% agarose gels. Similar variation 
was evident from analysis of reaction products on native Polyacrylamide gels (not shown). 
Though both gel systems are relatively easy to use, they have only poor resolving power and do 
not discriminate optimally between the [TG]n[AG]m bearing PCR-fragments and contaminating 
reaction products. We therefore decided to make use of DNA-sequencing gels, DNA blotting 
and hybridization with an end-labeled [TG]7T oligonucleotide to visualize the specific 
[TG]n[AG]m block. In this manner, two bands were observed for almost every person analyzed 
(Fig.3). In contrast, in all control experiments where human-rodent hybrid cells containing only 
one chromosome 19 (see Schonk et al. 1989 for details) were used, only a single band was 
observed for every DNA analyzed. This shows that the number of the observed apoC2-VSSM 
bands corresponds to the number of apoC2 alleles present in the DNA preparation. A study of 20 
unrelated individuals revealed IS heterozygotes (75%) and at least 10 different allelic bands (not 
shown). It is clear, however, that a more precise estimation of the number of alleles and their 
frequencies will require the analysis of a far larger number of individuals. 
ApoC2-VSSM signals are microbeterogeneous 
Upon resolution on DNA-sequence gels, the allelic bands are not always distinct and appear as 
a ladder of one major band flanked by one or two minor bands. Two possibilities may account 
for this observation: the apparent microheterogeneity could reflect somatic heterogeneity in the 
blood or it could be caused by incomplete synthesis or, more probably, strand slippage during 
DNA replication by the Tcuj polymerase. We studied this problem by performing two separate 
tests. First, we sequenced several independent PCR clones of the apoC2-VSSM block originating 
from the DNA of one individual (Fig.4a., arrow) for which two rather distinct alleles of 
17*[TG/AG] and 29*[TG/AG] had been observed earlier. In total 10 clones, 7 originating from 
the smaller allele and 3 from the larger allele, were analysed (Table 1). Amongst those from the 
smaller allele, 5 were of identical length and 2 were reduced by one dinucleotide pair. Variation 
in the number of both TG and AG dinucleotides was observed. In addition to length variation, 
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other sequence variation (G to A transition; Table 1, clones 115 and 173) was observed; this can 
most easily be explained by errors introduced by the Tag polymerase and/or the cloning 
procedure involved (Saiki et al. 1988). Frequent G to A transitions in cloned oligonucleotides 
have been described before (Bauer and Holmes 1989) and are thought to result from mutagenic 
modifications during chemical synthesis of oligonucleotides (Eadie and Davidson 1987). 
Secondly, the PCR-reaction products generated from a single cloned apoC2 allele (cloned in 
plasmid pGEM3) were analyzed instead of genomic DNA. In this experiment, as shown in 
Fig.4b, microheterogeneity of the signal was much less conspicuous and was apparently not 
dependent on the batch of enzyme or the reaction conditions used (not shown). Therefore, it is 
likely that the observed microheterogeneity of signals results from both length heterogeneity 
existing at the somatic level (because of somatic DNA-replication errors during growth and 
development of the hematopoietic tissue) and from errors introduced during in vitro 
amplification. Thus far, attempts to confirm these findings by direct high-resolution analysis of 
small restriction enzyme segments bracketing the apoC2 VSSM area with omission of all 
amplification and cloning steps, have not been successful. 
1 2 3 4 5 6 
FAM 14 FAM 3 
Fig. 2a,b. Agarose gel analysis of in vitro amplified SSMs in the apoC2 and somatostatin I genes, a. 
Ethidium-bromide stained amplification products of the apoC2-[TG]n[AG]m segment from total genomic 
DNAs of three unrelated individuals (lanes 1-3), from apoC2-cosmid DNA (lane 4) and from plasmid 
subclones derived from two different apoC2-alleles (lanes 5, 6). Total genomic DNAs from three unrelated 
heterozygous individuals with allelic [TG]n[AG]m motifs composed of 104 and 80 bp were used. The cosmid 
clone contained a complete apoC2 gene with a 104 bp size [TG]n[AG]m motif. The two plasmid clones 
contained [TG]n[AG]m alleles of 78 bp (lane 5) and 80 bp (lane 6), respectively. The lengths of individual 
[TG]n[AG]m motifs were determined by sequencing, b . Ethidium-bromide stained reaction products of the 
amplified somatostatin I gene segment from total genomic DNAs of individuals belonging to 2 small families 
(pedigrees shown in Fig.3b). Bands are approximately 100 bp in size. 
VSSMs are highly abundant in the human genome 
To demonstrate that [TG]n motifs generally display polymorphic behavior among individuals, 
we studied several additional markers from a listing of in total 26 [TG]n-repeat (n > 7)-
containmg elements in the EMBL Heidelberg (version 1988) sequence database. Based on data 
from literature, |TG]n length variation in a subset of these sequences was anticipated. Clear 
examples can be found in reports on gene sequences of somatostatin I (Shen and Rutter 1984), 
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Fig. 3a,b. Mendelian inheritance of PCR amplified VSSMs visualized on denaturing sequence gels. a. 
Southern analysis of the ApoC2-[TG]n[AG]m motifs in genomic DNAs of three DM-families. Alleles that 
cosegregate with DM are indicated by arrows. Family 13 shows a recombination event between apoC2 and 
DM. The genomic DNAs from individuals indicated by asterisks in family 10 and 14 are similar to those 
used to generate the reaction products shown in Fig.2a lanes 1, 2, respectively, b. Southern analysis of the 
PCR-amplified somatostatin I VSSM in four DM-families. The method used was the same as for the apoC2-
VSSM except for the use of somatostatin I specific amplification primers. The agarose gel analysis of families 
14 and 3 is shown in Fig.2b. 
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apolipoprotein All (Tsao et al. 1985; Lackner et al. 1985), von Willebrand factor (Assouline et 
al. 1988) and globin 0 7 and Ay (Slightom et al. 1980). The PCR products of the VSSM in the 
first intron segment of the somatostatin I gene, visualized on a 4% agarose gel in Fig.2b, 
displayed considerable allelic variation when examined by high-resolution gel analysis (Fig.3B). 
This is consistent with results from Weber and May (1989), who independently investigated 10 of 
such loci and found them all highly polymorphic. 
Other markers examined were derived from phages and cosmids containing chromosome 19q 
specific inserts (for details see Hulscbos et al. 1986; Wieringa et al. 1988) that were detected by 
screening with a 15-mer |TG]7T oligonucleotide. From these experiments (to be published in 
more detail elsewhere), we obtained several [TG]n-repeat-bearing elements from within the 
19ql3 (DM) area. On average, variable [TG]n sequence elements were present in every 50-100 
kb of cloned 19q specific DNA (data not shown); this is consistent with an overall frequency of 
approximately 50,000 (TG]n-repeat segments per haploid genome based on quantitative 
hybridization assays (Hamada et al. 1982; Jelinek and Schmid 1982). This result means that in a 
random cosmid library at least one out of every two cosmids will contain a [TG] motif that could 
serve as a polymorphic marker. 
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Fig. 4a,b. Comparison of signal micro-heterogeneity between PCR-amplified products from genomic and 
cloned apoC2-VSSM alleles, a. Part of the pedigree from DM-family 19 and gel analysis of apoC2 VSSM 
PCR-reaction products showing a total of 3 distinct alleles each composed of multiple bands. Both alleles of 
the individual indicated with an arrow are also shown in Fig.2 lane 3). b. Lanes 1 and 2 signals generated 
from cloned plasmid DNAs containing PCR products, 78 (lane 1) and 80 (lane 2) nucleotides long, 
respectively). Plasmids were diluted in a solution containing herring sperm DNA in order to obtain an apoC2 
gene copy number and a total DNA concentration comparable to those used in the reaction mixtures contain­
ing genomic DNAs. Amplification was for 30 cycles. 
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VSSMs can be used as highly informative genetic markers 
In order to demonstrate the chromosome specificity of the new markers, we tested the 
segregation of the apoC2 and somatostatin I VSSM in several pedigrees that were informative for 
the ароС2-Га^І and the CKMM-Taq\ and -Ncol RFLPs. As expected, the allelic segregation of 
the apoC2-VSSM was completely concordant with the apoC2 RFLP ( тах = 0.0; lod score = 
7.52) indicating that the new marker represents the apoC2 locus. Between the CKMM locus and 
the apoC2 VSSM-markcr, no crossovers were seen in a subset of families ( тах = 0; lod 
score = 3.17), confirming previous findings that the two markers are very closely linked. As 
expected, the somatostatin I-VSSM, a chromosome 3 marker, segregated independently from all 
chromosome 19 markers tested (results not shown). 
Presymptomatic diagnosis in DM is routinely done with one or several probes specific for the 
apolipoprotein E-C1-C2 gene cluster (Pericak-Vance et al. 1986; Shaw et al. 1985; Smeets et al. 
1988b), with the CKMM gene probe (Brunner et al. 1989b) or with other closely linked 19q 
markers (Korneluk et al. 1989). However, even with all of these marker loci combined, 
diagnosis is only possible in about 75% of DM-families; this is partly because of linkage disequi­
librium. We have employed our apoC2-[TG]n marker to re-examine several families that had not 
been informative for any of the 7 known ApoC2-RFLPs. When we included our marker, 19 out 
of 20 families tested became informative for the apoC2 locus. In order to refine the genetic 
map around the DM gene, we followed segregation of the VSSM marker through some of the 
scarce DM families with a confirmed crossover between the disease gene and close marker loci. 
In a family with a crossover separating DM from D19S16 (probe pJSBll; Schepens et al. 1987) 
and apoE, the DM-trait segregated with the apoC2 VSSM and D19S22 (probe pEFD4.2; 
Nakamura et al. 1988) as shown in Fig.5. From physical and genetic mapping studies (Schonk et 
al. 1989; Brunner et al. 1989a), we know that D19S16 maps proximal to DM at a distance of 
6cM and that D19S22 is a distal marker (12cM from DM). The gene order in the apolipoprotein 
gene cluster had previously been established to be apoE-apoCla-apoClß-apoC2 (Smit et al. 
1988; Myklebost and Rogne 1988). Therefore, we now suggest that the chromosomal orientation 
of this apolipoprotein cluster should read cen-apoE-apoClQ;-apoClß-apoC2-terand that the 5'-3' 
transcription of the genes is in cen to ter direction. In addition, if combined with apoC2-VSSM 
analyses in other DM-families (not shown), our results confirm the gene order D19S16-apoE-
apoC2-[DM,CKMM]-D19S22-ter previously established by use of RFLP typing (Brunner et al. 
1989c). 
Family 10 
DI9SI6 11 12 
ApoE 33 34 
ApoCII 24 13 
DI9S22 22 21 
Fig. 5. Orientation of the apolipoprotein cluster on chromosome 19. Results from haplotype determinations 
for anonymous markers D19S16 [Taq\ alleles 8.5 kb (1) and 6.5 kb (2); Schepens et al. 1987a) and D19S22 
(Pstl alleles 2.4 kb (J) and 2.2 kb (2)i Nakamura et al. 1988], apoE-isoforms [genotyped with ароЕЗ (3) or 
apoE4 (4) specific oligonucleotides; for details see Smeets et al. 1988a,b) and ApoC2-VSSM alleles (numbers 
1 to 4 refer to the four allelic-lengths of the [TG]n[AG]m segment in this family) are given for individuals in 
a family with a previously identified apoE vs. DM crossover. 
^ 
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DISCUSSION 
We have identified a [TG]n[AG]m motif in the apoC2 gene, which (like other tandem di- and 
trinucleotide repeats) is highly polymorphic and forms a valuable addition to the currently 
existing set of markers that can be employed for presymptomatic DM diagnosis. In addition, we 
have developed a generally applicable methodology, involving PCR-mediated DNA amplification 
and high-resolution gel analysis to visualize, in a locus-specific manner, other simple nucleotide 
sequence repeats that are ubiquitously dispersed throughout the human genome. As an illustration 
of the potential value of these elements for applications in mapping and diagnosis of disease and 
in forensic medicine, we also analyzed the variability and segregation of the [TG]n motif in the 
somatostatin I gene (Fig. 3b). Moreover, preliminary results (H.J.M. Smeets and Wieringa В., 
details to be reported elsewhere) have revealed a variable repeat just S' of the start site of 
transcription in the gene coding for the von Willebrand factor. This marker should also become 
very useful for the presymptomatic diagnosis of von Willebrand disease, an autosomal blood 
clotting disorder. To distinguish the motifs studied here from other classes of polymorphic loci, 
we would like to propose the use of the designation VSSMs (variable simple sequence motifs) for 
these markers. 
When this work was in progress, similar results were reported by Weber and May (1988, 
1989), who investigated 10 polymorphic [TG]n loci and by Litt and Luty (1989), who used the 
[TG]n motif in the cardiac muscle actin gene as a polymorphic marker. Earlier, Kovacs et al. 
(1988) showed variability in repeat number in codon-tandem repeats; they also used oligonucle­
otides composed of trinucleotide repeats as fingerprint probes. Similarly, Schäfer et al. (1988) 
used oligonucleotides, composed of di- and trinucleotides for fingerprinting. By cloning and 
sequencing different apoC2 alleles, we have shown that the length variation in the VSSM can be 
arise from expansion and contraction of the [TG] or [AG] repeats. Against this background, we 
consider it highly likely that length variation is a general property of all kinds of SSMs and is 
not confined to particular types of di- or trinucleotide repeat sequences. 
CLONE DINUCLEOTIDE LENGTH SEQUENCE 
NUMBER 
AGCCCGTGTTGGAACCATGAC TG [TG]7 [AG]g GGAGATGGAGTCTCGCTATGTA 
AGCCCGTGTTGGAACCATGAC TG [TGlg [AG]g GGAGATGGAGTCTCGCTATGTA 
AGCCCGTGTTGGAACCATGAC TA [TG]7 [AG], GGAGATGGAGTCTCGCTATGTA 
AGCCCGTGTTGGAACCATGAC TA [TG]7 [AG]g GGAGATGGAGTCTCGCTATGTA 
Table 1. Microheterogeneity in cloned PCR-amplified variable simple sequence motif (VSSM) alleles 
genenled from the genomic DNA of the individual indicated by the arrow in Fig.3: Size frequencies 10 and 
the actual tequences of 4 cloned segments bearing the apoC2-[TG]n[AG]m VSSM. In addition to variation in 
the number of dinucleotides [compare clones 30, 78, 100, 115, 158 (80 nucleotides) with clones 13 and 173 
(78 nucleotides)], single base mutations [G to A transvenions; compare clones 13, 78 [TG] with clones 115 
and 173 (TA)] are identified. 
13 
30 
64 
78 
100 
115 
129 
158 
164 
173 
16 
17 
29 
17 
17 
17 
29 
17 
28 
16 
78 
80 
104 
80 
80 
80 
104 
80 
102 
78 
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SSMs are shared by the genomes of diverse organisms ranging from yeast to man (Tautz and 
Renz 1984). Suggestions have been made that these ubiquitous elements may have a role in 
biological phenomena as diverse as gene regulation (Nordheim and Rich 1983), DNA-replication 
(Rao et al. 1988; Rogers 1983), chromatin structure (Gross et al. 1985; Pardue et al. 1987) and 
recombination and gene conversion (Shen et al. 1981; Kmiec and Holloman 1986; Hellmann et 
al. 1988). Some of these roles have been postulated because there is evidence that SSMs cause 
conformational discontinuities, such as Z-DNA (alternating purines and pyrimidines), cruciforms 
(reviewed by Mclean and Wells 1988) or triple-stranded structures (Johnston 1988). Sequence 
rearrangements, such as the length variations reported here, might arise by unequal crossover 
events that take place at all regions in the genome where short runs of mononucleotide, 
dinucleotide or codon repeats reside. Alternatively, DNA slippage during replication has been 
suggested as the major cause of instability of certain types of SSMs (Hentschel 1982; Tautz et al. 
1986). 
In our family analyses, we did not observe any new mutation. None of the VSSM alleles 
examined showed any evidence for size alterations during meiotic transmission in families, other 
than the nucroheterogeneity seen in Figs.3 and 4. From a comparison of apoC2 and somatostatin 
I VSSM signals shown in Fig.3, and from a comparison of published data on VSSMs that were 
independently cloned and sequenced, it is evident however that the size spread of alleles and the 
degree of heterozygosity observed is not the same for all VSSM loci. This suggests that 
mutation frequencies may differ between various VSSM loci. Therefore, care should be taken in 
the use of VSSMs as diagnostic markers until more extensive data about their genetic stability 
become available. By using the methodology reported here, identincation and detailed analysis of 
other VSSM markers in man and other species is possible and should soon clarify this matter. 
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SUMMARY 
We report on the physical ordering of genes in a relatively small area of chromosome 19, 
segment q l3 , containing the locus for myotonic dystrophy (DM), the most frequent heritable 
muscular dystrophy of adulthood in man. DNAs from somatic cell hybrids with der 19q products 
that carry a breakpoint across the muscle-specific creatine kinase (CKMM) gene were analysed 
by Southern blotting using probes for CKMM, APOC2, and the repair genes ERCC1 and 
ERCC2. Results were combined with data from CHEF and field inversion-gel-electrophoresis 
separation of large-sized DNA restriction fragments to establish a map localizing both DNA-
repair genes and the CKMM gene within the same 250 kb of DNA, the order being cen-
CKMM-ERCC2-ERCCl-ter, with APOC2 being at more than 260 kb proximal to CKMM. 
Transcriptional start sites of the CKMM and DNA-repair genes are all on the telomeric side of 
the genes. Our results provide a framework for the construction of a larger physical map of the 
area, which will facilitate the search for the DM gene. 
INTRODUCTION 
Presumably, more than 95% of the genome is now covered in the various genetic linkage maps 
available for every human chromosome. Adequate genetic maps with polymorphic markers 
located every 5-10 million bases can be used for localization and indirect diagnosis of a number 
of human disorders and will assist the construction of a complete physical map of the human 
genome. The latter goal has come into reach since the development of (1) novel cloning techni-
ques to bridge large-sized DNA fragments (Collins and Weissmann 1984; Poustka and Lehrach 
1986; Burke et al. 1987), (2) methods for separation of large DNA fragments (Schwartz and 
Cantor 1984), and (3) new in situ hybridization techniques applicable to cytogenetic- and somatic 
cell genetic studies (Lawrence et al. 1988; Pinkel et al. 1988). Once physical chromosome maps 
consisting of overlapping collections of cloned DNAs become available for every chromosome, 
they will greatly facilitate attempts to identify chromosomal regions involved in disease and 
development. Moreover, they are absolute prerequisites for obtaining a better understanding of 
the relationship between gene expression and subchromosomal location and for study of the 
evolutionary relationships between chromosome segments in mammals. 
We -in collaboration with several other groups- have been involved in projects aiming at the 
complete physical and genetic characterization of the human chromosome 19q region around the 
locus involved in myotonic dystrophy (DM). DM is an autosomal dominant multisystem disorder 
(Harper 1979) and is the most frequent muscular dystrophy in adults, occurring at a frequency of 
1/7,500 individuals. As yet, no chromosomal aberrations in this region have been reported to be 
associated with DM, and no clues to the biochemical defect of the disease exist. We therefore 
decided to approach the defect by applying reverse genetics strategies. Our studies started with 
the cloning of several 19q-specific anonymous unique DNAs, dispersed and clustered repeat 
elements (Hulsebos et al. 1988; Smeets et al. 1989), CpG islands and expressed genes (H.J.M. 
Smeets and E.C.M. Mariman, unpublished data). These DNAs were assigned to various intervals 
across 19q by use of somatic cell hybrids (Stallings et al. 1988; Schonk et al. 1989). Detailed 
genetic linkage analysis in DM families (Brunner et al. 1989b) showed that the markers most 
closely linked to DM reside in a chromosomal interval estimated to be, at most, 5,000 kb. This 
spans the area at 19ql3.2-ql3.3 just distal to the APOE-C1-C2 gene cluster and the muscle-
specific creatine kinase M (CKMM) gene, which is at the moment the nearest proximal poly-
morphic marker for DM diagnosis (Brunner et al. 1989a; Le Beau et al. 1989). Moreover, it has 
become evident that the DM gene is situated on a chromosome segment spanning one of the 
largest evolutionarily conserved mammalian linkage groups known (Lyon 1987; Thompson et al. 
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in press). 
As a first attempt to identify the DM gene, we decided to physically characterize the 
chromosomal area at 19ql3.2-ql3.3 using the CKMM gene as a proximal demarcation point. 
Recent data from somatic cell studies (Stallings et al. 1988) indicated that APOC2, CKMM, and 
ERCCl were in close proximity. We therefore concentrated on these genes and on the ERCC2 
gene, which has recently also been mapped to this region of chromosome 19q (Mohrenweiser et 
al., in press; Thompson et al., in press). Here we present evidence that the CKMM gene and 
both DNA-repair genes are physically linked within a segment of approximately 250 kb that does 
not include the APOC2 gene. Evidence for the relative gene order and the chromosomal orienta-
tion of these genes are provided, and implications for further research into DM are discussed. 
MATERIALS AND METHODS 
DNA Clones 
Preliminary data on the cloning of overlapping human CKMM-specific DNAs from a lambda 
EMBL3 phage library have been published (Mariman et al. 1987) or will be published elsewhere 
(E.C.M. Mariman, personal communication). Subclones pCKMM-BS2a (insert size 1.5 kb) and 
pCKMM 3 ' (insert size 3 kb [Coerwinkel-Driessen et al. 1988]) contain, respectively, the 5'- and 
3'outermost gene regions and flanking genomic DNA elements. The cloning of the ERCC1-
specific cosmid 43-34 and the generation of subclones pT56-4.2 (1.7-kb Taql insert from the 5' 
end of the gene) and pBal.O (1.0-kb BamHl insert from the 3 ' end) have been described in detail 
elsewhere (van Duin 1988). ERCCl cDNA probes pE12-12 (900 bp) and pcd4a4, a 3 ' end 
specific probe of 640 bp, have been described by Van Duin (1988;scc also refs. therein). Clone 
pKER2 containing a 2.4-kb Kpn\ insert from the 3 ' end of ERCC2 in vector pKSVIO was 
derived from the p5T4-l-7 cosmid clone of the ERCC2 gene (Weber et al. 1988). All other 
DNAs used have been described elsewhere (Wieringa et al. 1988; Schonk et al. 1989). 
Cell Lines and Somalie Cell Hybrids 
The 908K1 hybrid containing the cen-ql3.2 (i.e., proximal) portion of the long arm of 
chromosome 19q, as well as the GM89A99C-7 hybrid containing the distal ql3.2-ter portion of 
the long arm, have been described elsewhere (Hellkuhl and Grzeschik 1978; Mohandas et al. 
1980; Hulsebos et al. 1986). These reciprocal human/hamster and human/mouse hybrids were 
derived from a patient with a 46,X t(X;19)(q22::ql3) karyotype (NIGMS Human Genetic Mutant 
Cell Repository GM0089). The hybrid 20XP3542-1~4, containing a small segment of 19q, has 
been described by Stallings et al. (1988). All other hybrids used are described in detail elsewhere 
(Schonk et al. 1989). 
Pulsed-Field Gel Electropboresb 
Field-inversion-gel-electrophoresis (FIGE) separation of large DNA fragments was carried out 
as described (Cremers et al. 1989). CHEF-electrophoresis was carried out at 140C in 50 mM 
Tris-Borate, ImM EDTA in a homemade device using a hexagonal array of electrodes and 
constructed according to specifications given by Chu et al. (1986). Electric fields were alternat-
ed between orientations 120° apart; switch times were 120 s at 150 V and 170 mA. For detailed 
mapping around the ERCCl gene, either conventional electrophoresis on 0.5% agarose gels or 
transverse alternating-field electrophoresis (TAFE) (Gardiner et al. 1986) was used. DNA from 
lymphoblastoid cells and somatic cell hybrids was immobilized in agarose blocks (LGT-agarose; 
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Biorad) and restriction-enzyme digestions of agarose-immobilized DNAs were performed 
overnight with 10-20 U of enzyme/agarose block, containing DNA from approximately 0.4 χ 10^ 
cells, at conditions given by the manufacturer. 
1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 
Fig. 1. Regional assignment of CKMM, ERCCl, and ERCC2 on 19q by using a panel of somatic cell 
hybrids. Southern blot hybridization patterns obtained from (A) CKMM3'-(probe рСКММЗ'), (В) CKMMS' 
(probe pBS2a), (С) ERCC2 (probe pKER2), and (D) ERCCl (probe T56-4.2) DNA probes. Genomic DNAs 
from blood (lanes 1 and 2), cell line 1023 (hamster only; lanes 3) and hybrids 578 (X, hamster; lanes 4), 
1040A6 (19q; lanes 5), 908K1 (rearranged 19p + 19cen-ql3.2; lanes 6), ORIM 7.1 (19ql3.1-qter; lanes 7), 
1219G2 (19ql.l-qter; lanes 8), 908K1A1 (rearranged 19p; lanes 9), 908K1B18 (19cen-ql3.2; lanes 10), 
20XP3542-M (19ql3.2-ql3.3; lanes 11), and GM89A99C-7 (19ql3.2-qter; lanes 12) were digested with 
EcóRl, resolved on 0.8% agarose gels, blotted, and hybridized. Cell lines not further specified in Materials 
and Methods are described by Schonk et al. (1989). 
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Southern Blot Analysis 
Southern blot analysis of DNA fragments resolved on regular agarose gels or on CHEF or 
FIGE gels was carried out as described elsewhere (Hulsebos et al. 1986; 1988; Cremers et al. 
1989). DNAs were immobilized on Gene Screen Plus or BioTrace nylon membranes. Probe 
insert DNAs were excised from plasmids by appropriate restriction enzymes, separated from 
vector DNA on 1% (w/v) low-gel-temperature agarose gels, and "P-labeled by random-primer 
synthesis (Feinberg and Vogelstein 1983). Prehybridization and hybridization were in 0.5M 
NaHjro4/Na JHP04 buffer, 7% (w/v) SDS and 0.5 mg sonicated herring sperm carrier DNA/ml 
at 65 0C as described elsewhere (Schonk et al. 1989). Washing was at conditions equivalent to a 
stringency of 0.1 χ SSC at 65° С final temperature. All other procedures were according to 
standard protocols as given by Maniatis et al. (1982). 
RESULTS 
Somatic Cell Hybrid Analysis 
Hybridization analyses with single-copy probes for CKMM, ERCC1, and ERCC2 genes, both 
in somatic cell hybrids 908K1, 908K1B18, and GM89A99C-7, containing the reciprocal 
translocation products of the t(X;19) cell line GM0089, and in various other 19q-specific hybrids 
(Schonk et al. 1989) are shown in figure 1. With probe рСКММЗ', originating from the 3' end 
of the CKMM gene, a genomic EcoRI fragment with a rather unusual size of approximately 40 
kb was observed in blood DNAs and in most of the somatic cell hybrids (fig. 1A). In the 908K1 
and 908K1B18 hybrids (fig. 1A, lanes 6 and 10) wc identified only a 9.4-kb £coRI fragment. No 
signal was observed in hybrid GM89A99C-7 containing the distal segment of 19q (fig. 1A, lane 
12). As shown in figure IB, the reverse situation was seen with probe pCKMM-BS2a, derived 
from the 5'end of the gene. With this probe we observed the same large-sized 40kb-£coRI 
fragment as in figure 1A in blood DNA and in those cell lines that displayed the 40-kb fragment 
with the 3' probe. A signal of almost similar size was seen in hybrid GM89A99C-7 (fig. IB, 
lane 12). From hybrids 908K1 and 908K1B18 (fig. IB, lanes 6 and 10) no signal was obtained. 
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Rg. 2. CHEF and FIGE map of the CKMM, ERCC2, and ERCC1 gene area. The genes are represented by 
filled boxes, and the chromosomal orientation of the cluster is indicated. The location of the probes used is 
shown by arrows. A detailed map of the CKMM region showing the restriction sites relevant for Southern 
analysis and the location of the GM0089 breakpoint in the CKMM gene is given at the bottom. Exons are 
indicated by Roman numerals. С = Clal; N = Afori; M = Mlul; S = Sfil (ERCC1 contains 3 Sfil sites, see 
detailed map in fig. 5b); E = EcoRI (not all sites shown); В = Ватт. 
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These results indicate that both the chromosome 19 breakpoint in GM0089 and derived hybrids 
must be situated between the loci recognized by the two CKMM probes. The 5' probe pCKMM-
BS2a apparently detects the larger part of the broken EcoW fragment. This translocation 
fragment in hybrid GM89A99C-7 cannot be differentiated from the normal 40-kb fragment in 
control DNAs, owing to the limited resolution of conventional agarose-gel electrophoresis. In 
addition to these findings, our results establish a 5'-to-3Orientation of the CKMM transcription 
unit in the telomere-to-centromere direction on chromosome 19. 
Further support for this arrangement was obtained from more detailed restriction-enzyme 
mapping of cosmids and phages containing CKMM gene inserts. We have determined that the 
only £coRI site in the CKMM gene area is at approximately 3 kb 3 ' downstream of the 
polyadenylation site. The entire human CKMM gene spans approximately 16 kb. Because 
hybridization with the рСКММЗ' probe resulted in an altered signal of only 9.4 kb in all cellular 
DNAs with the translocation breakpoint, we can conclude that the breakpoint is within 9.4 kb 
upstream of the unique £coRI site and that it therefore indeed must be situated within the 
CKMM-transcribed segment. Subsequent experiments (data not shown) involving Southern 
analyses of various restriction fragments from 908K1 and GM89A99C-7 DNAs by means of 
individual exon-specific probes allowed us to determine that sequences within CKMM intron 4, 
just upstream of exon 5, must have been involved in the original reciprocal X;19 translocation 
event. Probes for exons 2-8 of the CKMM-gene were generated by PCR amplification (Saiki et 
al. 1988) using pairs of oligonucleotide primers which flank the intron-exon junctions. A 
schematic drawing summarizing our results and indicating the positions of the most important 
restriction sites in the CKMM gene relative to the X;19 translocation breakpoint is given at the 
bottom of figure 2. 
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Flg. 3. CHEF and FIGE analysis of Noll digestions of genomic DNAs. The probes CKMM 3' (panels a and 
d), ERCCl pT56 4.2 (panel b and e), and ERCC2 pKER2 (panel c) were hybridized to blots of genomic 
DNAs digested with Noll and resolved by CHEF electrophoresis (panels a-c) or FIGE (panels d-e). Lanes I 
and 2 contain DNA of the same individual, but at different concentrations corresponding to the use of 0.4 χ 
10' and 0.2 χ ï(f EBV immortalized lymphoblastoid cells, respectively. Lanes 3 and 4 contain DNA from 
0.4 χ 10* cells of two other unrelated individuals. 
As shown in Figures 1С and ID, analysis of our set of cell hybrids with probes specific for the 
ERCC2 and ERCCl gene regions yielded a picture similar to that obtained with the 5' CKMM 
probe, indicating that both genes are located distal to the translocation breakpoint on 19q. With 
all enzymes tested, including ÊcoRI, the ERCCl-specific pT56-4.2 probe (fig. ID) and pBal.O 
probe (data not shown) gave signals which were clearly different from the signals obtained with 
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the 5' СКММ probe. The size of the EcoRI fragment detected with the ERCC2 pKER2 probe 
(fig. 1С) was similar to the unusually large 40 kb fragment seen with both CKMM probes, 
suggesting that CKMM and ERCC2 are on the same fragment. 
Previously we had found that the APOC2 gene region, which is genetically closely linked to the 
DM and CKMM loci (Brunner et al. 1989b), is physically located just proximal to the breakpoint 
in cell hybrid 908K1 (Stallings et al. 1988; Schonk et al. 1989). From conventional Southern 
analyses of the various somatic cell hybrids no further proof for possible overlap between restric­
tion fragments specific for APOC2 and CKMM or ERCCl/2 was obtained (data not shown). We 
therefore decided to test this issue further by employing long range restriction-site mapping. 
П С Е and CHEF Analysis 
Inspection of the restriction-enzyme maps and of the partial nucleotide sequences generated 
from the ERCCl, ERCC2, and CKMM gene areas published earlier (Mariman et al. 1987 and 
unpublished data; van Duin, 1988 [and refs. therein]; Weber et al. 1988) revealed that cleavage 
sites for restriction enzymes Sail, Xhol, and Clal were rarely present. The presence of sites for 
rare-cutting enzymes Sftl, Noti, and A/M was tested directly by appropriate digestions of cosmid-
(ERCC1 clone 43-34 [Westerveld et al. 1984], ERCCl cosmid clones F8697 and F15123 [De 
Jong et al. 1989]) phage (CKMM phage lambda 3-1 and overlapping phages; ERCCl and -2 
phages [H.J.M. Smeets, unpublished data]), or plasmid (pKER2, ERCC2 [Weber et al. 1988]) 
clones. Digestion with Noti revealed that this enzyme does not cleave any of the DNAs. Two Sfil 
sites were detected near and within the first exon of the ERCCl gene, and another site within the 
third exon. An Mlul site was found in the region immediately flanking the 3' end of this gene. 
Figure 3 shows the results from resolving, on CHEF and FIGE gels, Noll digests of genomic 
DNAs isolated from Epstein-Barr virus-immortalized lymphoblastoid cells of three unrelated 
individuals. On a CHEF blot, the ERCCl specific probe pT56-4.2 (fig. 3b), as well as the 
ERCC2 (fig. 3c) probe and рСКММЗ' probe (fig. 3a) identify an identical 250-kb band. 
Though, on FIGE gels, the Noil fragment had migrated to a position corresponding to a 
somewhat different molecular weight of 300 kb, again complete identity was found with all three 
probes (only two are shown [figs. 3d and 3e]). We consider this to be strong evidence that all 
three genes are physically closely linked. 
As shown in the upper half of figure 4, with Mlul on both total genomic DNAs as well as on 
DNA from the 20XP3S42-1-4 cell hybrid containing the pertinent 19q area, an identical 400-kb 
fragment was identified with the S' and 3' CKMM probes and with ERCC2 probe pKER2. The 
fragment identified with ERCCl probe pT56-4.2 clearly had a much smaller size of 
approximately 30-40 kb. With Sfil (fig. 4, lower half) no similarity was observed between 
CKMM-, ERCCl- or ERCC2-specific fragments with sizes ranging between 60 and 200 kb. 
Partial Clal digestion generated identical fragments of 200 kb and 260 kb at rather different 
intensity, for both the ERCCl probe pT56-4.2 and ERCC2 probe pKER2. When the same blot 
was hybridized with the pCKMM 3' probe, only a band of 260 kb was observed (fig. 4, lower 
half). With the S' CKMM probe pBS2a the same 200-kb and 260-kb fragments were detected as 
with the ERCC-probes, confirming that all genes arc closely adjacent. The results seen for the 
partial digest can be explained by incomplete cleavage at the CM site, which separates the S' 
and 3' ends of the CKMM gene and is positioned in exon V (see fig. 2). An additional -
presumably polymorphic- Clal site is present at 1,800 bp downstream of exon V (E.P.M. van 
Kerkhoff, personal communication). WheOier this latter CM site is present in the DNAs tested is 
not known at the moment. Furthermore, our results are compatible with the fact that no other 
CM sites were identified either in any of the CKMM-specific phages with inserts extending S' 
and 3' of the transcribed region or in the regions cloned from the ERCCl and -2 loci. 
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Fig. 4. CHEF and FIGE analysis of A//ul(M), C7aI(C) and Sfil(S) digestions of cell hybrid and genomic 
DNAs. Hybridization patterns of CKMM 3' (panel a), pKER2 (ERRC2; panel b) and TS6-4.2 (ERCCl; panel 
c), on a CHEF-blot of M/uI(M)-digested DNAs (upper half of fig.), derived from the somatic cell hybrid 
20XP3542-1-4 (lane 1) and from lymphoblastoid cell lines of 2 unrelated individuals (lanes 2 and 3), and on 
a FIGE blot of Clai(C)- and {/7I(S)-digested DNAs (lower half of fig.) from the two individuals. 
The different findings for the 5' and 3' CKMM probes corroborate the results obtained from 
the t(X;19) hybrid analysis in that the 5' end of the CKMM gene is oriented towards the DNA-
repair genes. The similarities between fragments detected with the 5' probe of CKMM and the 
fragments detected with the ERCC2 probe pKER2 are in agreement with the gene order CKMM-
ERCC2-ERCC1. A map summarizing the results for the entire area is shown in figure 2. It 
should, however, be noted that sizes of various restriction fragments could not be determined 
very precisely because of the conspicuous difference in mobility between fragments resolved on 
the CHEF-system versus the FIGE-system. The overall arrangement, however, is clearly correct, 
as also with enzymes such as Sail, Xhol and Pvul (data not shown), evidence for (partial) 
identity of fragments bearing CKMM or ERCC sequences was obtained. For most enzymes the 
fragments migrated at the lower zone of the resolution range, indicating the presence, across this 
area of proximal 19ql3.3, of multiple cleavage sites for rare-cutting enzymes. 
In order to determine more precisely both the position of these sites around the ERCCl gene 
and the orientation of the transcribed region with respect to the ERCC2 and CKMM genes, we 
performed double digestions with either Non or MM and several restriction enzymes (i.e., Kpnl, 
Sad, Sfil, Xhol [van Duin 1988]) that cleave only rarely within the ERCCl gene and analyzed 
the digests on conventional agarose gels. In this way we could position the Noti site flanking the 
common 250 kb fragment close to an Mlul site at 17 kb upstream of the transcriptional start site, 
establishing a ter-S'S'-cen orientation for ERCCl. Another Mlul site was mapped just 
downstream of ERCCl. 
To further investigate the possibility of a CpG island in the 5'region of ERCCl, we took 
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advantage of a large, approximately 20-kb, //indili fragment that overlaps the upstream area and 
almost the entire gene (van Duin 1980). Double digests were done with //indili and a battery of 
rare-cutting enzymes such as Sfil, Sacll, Mlul, Nrul and Noli. The band shifts seen when these 
digests were compared with the //indili digest revealed presence of .Sacll and Sfil sites (fig. Sa). 
From sequencing data and cosmid mapping (M. van Duin, unpublished data) we know that, for 
SocII, two sites closely adjacent to each other and to the transcriptional start site are present. The 
resultant map for the region around ERCC1, showing a clustering of rare sites at the 5' region, 
is shown in figure 5b. 
With none of the enzymes tested was any overlap seen between the APOC2-hybridizing and 
CKMM-, ERCC1- or ERCC2-hybridizing fragments. These resulte demonstrate that the APOC2 
gene region is at least 260 kb (i.e., the size of the CKMM 3' Clal fragment) proximal to the 3' 
end of the CKMM gene. Since probes specific for the APOC2 gene recognize a 1,000 kb Noti 
fragment (not shown), we estimate that a substantially larger chromosome segment may separate 
these loci. 
10 11 12 
kb 
20 
115 
9 
TER CEN 
N M H Sa SaS*Sa S Χ Κ Η Κ Η ΧΜΚ 
J \ \ \ ^ J b . • I • » I n i L i LXJ 
I II III IV V VI VIIVIIIX X 
, , I ERCC1 ! 2 kb 
Fig. 5. Localization of a CpG island in the vicinity of the ERCC1 gene, a. Southern blot probed with the 
cDNA probe pE12-12. Odd-numbered lanes contain DNA from the somatic cell hybrid 20XP3S42-1-4. Even-
numbered lanes contain Heia DNA. All lanes were digested with WmllH. Lanes 3-13 were redigested with 
.VAI (lanes 3 and 4), Sacll (lanes 5 and 6), Mlul Oanes 7 and 8), І пЛ (lanes 9 and 10), or Noll (lanes 11 and 
12). b. Restriction map in the region of the ERCC1 gene. Exons are represented by filled boxes (Roman 
numerals), and the chromosomal orientation is indicated. N = Noll; M = Mlul; H • WndIII; Sa = Sacll; X 
= Xhol; К = Kpnl; S = Sfil; S' = two Sfil sites only 32 nucleotides apart. 
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DISCUSSION 
By Southern analysis of DNAs from somatic cell hybrids as well as by FIGE and CHEF 
analysis of genomic human DNAs, we have shown that the CKMM gene and the ERCC1 and 
ERCC2 repair genes are all located within a relatively small (250-300 kb) segment of 19ql3. 
Thus far -perhaps because of the low mutation frequency and the high evolutionary conservation 
of the repair-gene region (van Duin 1988; Thompson et al. in press)- RFLPs have not been 
found for either ERCC gene or in the immediate vicinity of the gene loci (R. Hermens, personal 
communication). This precluded a reliable estimation of the genetic distance between these loci 
and CKMM or DM. It was both (a) the serendipitous finding of similarity between unusually 
large 40-kb ÊcoRI fragments recognized by CKMM- and ERCC2-specific probes and (b) the 
assignment of the CKMM, ERCC1, and APOC2 genes to a relatively small area of 19q in 
somatic cell hybrid 20XP3542-1-4 (Stallings et al. 1988), that initiated the studies presented here. 
By identification of a translocation breakpoint across the fourth intron of the CKMM gene, we 
have established a fixed demarcation point that may serve to position all other loci in the DM-
relevant area. Combining all our results yields the following absolute gene order: cen-APOC2-
CKMM-ERCC2-ERCCl-ter. The APOC2 gene maps proximal to the t(X;19) breakpoint across 
the CKMM gene and both repair genes map distal to that breakpoint. Similarities between 
fragments determined by the CKMM and ERCC2 probes (i.e., EcoRI-, M lul-, and 5аЛ-
generated fragments), which were not detected by ERCC1, establishes the location of ERCC2 
between CKMM and ERCC1. The cen-3'5'-ter orientation of the CKMM gene was determined 
from analysis of derivatives of the GM0089 cell line. The orientation of the ERCC2 gene was 
inferred from the positions of EcoRI restriction sites in the CKMM and ERCC2 genes, as 
indicated in figure 2. Restriction-site mapping of the CKMM gene has revealed the presence of 
an EcoRI cleavage site at about l.S kb downstream from the CKMM polyadenylation site. In the 
ERCC2 gene no less than three EcoRI sites, all S' upstream of the region recognized by probe 
pKER2, have been demonstrated (see Weber et al. 1988, fig. 2). This determines a tandem 
arrangement of cen-3'CKMM 5,-3'ERCC2 5'-ter. 
The physical distance between the EcoRI sites in the CKMM and ERCC2 genes -i.e., the 
length of the common hybridizing fragment- was roughly estimated to be 40 kb. This means that 
the cap site of the CKMM gene and the polyadenylation site of the ERCC2 gene are no more 
than 25 kb apart. Attempts to confirm this result by isolation of cosmid clones that overlap both 
genes are in progress. 
The orientation of the ERCC1 gene can be inferred from the location of the Noll site in its 5' 
region, which flanks the 250 kb fragment. This means that the ERCC2 and CKMM gene are in 
the 3' region of ERCC1, establishing a ter-5' ERCC1 З'-cen orientation. The distance separating 
the ERCC1 and CKMM genes can be calculated from the fragment sizes given in figure 2 and is 
currently estimated to be a maximum of 250 kb (i.e., the size of the common Noti fragments) 
and a minimum of about 200 kb (i.e., the size of the Sfil fragment specific for ERCC2 plus the 
Sß fragment detected by the ERCC1 3' probe Bal.0). 
It appears likely that there is a CpG island at the 5' end of ERCC1. The presence of 
recognition sites for enzymes as Noll, M lul, Sacll, and Sfil in such close proximity are consistent 
with the definition of such islands. In addition, doing the same analysis with cDNA from ERCC2 
and CKMM, which also reveal large Hmdlll fragments, shows no deviation from the normal 
Hindlll pattern, suggesting the absence of such an island for these two genes (data not shown). 
Whether (a) the presence of CpG islands 5' of these closely spaced genes and (b) their common 
head-to-tail arrangement are relevant for their regulation is an interesting question that remains to 
be resolved. Transcription interference phenomena have been observed for gene pairs with 
opposite transcription directions (Adhya and Gottesman 1982; CuUen et al. 1984; Kadesch and 
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Berg 1986) and may have played a role in the selection of the most appropriate orientation 
during evolution of this gene cluster. 
The physical distance between CKMM and APOC2 could not be determined but is at least 260 
kb. On the basis of genetic studies, these genes are considered to be extremely tightly linked at a 
recombination fraction of .01-.02 and a lod score (Z) of more than 140 (Le Beau et al. 1989). 
This indicates either that any straightforward comparison between genetic and physical distances 
in the ql3 area is impossible or, a more trivial possibility, that the distance separating both genes 
simply cannot be bridged because too many non-overlapping small-sized restriction fragments are 
generated from this area. A map of the entire CKMM-ERCC2-ERCC1 region, summarizing our 
results, is depicted in figure 2. 
From linkage studies in DM families it has become evident that the mutation(s) underlying 
myotonic dystrophy are located distal to APOC2 and CKMM and proximal to the loci recognized 
by probes pEFD4.2 (D19S22; Nakamura et al. 1988; Brunner et al. 1989b) and probe pEWRBl 
(MacKenzie et al. 1989). These loci are at 13 cM (Z^ > 10) and at 9 cM ( Z _ = 15.45) from 
DM, respectively. Between CKMM and DM as yet only 3 confirmed crossovers have been found 
in affected family members, in about 300 méioses tested (Brunner et al. 1989a; Le Beau et al. 
1989). We consider this strong evidence for any DM-candidate gene to be situated within a 
relative small segment of 19ql3, telomeric from CKMM. Candidate genes from this area -such 
as the antisense transcribed sequence, which overlaps the ERCC1 3' region and is located 
between ERCC1 and ERCC2 (van Duin 1988), or various DNA elements associated with CpG-
islands- have to be tested by performing detailed comparisons between DNAs from DM patients 
and normal individuals. 
Somatic cell hybrids -including hybrid 20ХРЭ542-1-4 (Stellings et al. 1988), which contains the 
greater part of the segment of interest, and hybrids GM89A99C-7 (Mohandas et al. 1980) and 
908K1 (Hulsebos et al. 1986), which contain the reciprocal 19;X translocation products with the 
breakpoint in the CKMM gene- will prove particularly valuable as starting or reference material 
for attempts to approach the DM gene by molecular cloning. The CKMM-ERCC area charac­
terized here should serve not only as an ideal starting point to further complete the physical map 
of 19ql3 but also as an easily distinguishable landmark in genetic studies in DM families once 
new markers are identified. 
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SUMMARY 
Variable simple sequence motifs (VSSMs), or microsatellites, were used for the genetic 
delimitation of the myotonic dystrophy (DM) region at 19q. Three simple sequence motifs were 
identified in and around the ERCCl DNA-repair gene at 19ql3.2-13.3 and one in the vicinity of 
the RRAS gene at 19ql3.3-qter. A (TG). repeat, situated within the ninth intron of the ERCCl 
gene, was converted into a highly informative multiallelic marker using PCR-mediated DNA 
amplification and high-resolution gel analysis. The structurally similar sequence motif in the 
RRAS gene yielded a marker system with only two alleles. Use of these VSSMs for linkage 
analysis and haplotyping in a selected set of DM families revealed that the DM gene is distal but 
close to the ERCCl locus and can be excluded from the CKM-ERCCl interval at 19ql3.2. The 
order for RRAS and other distally located markers was established as DM-D19S50-
[RRAS ,KLK]-D 19S22-ter. 
INTRODUCTION 
Variable simple sequence motifs (VSSMs; Smeets et al., 1989), or microsatellites, composed of 
variable numbers of mono-, di-, and trinucleotides, are ubiquitous sequences that have been 
identified recently as members of the diverse family of genomic elements that display frequent 
genetic variation. Polymorphism, visualized as length variation, is most commonly associated 
with (TG). or (CA), repeats (Tautz et al., 1986; Weber and May, 1989; Litt and Luty, 1989; 
Tautz, 1989; Smeets et al., 1989). Earlier we have reported on the identification and use of a 
highly informative (TG).(AG). motif in the apolipoprotein C2 (APOC2) gene as a marker for 
linkage analysis in myotonic dystrophy (DM) families (Smeets et al., 1989). Our results and 
those of others (Weber and May, 1989; Litt and Luty, 1989; Tautz, 1989) indicate that VSSMs 
constitute a particularly attractive source of polymorphic markers for genetic fme mapping, even 
though informativeness may vary considerably between individual loci. 
In an attempt to define the smallest genetic interval that spans the mutation underlying DM we 
initiated a search for VSSM markers in a segment of approximately 4 million bp just distal to the 
region encompassing the closest proximal markers, i.e., the creatine kinase muscle type (CKM) 
gene and the apolipoprotein C2,C1,E (APOC2,Cl,E) cluster at 19ql3.2 (Le Beau et al., 1989). 
A recently identified translocation breakpoint across the CKM gene (Smeets et al., 1990) forms a 
fixed starting and demarcation point for this endeavour. PFGE analysis revealed that the DNA-
repair genes ERCC2 and ERCCl are located within 2S0 kb distal to CKM (Smeets et al., 1990). 
Therefore, we started our search for SSMs in all available cloned DNA material from this area 
and in several cloned DNAs associated with genes from slightly more distal regions of 19q 
(Schonk et al., 1990). 
We report here on the identification of a highly variable dinucleotide repeat in the ERCCl gene 
at 19ql3.2-13.3 and a biallelic dinucleotide repeat in the RRAS gene at 19ql3.3-qter and on the 
mapping of these motifs in DM families with crossovers between DM and closely linked 19q 
markers such as APOC2 and D19SS0 (Brunner et al., 1989; Korneluk et al., 1989). Our studies 
show that the DM gene is located distal to ERCCl, which excludes the DM gene from the region 
between APOC2 and ERCCl and which makes the ERCCl VSSM the most closely linked 
proximal DM marker currently known. 
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MATERIALS AND METHODS 
Materials 
Peripheral blood samples were collected from myotonic dystrophy families as published 
elsewhere (Brunner et al., 1989). Clinical diagnosis of patients was based on the criteria 
established by Griggs et al. (1989). Blood DNAs used for in vitro DNA amplification with the 
polymerase chain reaction (PCR) technique (Saiki et al., 1988) were prepared according to 
standard procedures (Aldridge et al., 1984). Oligonucleotides used for priming the PCR or for 
the detection of simple sequence motifs (SSMs) were synthesized by automated DNA synthesis 
using the β-cyanoethyl amidite chemistry on a Cyclone DNA synthesizer (Biosearch-Milligen 
Co.). 
Isolation of Gene-Specific Recombinant Phages and Cosmids 
CKM- and ERCC1- and -2- specific phages were isolated from the sorted chromosome 19 
Charon 40 library (Lawrence Livermore Library, obtained from Dr. P. de Jong; De Jong et al. 
1989). Positive phages were identified using probes pKER2 specific for ERCC2 (Weber et al., 
1988), T56-4.2 and Bal.O specific for ERCC1 (van Duin, 1988), and рСКМЗ' and pBS2A 
(Coerwinkel-Driessen et al., 1988; Smeets et al., 1990) specific for CKM. For isolation of 
phages containing gene regions from prostate-specific antigen (APS), pancreas/kidney kallikrein 
(KLK) and RRAS, fragments from clone 4P1 (APS) and clone 7P1 (KLK) (Schonk et al., 1990) 
and an 870-bp Smal-EcoRI fragment subcloned from the RRAS gene (probe pUC12-Rl.l; Lowe 
et al., 1987) were used. ERCCl-specific cosmid 43-34 (a gift from Drs. M.van Duin and 
J.Hoeijmakers, Erasmus University Rotterdam) was described previously (Westerveld et al., 
1984). Additional CKM-specific phages were isolated from a human EMBL3 phage library 
(Mariman et al., 1987). Plaque purification of phage clones and phage- and cosmid-DNA 
isolation was accomplished according to standard methods (Sambrook et al., 1989). 
Identification of DNA Elements Containing Simple Sequence Motifs 
For detection of simple sequence motifs, oligonucleotides (TG^T, ÇTA),T, (AG)7A and 
(CAC)jCA, specific for sequences that frequently display repeat length polymorphism (Schäfer et 
al., 1988), were employed. Oligonucleotides were S'-end-labeled with [γ"Ρ]ΑΤΡ and T4-
polynucleotide kinase to a specific activity of ltf-109 cpm/jig and used for hybridization to filter-
immobilized phage, cosmid, or plasmid DNAs at a concentration of 0.5 χ ICf cpm/ml. Briefly, 
DNA-filters (GeneScreen Plus) were hybridized in S χ SSPE, 0.3% SDS, 10 jig/ml herring 
sperm DNA at 30ФС and washed twice for S min and once for 30 min under the same conditions 
without herring sperm DNA. DNA inserts from individual positive cosmid or phage DNAs were 
subcloned into pGEM3/4 vector plasmids in Escherichia Coli HB 101 bacteria using standard 
methodology (Sambrook et al., 1989). Di- or trinucleotide repeat-containing plasmids were 
identified by using colony hybridization. Segments spanning the simple sequence motifs and 
adjacent DNA areas were sequenced by the supercoil DNA sequencing procedure of Hattori and 
Sakaki (1986). 
PCR Amplification and Analysis of VSSM Markers 
Individual reaction cycles for in vitro DNA amplification with Tag DNA polymerase (Perkin-
Elmer Cetus) involved denaturation at 9S0C for 0.8 min, annealing at 55°C for l.S min, and 
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elongation at 72 e C for 0.5 min. After 40 cycles, a sample of 0.3-3 μ\ of the reaction mixture 
(Smeets et al., 1989) was mixed with an equal volume of formamide/dye buffer (94% 
formamide; 0.05% xylene cyanol; 0.05% bromophenol blue; lOmM EDTA, pH 7.2) and loaded 
directly on a 10% (w/v) acrylamide/bisacrylamide (19:1 w/w) sequencing gel, containing 8 M 
urea. All other procedures involving agarose and Polyacrylamide electrophoresis, electroblotting 
and hybridization with an oligonucleotide specific for the VSSM were performed exactly as 
described by Smeets et al. (1989). 
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GGTTGCAGTGAGCCGAGATTGTGCCATGCATCCAGCCTGGCCACAGCAGATGTCT (CA>13 AAAAAG (GA) 5 CCTGTCCAT 
GTGCCTGGCTCACACCTGTAATCCCAGCACTTTGGGAAGC 
SSMZ 
GCAGGGAGATGGGGAAGGTTAATGGGTAC (CA) 7 AAGAAAGAATGAATAAGACATACTAT 
ER1: GCAGGGAGATGGGGAAGGTTAATG 
ER2: ATAGTATGTCTTATTCATTCTTTC 
S 9 G 
AGTTTCCCGGGGGCAGACTACACAGGC (TGC)^ GCGCTTCTTCCGCTTCTTGTCCCGGCC 
SSM IN RRAS 
GCCTGGCTACAGAGTGAGACTCCATCTCAGAAAAA (CA).. AACAGAAAGGGTAGAATCGCCCTGTTGAAGGGAAAGTGGGG 
GTCTAGGC 
RAS1: ACAGAGTGAGACTCCATCTCAG 
RAS2: CACTTTCCCTTCAACAGGGCGA 
Flg. 1. Structure of the ERCCl gene region and localization of the simple sequence motifs (SSMs). (A) 
Organization of the ERCCl gene. The 10 exons are indicated by Roman numerals. Arrows indicate the 
localization of a (CA^fGA^ repeat (SSM1 arrow 1, exact position unknown), a (CAX repeat (SSM2 arrow 2) 
and a (TGC), repeat (SSM3 arrow 3). Abbreviations: В.ватНІ; К,Д/>лІ. (В) Sequences of the SSM repeats 
and flanking regions in ERCCl and RRAS. Oligonucleotides ERI and ER2 and RASI and RAS2 used for 
priming the polymerase chain reaction are given. The Alu repeat adjacent to SSM1 is underlined. 
RESULTS AND DISCUSSION 
Strategy for Approaching the DM Gene 
In deciding which strategies to use for approaching the DM mutation within the interval flanked 
by CKM and D19S50 at 1 and 9 cM, respectively (Bninner et al., 1989; Komeluk et al., 1989) 
we took the following facts into consideration: (i) No cytogenetic aberrations have been found 
A . 
TER 
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associated with myotonic dystrophy, (ii) The physical content of the pertinent 19ql3.3 area is 
still grossly uncharacterized. Size estimates range between 3 and S million bp of DNA, an area 
far too large to evaluate all expressed sequences as candidate genes for DM. PFGE analysis has 
shown (Smeets et al., 1990) that the region is extremely rich in CG islands and may contain a 
high density of expressed sequences. Four genes (CKM, ERCC2, ERCCl, and ASE1) have 
already been identified in a DNA segment of only 250 kb, confirming this hypothesis (van Duin 
1988; Smeets et al., 1990). (iiì) As the genetic distance between the closest proximal and distal 
markers are narrowed down, conventional two-allele RFLP systems will be insufficiently 
informative for haplotype analysis. Further progress toward the identification of the DM mutation 
is likely to come from the development of highly informative markers from physically precisely 
located DNA regions. These can be used to analyze those DM families that have recombinations 
between DM and D19S50, DM and CKM (3 cases reported, worldwide) or between DM and the 
apolipoprotein cluster, for which CKM was uninformative. 
Identification and Characterization of Simple Sequence Motifs 
Overlapping phage clones for five loci, the CKM, ERCCl, ERCC2, RRAS, and KLK/APS 
genes, known to be located in the DM-relevant segment (Schonk et al., 1990) were isolated from 
a sorted chromosome 19 charon 40 library (Lawrence Livermore National Laboratories). Purified 
DNAs from each of these phages, together with DNAs from cosmid 43-34 (ERCCl; van Duin, 
1988) and CKM-containing EMBL3 phages, (Mariman et al., 1987), when screened with the '2P-
labeled oligonucleotides (TG^T, (TA),T, (AG)7A and (CACICA, yielded only positive 
hybridization for the (TG)7T probe on the ERCCl and RRAS DNA clones. Subsequent 
subcloning and sequencing revealed the presence of two (TG).-containing segments (SSM1 and -
2) and one -fortuitously identified - (TGC). repeat (SSM3) within the ERCCl gene. The 
sequences and the presumptive locations of these motifs are shown in Fig. 1. The (TG), motif in 
the RRAS gene region could not be mapped precisely because details regarding the sequence and 
the structural organization of this gene were lacking until now. 
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Flg. 2. Pedigree of a large myotonic dystrophy family screened with ERCCl VSSM2. (A) In the entire 
family 6 alleles are distinguishable (indicated by numbers, see Table I); DM cosegtegates with allele 6. (B) 
Autoradiogram of PCR-amplified DNAs of part of the family, screened with the (TG>,T oligonucleotide. 
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For ERCCl loci SSM2 and SSM3, PCR primers were designed to be used for detection of 
allelic variation. SSM1 was located immediately adjacent to an Alu repeat (Fig. IB) and we 
failed to identify unique primers. For the SSM2 motif, situated next to the Kpnl site present in 
intron IX (Fig. 1A), PCR primers were chosen to yield a PCR segment of approximately 80 
nucleotides (Fig. IB). Analysis on agarose gels of the PCR amplification products from total 
genomic DNA and ERCCl cosmid and phage DNAs revealed a unique band in all cases (not 
shown), indicating that the SSM2-oligomer combination indeed was specific for the ERCCl gene 
and occurred only once in the human genome. Identical results were obtained for the 
amplification product of locus SSM3. For more detailed analysis, products of various individuals 
were resolved on sequencing gels. Unfortunately, the triplet motif SSM3 did not display any 
length variation (not shown). In contrast, on the autoradiograms from SSM2 (examples shown in 
Fig. 2B and ЗА), we could discern at least 8 distinct alleles. Allele designations and frequencies 
are given in Table 1. 
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Flg. 3. Pedigree of our ERCCl-DM crossover family. (A) Autoradiogram of the ERCCl VSSM2 alleles in 
this family. (B) Haplotypes of all relevant markers from the 19ql2-13 area tested. The family does not show 
a recombination between DM and the D19S50 locus. 
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Using unique PCR primers (Fig. IB) to amplify a 90-bp DNA fragment containing the RRAS 
(TG). motif, we similarly demonstrated repeat length variability between individuals, albeit to a 
much lesser degree (Fig. 4). As yet, in a total of 12 DNAs from unrelated individuals, we have 
detected only two alleles comprising either a (TG)10 or a (TG),, motif with frequencies of 0.67 
and 0.33, respectively. For reasons unknown, it appeared that the amount of specific PCR 
product from the RRAS locus was consistently several-fold higher than that seen for the ERCC1 
VSSM2. To avoid the reassociation of single-stranded DNAs and the appearance of additional 
bands, we therefore loaded only minute fractions of the RRAS PCR products on sequencing gels. 
Earlier findings have shown that the informativity of the microsatellites is strongly dependent 
on the locus used (Weber and May, 1989; Litt and Luty, 1989; Smeets et al., 1989). This 
observation is corroborated by our findings for the ERCC1 VSSM2 and the RRAS (TG). motifs. 
For ERCC1, despite the overrepresentation of the smallest allele (46%), we can calculate a fairly 
high informativity with a corresponding PIC value of 0.66. In contrast, the RRAS VSSM, 
yielding only a two-allele system (PIC value 0.344), has no obvious advantages over any 
conventional two allelic RFLP marker system. When compared to other VSSMs (Weber and 
May, 1989) both marker systems have a lower informativity than the APOC2 VSSM (PIC value 
0.79), but are comparable to other loci with PIC values ranging from 0.31 to 0.69. 
Table 1: Allele Frequencies for the ERCC1 VSSMZ Marker 
Allele nimber Frequency (X) 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
46X 
9% 
-
-
5X 
3X 
27% 
5X 
3X 
2% 
Note. Allele 0 is the smallest and most abundant allele. 
Consecutive higher numbers correspond to the number of 
dinucleotide units differing between a given allele and 
allele 0. 
In a number of VSSMs, such as the ERCC1 VSSM2 shown here (and see also Weber and 
May, 1989; Litt and Luty, 1989), the dinucleotide repeats show a non-Gaussian length 
distribution and major and minor alleles can be discerned. This may reflect the existence of 
different mechanisms generating variability. Both slippage during replication and unequal 
crossover (Tautz et al., 1986; Litt and Luty, 1989) have been postulated. In addition, 
accumulating evidence points to a role of (TG)B.(AC), sequences in formation of Z-DNA 
(Haniford and Pulleyblank, 1983) or triple-helical DNA structures (Lee et al., 1989) which, in 
turn, may facilitate binding of eukaryotic topoisomerase II (Spitzner et al., 1990), stimulate 
homologous recombination and gene conversion events (Wahls et al., 1990), or cause 
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chromosomal translocations (Boehm et al., 1989) and deletions (Freund et al., 1989). Thus, quite 
in general, simple sequences are found in regions of greater chromosomal instability, but not 
much is known about the precise mechanisms involved in their evolution. Individual size 
variation and non-random distribution of alleles at distinct loci, therefore, may be most easiest 
explained by the influence of differentially acting evolutionary or topological constraints that 
favor certain repeat lengths. 
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Flg. 4. RRAS-VSSM in one of our DM pedigrees. By PCR amplification and (TG),T hybridization only 2 
alleles were identified; DM co-segregates with allele 1. 
Linkage analysis 
Mendelian inheritance of both the ERCCl SSM2 and the RRAS-specific VSSM marker was 
confirmed by testing their segregation behavior in various pedigrees. To localize the ERCCl 
VSSM2 system genetically, we decided not to perform extensive linkage analysis between this 
marker and various other 19q markers. Since we have shown that the ERCCl VSSM2 is within 
250 kb distal to CKM (Smeets et al., 1990), which is mapped at less than 1 cM from DM 
(Brunner et al., 1989), we expected to gain no additional information for this marker from 
extensive linkage analysis. Testing was therefore only performed in a few large DM families and 
in those families with known crossovers within the relevant area. For the ERCCl VSSM2 
marker in the large DM family displayed in Fig. 2A, we found at least six alleles (alleles 0, 1, 
4, 6, 7 and 8), of which DM always segregated with allele 6. Previously, we had identified two 
of the rare families that show recombinations between DM and the closely linked proximal 
markers APOE and APOC2 (Smeets et al., 1988; Brunner et al., 1989) as well as families with 
recombination events between DM and the distal loci D19SS0 and D19S22 (Brunner et al., 
1989). The haplotype analysis of a subset of those families for which the ERCCl VSSM2 
marker was informative is shown in Figs. 3 and S. In all families except one, the ERCCl locus 
cosegregated with loci within the APOC2-D19S50 interval spanning the DM locus. The only 
exception observed is the family shown in Figure 3. For this pedigree we had earlier established 
a recombination between the combined haplotype for the APOC2 gene locus (for details see 
Brunner et al., 1989) and both DM and the distal marker locus D19S50 (Komeluk et al., 1989). 
A summary of marker-typing data for this family is given in Fig. 3B. From our VSSM analysis 
(Fig. ЗА) we conclude that the crossover in this family separates DM and D19S50 from the 
ERCCl VSSM2 locus. To exclude all possible sources of errors, this family has been resampled 
144 
and patients were rediagnosed. As expected, our results are concordant with the physical location 
of the ERCCl gene close to the CKM gene and the apolipoprotein cluster. More importantly, our 
findings for the crossover family place DM distal to the entire APOC2-CKM-ERCCl interval 
and render ERCCl VSSM2 the closest known proximal marker for DM. The results with our 
family are corroborated by the recent findings of Shutler and co-workers (manuscript in 
preparation), who obtained similar evidence with an RFLP marker positioned 3' of the ERCCl 
gene. 
D19S15 
D19S19 
ApoE 
ApoC2 
CKMM 
ERCCl 
DM 
D19S50 
RRAS 
D19S22 
Fig. 5. Schematic representation of crossovers between various 19ql3 markers. Selected crossover events 
position ERCCl proximal to DM and RRAS between D19S50 and D19S22. The order of the other markers 
has been previously established (3, 13). Preliminary data on recombination distances in this region were 
reported by Le Beau et al. (14). · and о, informative proximal and distal loci; x, not determined. 
To position the RRAS VSSM locus genetically with respect to DM and various other 19q 
markers, we typed families with confirmed crossovers between the disease locus and the distal 
markers D19S50, D19S22 (Komeluk et al., 1989) or KLK (Mspl RFLP, Hermens et al., 1990), 
located at 9, 13, and 5-10 cM from DM, respectively. Both genes have been assigned to 
19ql3.3-qter, but are not present on hybrid 20XP3542-1-4 (Stallings et al., 1988; Schonk et al., 
1990). No other physical data are available to position them with respect to the D19S50 locus. A 
priori, the encoded products for the RRAS and the KLK loci, a protein involved in the signal-
transduction pathway (RRAS) and a serine protease (KLK), could not be excluded as candidate 
genes for DM. Based on the data shown in Figs. 4 and SB, involving only a single informative 
recombination event, we assign the RRAS gene distal to DM and D19S50 and proximal to 
D19S22. As none of the families tested was informative for both the RRAS and the KLK gene 
loci we are presently unable to position the RRAS gene with respect to the KLK locus. For the 
KLK a conventional, ill-informative, Mspl polymorphism (Hermens et al., 1990) has been 
identified. The map position of both genes exclude them from being candidates for DM (Brunner 
et al., in preparation). Although the RRAS and KLK genes are not closer to the DM-locus than 
D19S50, they are well suited to use in constructing haplotypes for the entire 19ql3.3 
chromosome area in DM families, if used in combination with the highly informative PRKCG 
(Johnson et al., 1988) and D19S22 loci. 
In conclusion, we have developed two new VSSM markers that provide a valuable asset for 
haplotype studies in DM families both for research and diagnostic purposes. With the ERCCl-
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VSSM2 marker we have developed a highly informative proximal marker, which is the closest 
currently known. 
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SUMMARY 
Myotonic dystrophy (DM) is the most frequent inherited muscular disorder 
among adults. This multisytem disease is characterized by myotonia, muscle 
wasting, cataract, mental deterioration and various other symptoms. The clinical 
picture is extremely variable and clearly depends on the age of onset. Usually 
the first symptoms appear in the third or fourth decade of life and affected 
individuals develop the classical pattern of myotonia and muscle wasting. At an 
age when they plan their families, many carriers of the DM gene are still 
clinically unaffected. The gene for DM displays autosomal dominant inheritance 
and is located on chromosome 19. For the studies discussed in this thesis, a 
molecular genetic analysis of the region on chromosome 19 carrying the DM 
gene, was initiated to improve both postnatal and prenatal diagnosis of 
individuals at risk of being gene carriers and, eventually, to identify the gene 
defect involved. 
In deciding which strategies to use for approaching the DM gene, we had to 
consider that biochemical studies did not provide a real clue to the primary 
defect involved in myotonic dystrophy and that no cytogenetic anomalies were 
found associated with the disease. Therefore, a combination of physical and 
genetic mapping strategies was applied to identify the chromosomal segment 
carrying the DM gene. As the DM gene co-segregated with markers of the 
proximal long arm of chromosome 19, we constructed genomic libraries from 
somatic cell hybrids, which contained the 19cen-ql3.2 region. We saturated this 
region of the long arm with more than 30 single copy probes. All these probes 
were physically mapped on panels of somatic cell hybrids, carrying different 
fragments of 19q. To establish the genetic distances of the probes and the 
segments to which they belonged, we employed three strategies to detect DNA 
polymorphisms. Initially, we screened for conventional restriction fragment 
length polymorphisms (RFLPs). One third of our single copy probes as well as 
a number of gene probes, which were also localized to 19q, turned out to be 
polymorphic and mainly two-allele systems were found. Later on, we 
introduced two other, powerful methods for the detection of small mutations at 
specific loci. Using allele specific oligonucleotides in combination with the 
polymerase chain reaction, we converted the apolipoprotein (APO) E marker, 
which is part of a cluster of 3 apolipoprotein genes (APOE, APOC1 and 
APOC2) on 19ql3.2, into a multi-allelic system. Moreover, we were among 
the first to realize the importance of simple sequence repeats as a general 
source of highly informative markers. As shown by us and others, variation of 
the number of (TG)n dinucleotides in the first intron of the APOC2 gene gives 
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rise to at least 10 alleles. It is clear that the multi-allelic appearance of (TG)n 
repeats (or Variable Simple Sequence Motifs or microsatellites) makes them 
extremely well suited for linkage analysis and DNA diagnostics. 
Using any of the polymorphic systems described above, we performed linkage 
analysis in myotonic dystrophy families and we were able to assign the DM 
gene to segment 19ql3.2-13.3, closely linked at 1 to 3 cM, but distal to the 
genes for APOC2 and creatine kinase M (CKM). These loci, as well as a 
marker that maps distal to DM, are present on a radiation-reduced hybrid cell 
line, containing only 2-5 Mb of chromosome 19 DNA. Clearly, this hybrid 
must contain the DM gene. The identification of a translocation breakpoint 
across the CKM gene in another somatic cell hybrid provided us with a further 
fixed demarcation point of the DM region. Therefore, a genomic library, 
encompassing this region, was constructed and new single copy probes were 
isolated and employed for polymorphism screening. Of these, probe pX75B 
(locus D19S112) is at the moment the most closely linked distal DM marker 
known. In addition, we constructed a long range restriction map around the 
CKM breakpoint and we were able to map the repair genes ERCC2 and 
ERCCl within 250 kb distal to CKM in the DM region. A specific search for 
(TG)n repeats in all clones available from this region, revealed the presence of 
such a repeat in the ERCCl gene. By screening the very few families with a 
crossover between DM and APOC2 and/or CKM, we were able to map 
ERCCl proximal to DM and to exclude the DM gene from the region between 
CKM and ERCCl. 
In conclusion, our studies have resulted in the isolation of a large number of 
polymorphic markers on 19q. These markers were implemented for the 
localization of the DM gene on 19ql3.2-13.3 and will be of value for the 
mapping of other disease loci as well. The identification of (TG)n repeats as 
polymorphic markers has dramatically improved the early diagnosis of DM. At 
the moment, presymptomatic diagnosis in DM families is performed almost 
exclusively by means of (TG)n-repeat markers. Finally, genetic studies have 
enabled us to narrow the region carrying the DM locus to a chromosome 19 
segment of 1 Mb or less. The precise regional assignment between two 
physically linked flanking markers has provided a solid basis for ongoing 
molecular studies, aimed at the isolation of the DM gene. 
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SAMENVATTING 
Myotone dystrofie, ook wel genoemd Dystrofia myotonica Curschmann-
Steinert of simpelweg DM, is de meest frequent voorkomende erfelijke spier-
aandoening onder volwassenen. Het klinisch beeld is sterk wisselend, maar 
betreft bijna altijd meerdere organen. Karakteristieke kenmerken zijn naast het 
spierverval (dystrofie) en de spierverkramping (myotonie), waaraan de naam 
van het ziektebeeld is ontleend, een specifieke vorm van staar en mentale 
veranderingen. In het merendeel van de gevallen openbaren de eerste 
symptomen zich tussen het twintigste en veertigste levensjaar. Dit houdt in dat 
mensen op een leeftijd dat zij kinderen willen, nog geen klinische verschijn-
selen hoeven te vertonen, maar toch dragers van het ziektegen kunnen zijn. 
Myotone dystrofie vertoont een dominant overervingspatroon en het is al sinds 
1954 bekend dat het genetisch defect op chromosoom 19 gelokaliseerd moet 
zijn. Het onderzoek dat beschreven is in dit proefschrift, is erop gericht om de 
post- en prenatale diagnostiek naar dragerschap van het DM-gen te verbeteren 
en tevens om uiteindelijk de oorzaak van myotone dystrofie op genniveau te 
bepalen. 
Bij onze overwegingen over de te volgen strategie heeft meegespeeld dat er 
biochemisch geen defect aanwijsbaar is dat het ziektebeeld bij patiënten kan 
verklaren. Bovendien is er cytogenetisch geen chromosomale verandering 
bekend die samengaat met DM, waardoor de precieze lokatie van het genetisch 
defect wordt onthuld. Wij hebben daarom gekozen om via moleculair 
biologische technieken stukjes DNA (probes) te isoleren van chromosoom 19 en 
deze fysisch en genetisch in kaart te brengen. De fysische kaart is voornamelijk 
gebaseerd op somatische celhybriden die verschillende fragmenten van 
chromosoom 19 bevatten, de genetische op koppelingsonderzoek in families, 
waarin myotone dystrofie voorkomt. Hiermee wordt het kleinste fysische 
segment bepaald dat de nauwst met DM gekoppelde probes bevat. Omdat DM 
overerft met probes, die op het proximale deel van de lange arm van 
chromosoom 19 gelokaliseerd zijn, zijn genomische banken gemaakt van 
somatische celhybriden die dit deel van het chromosoom bevatten. Uit deze 
banken zijn willekeurig 30 unieke probes geïsoleerd, die fysisch in kaart zijn 
gebracht op panels van somatische celhybriden met onderscheidbare fragmenten 
van chromosoom 19. Om deze probes genetisch in kaart te brengen en hun 
positie ten opzichte van het DM-locus te bepalen, is gezocht naar 
polymorfismen. In eerste instantie hebben wij ons gericht op conventionele 
polymorfe systemen, zoals restrictiefragmentlengtepolymorfismen (RFLPs). Een 
derde deel van onze probes, alsmede een aantal gekloneerde genen, die ook op 
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de lange arm van chromosoom 19 waren gelokaliseerd, detecteert dergelijke 
RFLPs. Omdat RFLPs slechts een deel van de variatie op DNA niveau 
weerspiegelen en meestal slechts een beperkte informativiteit hebben, zijn 
andere methoden opgezet om alle mutaties aan te kunnen tonen. Voor apolipo-
proteïn E (APOE), dat deel uitmaakt van een cluster van 3 genen, coderend 
voor de apolipoproteïnen E, Cl en C2, is de verder algemeen toepasbare 
methode geïntroduceerd om puntmutaties te kunnen gebruiken als 
polymorfismen voor koppelingsonderzoek. Een combinatie van allel-specifieke 
oligonucleotiden met in vitro amplificatie van DNA via de PCR-techniek, maakt 
de detectie van bekende puntmutaties in het APOE gen mogelijk, waarmee 
APOE omgevormd wordt tot een multiallelisch polymorf systeem. Verder zijn 
wij, samen met enkele andere groepen, de eersten geweest, die variatie in 
repeterende sequenties van dinucleotiden onderkenden als waardevolle 
polymorfismen. Met name sequenties van (TG)-dinucleotiden zijn hiervoor 
uitermate geschikt, omdat zij enerzijds ruim voorhanden zijn in het humane 
genoom en zich anderzijds manifesteren als multiallelsystemen. De variabiliteit 
wordt veroorzaakt, doordat het aantal dinucleotiden dat een dergelijke sequentie 
bevat, wisselt tussen individuen. In het eerste intron van het APOC2 gen is een 
(TG)n-sequentie aangetroffen, waarvan minimaal 10 allelen aantoonbaar zijn in 
de bevolking. Dit APOC2 (TG)n-polymorfisme is direct toepasbaar voor 
diagnostiek van myotone dystrofie. Meer algemeen blijken deze polymorfe 
systemen door hun hoge informativiteit ideaal te zijn voor DNA diagnostiek bij 
allerlei erfelijke ziekten en voor koppelingsonderzoek in families. 
Gebruikmakend van bovenstaande polymorfe systemen, is koppelings-
onderzoek verricht in families, waarin myotone dystrofie voorkomt. Het DM 
gen blijkt gelokaliseerd te zijn in het chromosomale segment 19ql3.2-13.3, 
nauw gekoppeld op 1-3 cM, maar distaal ten opzichte van de genen voor 
APOC2 en creatine kinase M (CKM). Deze beide genen zijn samen met een 
andere probe die distaal van het DM-locus ligt, aanwezig op een somatische 
celhybride, die slechts 2-5 Mb DNA van chromosoom 19 bevat. Het is 
duidelijk dat op deze cellijn ook het DM-gen aanwezig is. De identificatie van 
een translocatiebreekpunt in een van de intronen van het CKM-gen in een 
andere somatische celhybride verschaft ons een baken voor verder onderzoek in 
het chromosomale gebied dat het DM-gen bevat. Van dit gebied is een nieuwe 
genomische bank gemaakt en hieruit zijn een aantal unieke probes geïsoleerd, 
waarmee naar polymorfismen is gezocht. Een van deze probes, probe pX75B 
(D19S112), ligt distaal van het DM-locus en is op dit moment de nauwst 
gekoppelde distale probe. 
Verder is een gedetailleerde fysische kaart van het gebied rond CKM 
gemaakt. Als eerste konden hierop de repair-genen ERCC2 en ERCCl worden 
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geplaatst, binnen 250 kb distaal van CKM. Alle gekloneerde sequenties uit dit 
gebied zijn getest op de aanwezigheid van repeterende (TG)n-dinudeotiden. In 
het eerste intron van het ERCC1 gen is een dergelijke sequentie aangetoond. 
Via de paar resterende families met een recombinatie tussen het DM-locus en 
APOC2 en/of CKM, kon ERCC1 proximaal van DM worden geplaatst en werd 
een lokatie van het DM gen tussen CKM en ERCC1 uitgesloten. Via een 
dergelijke minitieuze benadering hebben wij de recombinatiebreekpunten in DM 
families exact vastgesteld en zijn de genetische grenzen bepaald, waarbinnen het 
DM gen gelegen moet zijn. 
Concluderend valt vast te stellen dat een groot aantal nieuwe probes van de 
lange arm van chromosoom 19 zijn geïsoleerd. Deze probes zijn gebruikt om 
de lokatie van het DM gen nader te bepalen, maar zij zijn ook zeer geschikt 
om andere ziekteloci in dit chromosomale gebied in kaart te brengen. Verder 
heeft de ontdekking van (TG)n sequenties als hooginformatieve polymoifismen 
de pre- en postnatale diagnostiek van myotone dystrofie sterk verbeterd. Het 
merendeel van de diagnostische vragen in families met myotone dystrofîe 
kunnen wij beantwoorden door het testen van enkel (TG)n polymorfismen. Tot 
slot hebben wij de positie van het DM gen kunnen preciseren van ergens op de 
lange arm van chromosoom 19 tot een discreet gebied van 1 miljoen baseparen 
of minder, tussen 2 fysisch gelokaliseerde, DM flankerende loei. Uit dit gebied 
moet het DM gen geïsoleerd worden, waarna de mutaties in het gen bij de 
patiënten bepaald kunnen worden. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd geboren op 30 september 1960 in 
Maastricht. Zijn middelbare schoolopleiding aan het St. Maartenscollege aldaar 
werd in het voorjaar van 1978 afgesloten met het diploma Gymnasium-jS. In het 
najaar startte hij met zijn studie biologie aan de Katholieke Universiteit te 
Nijmegen. Na 3 jaar werd het kandidaatsexamen biologie met hoofdvak chemie 
afgelegd. Tijdens de doctoraalfase werden twee bijvakstages gelopen op de 
afdelingen Chemische Cytologie en Cyto-Histologie, waarbij achtereenvolgens 
onderzoek werd verricht naar de biochemische oorzaken van longemfyseem 
o.l.v. Prof. Dr. Kuiper en naar immuunreacties en malaria-antigenen in een 
malaria-muis-model o.l.v. Dr. Eling. Zijn hoofdvakstage doorliep hij op het 
laboratorium van Prof. Dr. Schoenmakers, waar hij fundamenteel moleculair 
biologisch onderzoek verrichtte aan bacteriofaag Ike. Op 26 februari 1985 
studeerde hij af. Vanaf april 198S tot april 1990 werd het in dit proefschrift 
beschreven onderzoek verricht op de afdeling Anthropogenetica van het St. 
Radboudziekenhuis te Nijmegen. Aansluitend werd hij aangesteld als 
wetenschappelijk medewerker binnen de DNA-diagnostiekgroep van dezelfde 
afdeling. 
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STELLINGEN 
behorend bij het proefschrift 
"A Molecular Genetic Approach to Myotonic Dystrophy" 
van H.J.M. Smeets 
I 
Het myotone dystrofie locus is genetisch afgebakend tot een gebied 
van maximaal 1 miljoen nucleotiden. 
Dit proefschrift. 
Π 
Variabiliteit in repeterende sequenties van (TG)-dinucleotiden levert 
de meest geschikte polymorfismen voor genetisch onderzoek. 
Wijmenga et al., Lancet (1990) 336:651-653 en dit proefschrift. 
ΠΙ 
Mutaties veroorzaakt door een instabiele DNA-sequentie kunnen ten 
grondslag liggen aan anticipatie en variabele expressie bij myotone 
dystrofie. 
Sutherland et al, Lancet (1991) 338:289-292 
IV 
Zogenaamd specifieke lenstroebelingen vormen een gevaarlijke bron 
van foutieve diagnoses bij myotone dystrofie. 
Eigen waarneming. 
V 
De diagnose Alport syndroom moet gelden voor alle patiënten met 
ziekteverwekkende mutaties in het COL4A5-gen, ook als deze 
patiënten niet aan de klinische criteria beantwoorden. 
VI 
De expansie van een repeterende (CGG)-sequentie, leidend tot het 
fragiele X-syndroom (Verkerk et al., Cell (1991) 65:905-914), roept 
de vraag op of wij als populatie evolutionair op weg zijn naar 
mentale retardatie. 
П 
Door DNA-diagnostiek niet via research te ondersteunen, wordt 
adviesvragers optimale diagnostiek onthouden. 
ПІ 
Een geneticus die bij een voordracht rood-groene dia's vertoont, is 
een slecht geneticus. 
IX 
Pogingen om Mars tot leven te brengen, staan in schril contrast met 
de huidige activiteiten op aarde. 
X 
M.V.V. wordt binnen 25 jaar landskampioen. 
Nijmegen, 29 november 1991 


